Home HIV Medicine FAQ Unsubscribe Change Email Policy About Free Journals     

 
The Best Medical Websites:
Amedeo's Golden Links

  Bladder Cancer, January 2002

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1224 articles:
HTML format


 

Single Articles

  1. OBERMANN E, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J et al
    Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    J Pathol 2003; 199: 50-57.
    Abstract     Related articles   

  2. OLSBURGH J, Harnden P, Weeks R, Smith B, Joyce A, Hall G et al
    Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
    J Pathol 2003; 199: 41-9.
    Abstract     Related articles   

  3. GAZZANIGA P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I et al
    Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Ann Oncol 2003; 14: 85-90.
    Abstract     Related articles   

  4. LACOSTE-COLLIN L, Gomez-Brouchet A, Escourrou G, Delisle M, Levade T, Uro-Coste E
    Expression of p27(Kip1) in bladder cancers: immunohistochemical study and prognostic value in a series of 95 cases.
    Cancer Lett 2002; 186: 115
    Abstract     Related articles   

  5. WU AJ, Park II, Zhaung L, Lee C
    Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoptosis in prostate and bladder cancer cells.
    Prostate 2002; 53: 277-85.
    Abstract     Related articles   

  6. EIJAN AM, Piccardo I, Riveros MD, Sandes EO, Porcella H, Jasnis MA et al
    Nitric oxide in patients with transitional bladder cancer.
    J Surg Oncol 2002; 81: 203-208
    Abstract     Related articles   

  7. KUNIKATA H, Udono T, Nishikawa S, Tamai M
    Bilateral serous macular detachment in a patient with anaemic retinopathy secondary to gall bladder cancer.
    Br J Ophthalmol 2002; 86: 1456-7
    Abstract     Related articles   

  8. VAN RHIJN BW, Van Tilborg AA, Lurkin I, Bonaventure J, De Vries A, Thiery JP et al
    Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
    Eur J Hum Genet 2002; 10: 819-24
    Abstract     Related articles   

  9. JUFFS HG, Moore MJ, Tannock IF
    The role of systemic chemotherapy in the management of muscle-invasive bladder cancer.
    Lancet Oncol 2002; 3: 738-47.
    Abstract     Related articles   

  10. KOEA J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J
    Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    ANZ J Surg 2002; 72: 857-61.
    Abstract     Related articles   

  11. MAURY E, Lemant J, Dussaule JC, Penicaud Vedrine A, Offenstadt G
    A reversible paralysis.
    Lancet 2002; 360: 1660.
    Abstract     Related articles   

  12. MOORE LE, Smith AH, Eng C, Kalman D, DeVries S, Bhargava V et al
    Arsenic-related chromosomal alterations in bladder cancer.
    J Natl Cancer Inst 2002; 94: 1688-96
    Abstract     Related articles   

  13. CRESSWELL J, Wong WK, Henry MJ, Robertson H, Neal DE, Kirby JA
    Adhesion of lymphocytes to bladder cancer cells: the role of the alpha(E)beta(7) integrin.
    Cancer Immunol Immunother 2002; 51: 483-91
    Abstract     Related articles   

  14. VAN TILBORG AA, De Vries A, De Bont M, Groenfeld LE, Zwarthoff EC
    The random development of LOH on chromosome 9q in superficial bladder cancers.
    J Pathol 2002; 198: 352-358
    Abstract     Related articles   

  15. PASHOS CL, Botteman MF, Laskin BL, Redaelli A
    Bladder cancer.
    Cancer Pract 2002; 10: 311-22
    Abstract     Related articles   

  16. MICHAUD DS, Hartman TJ, Taylor PR, Pietinen P, Alfthan G, Virtamo J et al
    No Association between Toenail Selenium Levels and Bladder Cancer Risk.
    Cancer Epidemiol Biomarkers Prev 2002; 11: 1505-6
    Abstract     Related articles   

  17. ZEEGERS MP, Goldbohm RA, Bode P, Van Den Brandt PA
    Prediagnostic toenail selenium and risk of bladder cancer.
    Cancer Epidemiol Biomarkers Prev 2002; 11: 1292-7
    Abstract     Related articles   

  18. PARDALIDIS NP, Papatsoris AG, Kosmaoglou EV, Georganas C
    Two Cases of Acute Polyarthritis Secondary to Intravesical BCG Adjuvant Therapy for Superficial Bladder Cancer.
    Clin Rheumatol 2002; 21: 536-7
    Abstract     Related articles   

  19. SHU X, Wu W, Mosteller RD, Broek D
    Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.
    Mol Cell Biol 2002; 22: 7758-68
    Abstract     Related articles   

  20. STOEHR R, Knuechel R, Boecker J, Blaszyk H, Schmitt R, Filbeck T et al
    Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones.
    Lab Invest 2002; 82: 1553-61.
    Abstract     Related articles   

  21. MHAWECH P, Uchida T, Pelte MF
    Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
    Hum Pathol 2002; 33: 1136-40.
    Abstract     Related articles   

  22. WILLIAMS RD
    What’s new in urology.
    J Am Coll Surg 2002; 195: 663-74.
    Abstract     Related articles   

  23. SANDBERG AA
    Cytogenetics and molecular genetics of bladder cancer: A personal view.
    Am J Med Genet 2002; 115: 173-82
    Abstract     Related articles   

  24. LAMARRE-CLICHE M, Hernigou A, Boutouyrie P, Plouin PF, Azizi M
    Images in cardiovascular medicine. Pheochromocytoma of the urinary bladder.
    Circulation 2002; 106: 2143-4
    Abstract     Related articles   

  25. MULLER T, Bain G, Wang X, Papkoff J
    Regulation of epithelial cell migration and tumor formation by beta- catenin signaling.
    Exp Cell Res 2002; 280: 119-33
    Abstract     Related articles   

  26. CALABRO F, Sternberg CN
    Localized and locally advanced bladder cancer.
    Curr Treat Options Oncol 2002; 3: 413-28
    Abstract     Related articles   

  27. LAMM DL
    Superficial bladder cancer.
    Curr Treat Options Oncol 2002; 3: 403-11
    Abstract     Related articles   

  28. MARSH GM, Gula MJ, Youk AO, Cassidy LD
    Bladder cancer among chemical workers exposed to nitrogen products and other substances.
    Am J Ind Med 2002; 42: 286-95
    Abstract     Related articles   

  29. DE JONG IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W
    Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
    Eur J Nucl Med Mol Imaging 2002; 29: 1283-8
    Abstract     Related articles   

  30. GAERTNER RR, Theriault GP
    Risk of bladder cancer in foundry workers: a meta-analysis.
    Occup Environ Med 2002; 59: 655-63
    Abstract     Related articles   

  31. ASO Y
    Prevention of recurrent superficial bladder cancer.
    Curr Urol Rep 2002; 3: 335-6
    Abstract     Related articles   

  32. URIST MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP et al
    Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer.
    Am J Pathol 2002; 161: 1199-206
    Abstract     Related articles   

  33. SIEGEL M, Frost F, Tollestrup K
    #62-S ecological study of bladder cancer in counties with high levels of arsenic in drinking water.
    Ann Epidemiol 2002; 12: 512
    Abstract     Related articles   

  34. STERN MC, Johnson LR, Bell DA, Taylor JA
    XPD Codon 751 Polymorphism, Metabolism Genes, Smoking, and Bladder Cancer Risk.
    Cancer Epidemiol Biomarkers Prev 2002; 11: 1004-1011
    Abstract     Related articles   

  35. KEEGAN MT, Whatcott BD, Harrison BA
    Osteogenesis imperfecta, perioperative bleeding, and desmopressin.
    Anesthesiology 2002; 97: 1011-3
    Abstract     Related articles   

  36. NISHIYAMA T, Hanaoka K, Ochiai Y
    The median approach to transsacral epidural block.
    Anesth Analg 2002; 95: 1067-70, table of contents
    Abstract     Related articles   

  37. HIGHSHAW RA, Tunuguntla HS, Perez RV, Gandour-Edwards R, Evans CP
    Initial report of bladder carcinoma following combined bladder-drained pancreas and kidney transplantation.
    Clin Transplant 2002; 16: 383-386
    Abstract     Related articles   

  38. MEZZELANI A, Dagrada G, Alasio L, Sozzi G, Pilotti S
    Detection of bladder cancer by multitarget multicolour FISH: comparative analysis on archival cytology and paraffin-embedded tissue.
    Cytopathology 2002; 13: 317-25
    Abstract     Related articles   

  39. COLQUHOUN AJ, Mellon JK
    Epidermal growth factor receptor and bladder cancer.
    Postgrad Med J 2002; 78: 584-9
    Abstract     Related articles   

  40. HUANG WC, Taylor S, Nguyen TB, Tomaszewski JE, Libertino JA, Malkowicz SB et al
    KIAA1096, a Gene on Chromosome 1q, is Amplified and Overexpressed in Bladder Cancer.
    DNA Cell Biol 2002; 21: 707-15
    Abstract     Related articles   

  41. SUN W, Herrera GA
    E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Hum Pathol 2002; 33: 996-1000
    Abstract     Related articles   

  42. HOPMAN AH, Kamps MA, Speel EJ, Schapers RF, Sauter G, Ramaekers FC
    Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.
    Am J Pathol 2002; 161: 1119-25
    Abstract     Related articles   

  43. GRECO O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD
    Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.
    Gene Ther 2002; 9: 1403-11
    Abstract     Related articles   

  44. BARTOLOME PACHECO MJ, Martinez-Taboada VM, Blanco R, Rodriguez-Valverde V, Valle JI, Lopez-Hoyos M
    Reactive arthritis after BCG immunotherapy: T cell analysis in peripheral blood and synovial fluid.
    Rheumatology (Oxford) 2002; : 1119-25
    Abstract     Related articles   


  45. Index of suspicion.
    Pediatr Rev 2002; 23: 359-64
    Abstract     Related articles   

  46. NOMATA K, Noguchi M, Kanetake H, Tsuda N, Hayashi M, Yamashita S et al
    Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment.
    Cancer Chemother Pharmacol 2002; 50: 266-70
    Abstract     Related articles   

  47. AYESH S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W et al
    Possible physiological role of H19 RNA.
    Mol Carcinog 2002; 35: 63-74
    Abstract     Related articles   

  48. GONZALEZ-ANGULO AM, Orzano JA, Davila E
    Ifosfamide-induced encephalopathy.
    South Med J 2002; 95: 1215-7
    Abstract     Related articles   

  49. ISOTALO PA, Robertson SJ, Futter NG
    Urinary bladder urachal remnants underlying papillary urothelial carcinoma.
    Arch Pathol Lab Med 2002; 126: 1252-3
    Abstract     Related articles   

  50. EVANS AJ, Al-Maghrabi J, Tsihlias J, Lajoie G, Sweet JM, Chapman WB
    Primary large cell neuroendocrine carcinoma of the urinary bladder.
    Arch Pathol Lab Med 2002; 126: 1229-32
    Abstract     Related articles   

  51. MIZUTANI Y, Yoshida O, Ukimura O, Kawauchi A, Bonavida B, Miki T
    Prognostic significance of a combination of soluble fas and soluble fas ligand in the serum of patients with ta bladder cancer.
    Cancer Biother Radiopharm 2002; 17: 563-7.
    Abstract     Related articles   

  52. SUN X, Hu J, Yang Q
    Combined modality therapy following bladder conservation surgery for bladder cancers.
    Chin Med J (Engl) 2002; : 1548-51.
    Abstract     Related articles   

  53. ZENSER T, Lakshmi V, Hsu F, Davis B
    Metabolism of N-acetylbenzidine and initiation of bladder cancer.
    Mutat Res 2002; 506-507: 29
    Abstract     Related articles   

  54. YU M, Skipper P, Tannenbaum S, Chan K, Ross R
    Arylamine exposures and bladder cancer risk.
    Mutat Res 2002; 506-507: 21
    Abstract     Related articles   

  55. ROBBIANO L, Carrozzino R, Bacigalupo M, Corbu C, Brambilla G
    Correlation between induction of DNA fragmentation in urinary bladder cells from rats and humans and tissue-specific carcinogenic activity.
    Toxicology 2002; 179: 115-28
    Abstract     Related articles   

  56. KIM DO K, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E et al
    Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
    Biochim Biophys Acta 2002; 1565: 112-21
    Abstract     Related articles   

  57. BUGAJSKA U, Georgopoulos NT, Southgate J, Johnson PW, Graber P, Gordon J et al
    The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
    J Natl Cancer Inst 2002; 94: 1381-95
    Abstract     Related articles   

  58. KIM HT, Kim BC, Kim IY, Mamura M, Seong do H, Jang JJ et al
    Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.
    J Biol Chem 2002; 277: 32510-5
    Abstract     Related articles   

  59. SEN S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S et al
    Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer.
    J Natl Cancer Inst 2002; 94: 1320-1329
    Abstract     Related articles   

  60. LOPEZ-BELTRAN A, Luque RJ, Mazzucchelli R, Scarpelli M, Montironi R
    Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer.
    J Clin Pathol 2002; 55: 641-647
    Abstract     Related articles   

  61. STERN MC, Umbach DM, Lunn RM, Taylor JA
    DNA Repair Gene XRCC3 Codon 241 Polymorphism, Its Interaction with Smoking and XRCC1 Polymorphisms, and Bladder Cancer Risk.
    Cancer Epidemiol Biomarkers Prev 2002; 11: 939-943
    Abstract     Related articles   

  62. BURTON A
    Urine test for bladder cancer.
    Lancet Oncol 2002; 3: 522
    Abstract     Related articles   

  63. DOERGER K, Sykes AM
    A known risk factor for bladder cancer.
    Radiographics 2002; 22: 1290
    Abstract     Related articles   

  64. GEE J, Sabichi A, Grossman H
    Chemoprevention of superficial bladder cancer.
    Crit Rev Oncol Hematol 2002; 43: 277
    Abstract     Related articles   

  65. ENOKIDA H, Gotanda T, Oku S, Imazono Y, Kubo H, Hanada T et al
    Reversal of P-Glycoprotein-mediated Paclitaxel Resistance by New Synthetic Isoprenoids in Human Bladder Cancer Cell Line.
    Jpn J Cancer Res 2002; 93: 1037-46
    Abstract     Related articles   

  66. WAI CY, Miller DS
    Urinary Bladder Cancer.
    Clin Obstet Gynecol 2002; 45: 844-854
    Abstract     Related articles   

  67. HINOTSU S, Akaza H
    [Urology]
    Gan To Kagaku Ryoho 2002; 29: 1549-69
    Abstract     Related articles   

  68. STEIDL C, Simon R, Burger H, Brinkschmidt C, Hertle L, Bocker W et al
    Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium.
    J Pathol 2002; 198: 115-20
    Abstract     Related articles   

  69. HUANG HY, Ko SF, Chuang JH, Jeng YM, Sung MT, Chen WJ
    Primary yolk sac tumor of the urachus.
    Arch Pathol Lab Med 2002; 126: 1106-9
    Abstract     Related articles   

  70. REDMAN JF, Parham DM
    Extensive inflammatory eosinophilic bladder tumors in children: experience with three cases.
    South Med J 2002; 95: 1050-2
    Abstract     Related articles   

  71. COLT JS, Baris D, Clark SF, Ayotte JD, Ward M, Nuckols JR et al
    Sampling private wells at past homes to estimate arsenic exposure: a methodologic study in New England.
    J Expo Anal Environ Epidemiol 2002; 12: 329-34
    Abstract     Related articles   

  72. KERR P, Evely R, Pawade J
    Bladder chloroma complicating refractory anaemia with excess of blasts.
    Br J Haematol 2002; 118: 688
    Abstract     Related articles   

  73. PERERA ND
    Characterisation of a bladder cancer cohort in a urological unit.
    Ceylon Med J 2002; 47: 102
    Abstract     Related articles   

  74. KAJIWARA M, Mutaguchi K, Usui T
    [Ductal carcinoma of the prostate with multilocular cystic formation]
    Hinyokika Kiyo 2002; 48: 557-60
    Abstract     Related articles   

  75. MIWA S, Amano T, Takashima H, Takemae K
    [A case of carcinosarcoma of the urinary bladder]
    Hinyokika Kiyo 2002; 48: 553-5
    Abstract     Related articles   

  76. TANIGUCHI M, Miwa K, Takeuchi T, Sakai S, Takahashi Y, Ishihara S et al
    [Voiding function and sexual activity in patients following Hautmann neobladder construction]
    Nippon Hinyokika Gakkai Zasshi 2002; 93: 694-701.
    Abstract     Related articles   

  77. SANTACATERINA A, Settineri N, De Renzis C, Frosina P, Brancati A, Delia P et al
    Muscle-invasive bladder cancer in elderly-unfit patients with concomitant illness: can a curative radiation therapy be delivered?
    Tumori 2002; 88: 390-4.
    Abstract     Related articles   

  78. GELABERT MAS A, Bielsa Gali O
    [Saving surgical time with great hemostatic safety and efficiency using the LIGA-SURE system in complete pelvic urologic surgery]
    Arch Esp Urol 2002; 55: 839-41.
    Abstract     Related articles   

  79. INGELFINGER JR
    Nephrogenic adenomas as renal tubular outposts.
    N Engl J Med 2002; 347: 684-6
    Abstract     Related articles   

  80. MAZAL PR, Schaufler R, Altenhuber-Muller R, Haitel A, Watschinger B, Kratzik C et al
    Derivation of nephrogenic adenomas from renal tubular cells in kidney- transplant recipients.
    N Engl J Med 2002; 347: 653-9
    Abstract     Related articles   

  81. MUDUR G
    Researchers question ethics of diabetes drug trial.
    BMJ 2002; 325: 353
    Abstract     Related articles   

  82. ROYSTON P, Parmar MK
    Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
    Stat Med 2002; 21: 2175-97
    Abstract     Related articles   

  83. TALASKA G, Maier A, Henn S, Booth-Jones A, Tsuneoka Y, Vermeulen R et al
    Carcinogen biomonitoring in human exposures and laboratory research: validation and application to human occupational exposures.
    Toxicol Lett 2002; 134: 39-49
    Abstract     Related articles   

  84. YAMASHITA M, Rosser CJ, Zhou JH, Zhang XQ, Connor RJ, Engler H et al
    Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.
    Cancer Gene Ther 2002; 9: 687-91
    Abstract     Related articles   

  85. ZHOU JH, Rosser CJ, Tanaka M, Yang M, Baranov E, Hoffman RM et al
    Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression.
    Cancer Gene Ther 2002; 9: 681-6
    Abstract     Related articles   

  86. BUSCH C, Algaba F
    The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems.
    Virchows Arch 2002; 441: 105-8
    Abstract     Related articles   

  87. MEYER JP, Persad R, Gillatt DA
    Use of bacille Calmette-Guerin in superficial bladder cancer.
    Postgrad Med J 2002; 78: 449-54
    Abstract     Related articles   

  88. RIBEIRO-FILHO LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D et al
    CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Mol Carcinog 2002; 34: 187-98
    Abstract     Related articles   

  89. PELUCCHI C, La Vecchia C, Negri E, Dal Maso L, Franceschi S
    Smoking and other risk factors for bladder cancer in women.
    Prev Med 2002; 35: 114
    Abstract     Related articles   

  90. TIGUERT R, Lessard A, So A, Fradet Y
    Prognostic markers in muscle invasive bladder cancer.
    World J Urol 2002; 20: 190-5
    Abstract     Related articles   

  91. KUCZYK M, Machtens S, Bokemeyer C, Kollmannsberger C, Hartmann J, Kondoh M et al
    Surgical bladder preserving strategies in the treatment of muscle- invasive bladder cancer.
    World J Urol 2002; 20: 183-9
    Abstract     Related articles   

  92. SYED S, Weiss GR
    Management of locally advanced bladder cancer: early vs deferred chemotherapy.
    World J Urol 2002; 20: 175-82
    Abstract     Related articles   

  93. BRADLEY BA, Wajsman Z
    The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer.
    World J Urol 2002; 20: 167-74
    Abstract     Related articles   

  94. SAROSDY MF, Machtens S
    Advanced bladder cancer.Where are we now and where are we going?
    World J Urol 2002; 20: 143
    Abstract     Related articles   

  95. ZHANG Z, Zhang Z, Zeng G, Et Al
    Extracellular domain of kinase domain region mediated by adeno- associated virus inhibits growth and angiogenesis of bladder cancer in Balb-c mice.
    Chin Med J (Engl) 2002; : 1209-12
    Abstract     Related articles   

  96. ASANO T, Morimoto S, Kitami Y, Miyauchi T, Sakai K, Takagi K
    [Bladder cancer producing granulocyte colony-stimulating factor (G- CSF): a case report]
    Hinyokika Kiyo 2002; 48: 495-8
    Abstract     Related articles   

  97. STRANZL H, Gabor S, Mayer R, Prettenhofer U, Wurzinger G, Hackl A
    Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non- bronchogenic primaries.
    Strahlenther Onkol 2002; 178: 442-5
    Abstract     Related articles   

  98. BARLANDAS-RENDON E, Muller MM, Garcia-Latorre E, Heinschink A
    Comparison of urine cell characteristics by flow cytometry and cytology in patients suspected of having bladder cancer.
    Clin Chem Lab Med 2002; 40: 817-23
    Abstract     Related articles   

  99. ABDEL-HAKIM AM, Bassiouny F, Abdel Azim MS, Rady I, Mohey T, Habib I et al
    Laparoscopic radical cystectomy with orthotopic neobladder.
    J Endourol 2002; 16: 377-81
    Abstract     Related articles   

  100. MATIN SF, Gill IS
    Laparoscopic radical cystectomy with urinary diversion: completely intracorporeal technique.
    J Endourol 2002; 16: 335-41
    Abstract     Related articles   

  101. MADERSBACHER S, Studer UE
    Contemporary cystectomy and urinary diversion.
    World J Urol 2002; 20: 151-7
    Abstract     Related articles   

  102. LEHMANN J, Retz M, Stockle M
    Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
    World J Urol 2002; 20: 144-50
    Abstract     Related articles   

  103. DEL PRETE R, Ditonno P, Mosca A, Battaglia M, PaoloSelvaggi F, Miragliotta G
    BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy.
    J Infect 2002; 45: 112-4.
    Abstract     Related articles   

  104. OOSTERHUIS JW, Smeets AW, Janssen-Heijnen ML, Schapers RF, Pauwels RP, Newling DW
    Abnormalities detected in metaphase chromosomes in bladder carcinoma: prognostic value and comparison with histopathological factors.
    Virchows Arch 2002; 441: 187-93
    Abstract     Related articles   

  105. LOPEZ-BELTRAN A, Luque RJ, Moreno A, Bollito E, Carmona E, Montironi R
    The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases.
    Virchows Arch 2002; 441: 148-53
    Abstract     Related articles   

  106. KANNO T, Ito M, Kawase N, Taki Y, Hosaka N
    [A case of corpus cancer presenting with positive urine cytology]
    Hinyokika Kiyo 2002; 48: 479-81
    Abstract     Related articles   

  107. GLIGOROV J, Andre T, Epaud C, Culine S
    [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ]
    Bull Cancer 2002; 89 Spec No: S134-44.
    Abstract     Related articles   

  108. CULINE S
    [Gemcitabine and urogenital tumors]
    Bull Cancer 2002; 89 Spec No: S102-6.
    Abstract     Related articles   

  109. ASHWORTH DR, Whear NM
    Enophthalmos caused by metastatic breast carcinoma.
    Br J Oral Maxillofac Surg 2002; 40: 350-1.
    Abstract     Related articles   

  110. MIYAZAKI J, Ba-Thein W, Kumao T, Akaza H, Hayashi H
    Identification of a type III secretion system in uropathogenic Escherichia coli.
    FEMS Microbiol Lett 2002; 212: 221-8
    Abstract     Related articles   

  111. LEE YG, Macoska JA, Korenchuk S, Pienta KJ
    MIM, a Potential Metastasis Suppressor Gene in Bladder Cancer.
    Neoplasia 2002; 4: 291-4
    Abstract     Related articles   

  112. URRUTIA G, Serra C, Bonfill X, Bastus R
    [Incidence of urinary bladder cancer in an industrialized area of Spain]
    Gac Sanit 2002; 16: 291-7
    Abstract     Related articles   

  113. GU L, Wu J, Zhu BB, Li GM
    Deficiency of a novel mismatch repair activity in a bladder tumor cell line.
    Nucleic Acids Res 2002; 30: 2758-63
    Abstract     Related articles   

  114. ZHENG T, Cantor KP, Zhang Y, Lynch CF
    Occupation and bladder cancer: a population-based, case-control study in Iowa.
    J Occup Environ Med 2002; 44: 685-91
    Abstract     Related articles   

  115. FORD-DUNN S, Smith A, Sykes N
    Tumour-induced hypoglycaemia.
    Palliat Med 2002; 16: 357-8
    Abstract     Related articles   

  116. BLANES A, Rubio J, Martinez A, Wolfe HJ, Diaz-Cano SJ
    Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes.
    Am J Clin Pathol 2002; 118: 93-100
    Abstract     Related articles   

  117. WAX JR, Ross J, Marotto L, Pinette MG, Blackstone J
    Nonbilharzial bladder carcinoma complicating pregnancy--treatment with bacille Calmette-Guerin.
    Am J Obstet Gynecol 2002; 187: 239-40
    Abstract     Related articles   

  118. LEROY X, Leteurtre E, De La Taille A, Augusto D, Biserte J, Gosselin B
    Microcystic transitional cell carcinoma: a report of 2 cases arising in the renal pelvis.
    Arch Pathol Lab Med 2002; 126: 859-61
    Abstract     Related articles   

  119. OMEROGLU A, Paner GP, Wojcik EM, Siziopikou K
    A carcinosarcoma/sarcomatoid carcinoma arising in a urinary bladder diverticulum.
    Arch Pathol Lab Med 2002; 126: 853-5
    Abstract     Related articles   

  120. NAKAHATA K, Miyakoda M, Suzuki K, Kodama S, Watanabe M
    Heat shock induces centrosomal dysfunction, and causes non-apoptotic mitotic catastrophe in human tumour cells.
    Int J Hyperthermia 2002; 18: 332-43
    Abstract     Related articles   

  121. VAN DER STEEN-BANASIK EM, Visser AG, Reinders JG, Heijbroek RP, Idema JG, Janssen TG et al
    Saving bladders with brachytherapy: implantation technique and results.
    Int J Radiat Oncol Biol Phys 2002; 53: 622-9
    Abstract     Related articles   

  122. KASSIS J, Radinsky R, Wells A
    Motility is rate-limiting for invasion of bladder carcinoma cell lines.
    Int J Biochem Cell Biol 2002; 34: 762-75
    Abstract     Related articles   

  123. PELUCCHI C, Negri E, Franceschi S, Talamini R, La Vecchia C
    Alcohol drinking and bladder cancer.
    J Clin Epidemiol 2002; 55: 637
    Abstract     Related articles   

  124. NOMATA K, Sagara Y, Toubu S, Hakariya T, Tsuda S, Noguchi M et al
    [Feasibility and change in the level of blood paclitaxel concentration after paclitaxel therapy for a hemodialysis patient with cisplatin resistant metastatic transitional cell cancer]
    Gan To Kagaku Ryoho 2002; 29: 1247-50
    Abstract     Related articles   

  125. KILANI R, Tamimi Y, Karmali S, Mackey J, Hanel E, Wong K et al
    Selective cytotoxicity of gemcitabine in bladder cancer cell lines.
    Anticancer Drugs 2002; 13: 557-566
    Abstract     Related articles   

  126. KROBER SM, Aepinus C, Ruck P, Muller-Hermelink HK, Horny HP, Kaiserling E
    Extranodal marginal zone B cell lymphoma of MALT type involving the mucosa of both the urinary bladder and stomach.
    J Clin Pathol 2002; 55: 554-7
    Abstract     Related articles   

  127. MERCADANTE S, Villari P, Ferrera P
    Block of interdigital nerves for cancer pain.
    J Pain Symptom Manage 2002; 24: 3
    Abstract     Related articles   

  128. JICHLINSKI P, Marti A, Leisinger HJ
    [Fluorescence cystoscopy in bladder cancer: what future?]
    Ann Urol (Paris) 2002; : 264-8
    Abstract     Related articles   

  129. JAYET C, Deperthes D, Leisinger HJ
    [Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?]
    Ann Urol (Paris) 2002; : 258-63
    Abstract     Related articles   

  130. ISHII N, Yonese J, Tsukamoto T, Maezawa T, Fukui I, Ishikawa Y et al
    [Multiple synchronous primary malignant tumors of fibrosarcoma and squamous cell carcinoma in the urinary bladder: a case report]
    Nippon Hinyokika Gakkai Zasshi 2002; 93: 642-7
    Abstract     Related articles   

  131. SHVARTS O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS
    Positron emission tomography in urologic oncology.
    Cancer Control 2002; 9: 335-42
    Abstract     Related articles   

  132. CARRION R, Seigne J
    Surgical management of bladder carcinoma.
    Cancer Control 2002; 9: 284-92
    Abstract     Related articles   

  133. ROGERS L, Lopez A, Gillis A
    Priapism secondary to penile metastasis in a dog.
    Can Vet J 2002; 43: 547-9
    Abstract     Related articles   

  134. ALONSO JM, Fas MJ
    Malignant bladder tumor transurethral resection in a patient with acquired C1 inhibitor deficiency.
    Acta Anaesthesiol Scand 2002; 46: 740-3
    Abstract     Related articles   

  135. NAKATANI T, Kuratsukuri K, Uchida J, Sugimura K, Kuroki Y, Morikawa Y
    Nephrogenic adenoma of the bladder: two case reports and literature review.
    Hinyokika Kiyo 2002; 48: 463-6
    Abstract     Related articles   

  136. KOIE T, Kawaguchi T, Takahashi N
    [Intraarterial neoadjuvant chemotherapy with cisplatin effective against neuroendocrine carcinoma of the urinary bladder: a case report]
    Hinyokika Kiyo 2002; 48: 423-6
    Abstract     Related articles   

  137. KOIE T, Kawaguchi T, Takahashi N
    Orthotopic ileal neobladder reconstruction using a modified Goodwin method: functional outcome in 37 patients.
    Hinyokika Kiyo 2002; 48: 407-13
    Abstract     Related articles   

  138. LUMMEN G, Sperling H, Schneider T, Otto T, Rubben H
    [Urothelial carcinoma. Role of G-protein coupled receptors in cell movement and proliferation]
    Urologe A 2002; 41: 353-61
    Abstract     Related articles   

  139. RUBBEN H, Lummen G
    [Tumors in the elderly]
    Urologe A 2002; 41: 333-7
    Abstract     Related articles   

  140. AMIN MB, McKenney JK
    An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization/ International Society of Urological Pathology consensus classification system.
    Adv Anat Pathol 2002; 9: 222-32
    Abstract     Related articles   

  141. GROMOV PS, Ostergaard M, Gromova I, Celis JE
    Human proteomic databases: a powerful resource for functional genomics in health and disease.
    Prog Biophys Mol Biol 2002; 80: 3-22
    Abstract     Related articles   

  142. GELABERT MAS A
    [Basic sciences and urology]
    Actas Urol Esp 2002; 26: 500-3.
    Abstract     Related articles   

  143. GARCIA DE JALON MARTINEZ A, Sancho Serrano C, Trivez Boned MA, Valdivia Navarro P, Gonzalvo Ibarra A, Roncales Badal A et al
    [Urinary diversions and bladder enlargements]
    Actas Urol Esp 2002; 26: 467-80.
    Abstract     Related articles   

  144. CARVALHAL EF, Gill IS
    Laparoscopic cystectomy: indications and limitations.
    Arch Esp Urol 2002; 55: 721-9.
    Abstract     Related articles   

  145. HUDDLE KR
    Phaeochromocytoma by way of case reports.
    Cardiovasc J S Afr 2002; 13: 205-8.
    Abstract     Related articles   

  146. ZOU C, Guan Y, Zou C, Wang J, Wang LE, Liebert M et al
    N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines.
    Cancer Lett 2002; 180: 131-7
    Abstract     Related articles   

  147. ZOU C, Guan Y, Zou C, Wang J, Wang L, Liebert M et al
    N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines.
    Cancer Lett 2002; 180: 131
    Abstract     Related articles   

  148. GEETHA D, Tong BC, Racusen L, Markowitz JS, Westra WH
    Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent.
    Transplantation 2002; 73: 1933-6
    Abstract     Related articles   

  149. VON DER MAASE H, Steven K
    [Urinary bladder cancer]
    Ugeskr Laeger 2002; 164: 3052-6
    Abstract     Related articles   

  150. NAWROCKI S, Skacel T, Skoneczna I
    Pharmacotherapy of bladder cancer - practice and prospects.
    Expert Opin Pharmacother 2002; 3: 671-9
    Abstract     Related articles   

  151. STREETER EH, Harris AL
    Angiogenesis in bladder cancer-prognostic marker and target for future therapy.
    Surg Oncol 2002; 11: 85-100
    Abstract     Related articles   

  152. BASSI P
    BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer.
    Surg Oncol 2002; 11: 77-83
    Abstract     Related articles   

  153. RAGHAVAN D, Quinn D, Skinner DG, Stein JP
    Surgery and adjunctive chemotherapy for invasive bladder cancer.
    Surg Oncol 2002; 11: 55-63
    Abstract     Related articles   

  154. PRIMDAHL H, Von Der Maase H, Sorensen FB, Wolf H, ORntoft TF
    Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer.
    J Cancer Res Clin Oncol 2002; 128: 295-301
    Abstract     Related articles   

  155. GENTILE V, Mariotti G, Fattore F, Cardi A, Di Silverio F
    Metastases of the penile body from bladder cancer. A case report.
    Minerva Urol Nefrol 2002; 54: 129-30
    Abstract     Related articles   

  156. CULINE S
    The present and future of combination chemotherapy in bladder cancer.
    Semin Oncol 2002; 29: 32-9
    Abstract     Related articles   

  157. LIU MC, Gelmann EP
    P53 gene mutations: case study of a clinical marker for solid tumors.
    Semin Oncol 2002; 29: 246-57
    Abstract     Related articles   

  158. LAMMLE M, Beer A, Settles M, Hannig C, Schwaibold H, Drews C
    Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder.
    AJR Am J Roentgenol 2002; 178: 1483-8
    Abstract     Related articles   

  159. SAITOH H, Mori K, Kudoh S, Itoh H, Takahashi N, Suzuki T
    BCG effects on telomerase activity in bladder cancer cell lines.
    Int J Clin Oncol 2002; 7: 165-70
    Abstract     Related articles   

  160. ROEMER HC, Golka K, Schulze H, Loehlein D
    Two extrapulmonary neoplasms in a uranium miner.
    J R Soc Med 2002; 95: 302
    Abstract     Related articles   

  161. STREFFORD JC, Lillington DM, Steggall M, Lane TM, Nouri AM, Young BD et al
    Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.
    Cancer Genet Cytogenet 2002; 135: 139-46
    Abstract     Related articles   

  162. YAMAMOTO S
    Bladder cancer incidence in the world.
    Jpn J Clin Oncol 2002; 32: 224
    Abstract     Related articles   

  163. AKAZA H, Miyanaga N
    [Guideline for proper use of antineoplastic agents. Urologic cancer]
    Gan To Kagaku Ryoho 2002; 29: 1055-64
    Abstract     Related articles   

  164. RAMAZAN SEKEROGLU M, Aydin S, Dulger H, Yilmaz Y, Bayrakli H, Noyan T
    Diagnostic value of cytokeratin-18 as a tumor marker in bladder cancer.
    Clin Biochem 2002; 35: 327-31
    Abstract     Related articles   

  165. WERTHEIM M, Astbury N
    Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma.
    Br J Ophthalmol 2002; 86: 706
    Abstract     Related articles   

  166. STARTSEV VY
    The role of combined method in organ-sparing treatment of muscle- invasive bladder cancer recurrences.
    Arch Ital Urol Androl 2002; 74: 54-6
    Abstract     Related articles   

  167. OKA D, Noda Y, Takada S, Fujimoto N, Koide T, Yamazaki M et al
    [Sarcomatoid carcinoma of the urinary bladder: a case report]
    Hinyokika Kiyo 2002; 48: 375-7
    Abstract     Related articles   

  168. UEMURA M, Mukai M, Fukuhara S, Kanno N, Nishimura K, Miyoshi S et al
    [Squamous cell carcinoma of the renal pelvis after intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of upper urinary tract: a case report]
    Hinyokika Kiyo 2002; 48: 355-7
    Abstract     Related articles   

  169. MORI N, Noma M, Hara T, Yamaguchi S, Shibata K, Ishii T et al
    [A case of mucinous cystadenocarcinoma of the appendix penetrating the urinary bladder]
    Hinyokika Kiyo 2002; 48: 351-4
    Abstract     Related articles   

  170. MUTTARAK M, Lojanapiwat B, Chaiwun B, Wudhikarn S
    Preoperative diagnosis of bilateral tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guerin therapy for superficial bladder carcinoma.
    Australas Radiol 2002; 46: 183-5
    Abstract     Related articles   

  171. ARAI Y, Hiramatu M
    [Erectile dysfunction after radical cystectomy]
    Nippon Rinsho 2002; 60 Suppl 6: 396-9
    Abstract     Related articles   

  172. SHIMADA E, Tadokoro K, Watanabe Y, Ikeda K, Niihara H, Maeda I et al
    Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies.
    Transfusion 2002; 42: 766-73
    Abstract     Related articles   

  173. AL-ALI MA, Kashmoula DM, Haddad LF
    Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Saudi Med J 2002; 23: 695-9
    Abstract     Related articles   

  174. KILBURN K
    Improving a nurse-led flexible cystoscopy service through audit.
    Prof Nurse 2002; 17: 601-4
    Abstract     Related articles   

  175. BLANCO DIEZ A, Alvarez Castelo L, Suarez Pascual G, Fernandez Rosado E, Sanchez Rodriguez Losada J, Rodriguez Gomez I et al
    [Ureteroplasty using the appendix: apropos of a case]
    Arch Esp Urol 2002; 55: 564-8
    Abstract     Related articles   

  176. FERNANDEZ ROSADO E, Suarez Pascual G, Rodriguez Gomez I, Blanco Diez A, Alvarez Castelo L, Gomez Veiga F et al
    [Bladder choriocarcinoma: retrospective analysis of the de- differentiation of a transitional-cell papillary bladder carcinoma. Apropos of a case]
    Arch Esp Urol 2002; 55: 556-9
    Abstract     Related articles   

  177. LANZAS PRIETO JM, Alonso de la Campa JM, Guate Ortiz JL, Gonzalez Tuero J, Perez Garcia FJ, Gutierrez Garcia R et al
    [Fulminant hepatic insufficiency caused by diffuse intrasinusoidal liver metastases in a patient with transitional-cell carcinoma of the bladder]
    Arch Esp Urol 2002; 55: 547-51
    Abstract     Related articles   

  178. BHOJWANI AG, Mellon JK
    Contemporary cystectomy combined with ileal conduit or bladder substitution.
    Surg Oncol 2002; 11: 65-75
    Abstract     Related articles   

  179. ROY C, Merran S
    [Imaging and pathology of bladder tumors]
    J Radiol 2002; 83: 843-59, discussion 861-2
    Abstract     Related articles   

  180. CRISCI A, Giannarini G, Grossetti B, Selli C
    Jejunal loop interposition in the management of ureteral obstruction after ileal conduit diversion.
    Arch Ital Urol Androl 2002; 74: 95-7
    Abstract     Related articles   

  181. DEFIDIO L, Di Pinto A
    [Anterograde and retrograde ureteral stent placement using fluoroscopic guidance with a radio-opaque pusher]
    Arch Ital Urol Androl 2002; 74: 86-9
    Abstract     Related articles   

  182. TAKIGUCHI M, Watanabe T, Okada H, Kudo T, Yamada K, Yasuda J et al
    Rhabdomyosarcoma (botryoid sarcoma) of the urinary bladder in a Maltese.
    J Small Anim Pract 2002; 43: 269-71
    Abstract     Related articles   

  183. XIE DH, Tang XD, Xia SJ, Tan JM, Wang XH, Cai Y
    [Expression of NF-kappa B in human bladder cancer and its clinical significance]
    Ai Zheng 2002; 21: 663-7
    Abstract     Related articles   

  184. LEHNER R, Lucia MS, Jarboe EA, Orlicky D, Shroyer AL, McGregor JA et al
    Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.
    Appl Immunohistochem Mol Morphol 2002; 10: 134-8
    Abstract     Related articles   

  185. AKELE-AKPO MT, Hounasso PP, Akpo C, Deminiere C
    [Embryonal botryoid rhabdomyosarcoma of the bladder]
    Ann Pathol 2002; 22: 210-4.
    Abstract     Related articles   

  186. BLANCO DIEZ A, Alvarez Castelo L, Suarez Pascual GJ, Matheu Capo G, Lancina Martin JA, Gonzalez Martin M
    [Bladder metastasis of a stomach carcinoma. Presentation of a case]
    Actas Urol Esp 2002; 26: 436-9.
    Abstract     Related articles   

  187. MARTINEZ DIAZ F, Rico Galiano JL, Vicente Ortega V, Bernal Gilar M, Fontana Compiano LO, Ortuno Pacheco G
    [Nephrogenic bladder adenoma associated with glandular cystitis. Immunohistochemical study and significance]
    Actas Urol Esp 2002; 26: 416-9.
    Abstract     Related articles   

  188. HERRERA PUERTO J, Herrera Flores J, Barragan Casas JM, Galan Velasco JJ
    [Cutaneous metastasis of a transitional-cell bladder carcinoma]
    Actas Urol Esp 2002; 26: 413-5.
    Abstract     Related articles   

  189. LESUEUR F, Mesnil M, Delouvee A, Girault JM, Yamasaki H, Thiery JP et al
    NBT-II carcinoma behaviour is not dependent on cell-cell communication through gap junctions.
    Biochem Biophys Res Commun 2002; 294: 108-15
    Abstract     Related articles   

  190. BLAS A 3RD, McGill R, Sandroni S
    Case 4-2002: cancer-associated obstruction and glomerular damage.
    N Engl J Med 2002; 346: 1751-2
    Abstract     Related articles   

  191. SOULITZIS N, Sourvinos G, Dokianakis DN, Spandidos DA
    p53 codon 72 polymorphism and its association with bladder cancer.
    Cancer Lett 2002; 179: 175-83
    Abstract     Related articles   

  192. FENG Z, Hu W, Rom WN, Beland FA, Tang MS
    N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation.
    Biochemistry 2002; 41: 6414-21
    Abstract     Related articles   

  193. WILLIAMS SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J et al
    Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.
    Genes Chromosomes Cancer 2002; 34: 86-96
    Abstract     Related articles   

  194. MAGNO C, Melloni D, Gali A, Mucciardi G, Nicocia G, Morandi B et al
    The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin- 2.
    Immunol Lett 2002; 81: 235-8
    Abstract     Related articles   

  195. DALTON JT, Yates CR, Yin D, Straughn A, Marcus SL, Golub AL et al
    Clinical Pharmacokinetics of 5-Aminolevulinic Acid in Healthy Volunteers and Patients at High Risk for Recurrent Bladder Cancer.
    J Pharmacol Exp Ther 2002; 301: 507-512
    Abstract     Related articles   

  196. DROLLER MJ
    Bladder cancer: current diagnosis and treatment.
    Br J Surg 2002; 89: 630
    Abstract     Related articles   

  197. PATTON SE, Hall MC, Ozen H
    Bladder cancer.
    Curr Opin Oncol 2002; 14: 265-72
    Abstract     Related articles   

  198. LOSKOG A, Hedlund T, Wester K, de la Torre M, Philipson L, Malmstrom PU et al
    Human urinary bladder carcinomas express adenovirus attachment and internalization receptors.
    Gene Ther 2002; 9: 547-53
    Abstract     Related articles   

  199. LANGBEIN S, Szakacs O, Wilhelm M, Sukosd F, Weber S, Jauch A et al
    Alteration of the LRP1B gene region is associated with high grade of urothelial cancer.
    Lab Invest 2002; 82: 639-43
    Abstract     Related articles   

  200. SCHLEINITZ N, Bernit E, Harle JR
    Severe hemophagocytic syndrome after intravesical BCG instillation.
    Am J Med 2002; 112: 593-4
    Abstract     Related articles   

  201. MIYANAGA N, Tsukamoto S, Hattori K, Kawai K, Shimazui T, Uchida K et al
    [Chemotherapy and radiotherapy for urological cancer]
    Gan To Kagaku Ryoho 2002; 29: 709-16
    Abstract     Related articles   

  202. KURIZAKI Y, Fujiwara M, Nakazawa M, Yoneyama T
    [A case of stone formation in the Mainz pouch using appendix as the efferent limb: a case report]
    Nippon Hinyokika Gakkai Zasshi 2002; 93: 573-6
    Abstract     Related articles   

  203. FURUYA S, Ogura H, Shimamura S, Itoh N, Tsukamoto T
    [The value of using urinary red cell volume distribution curve of patients with positive urinary occult blood detected in a mass examination]
    Nippon Hinyokika Gakkai Zasshi 2002; 93: 525-31
    Abstract     Related articles   

  204. NIHO N, Shibutani M, Toyoda K, Sato H, Hirose A, Imaida K et al
    Dose- and time-response studies of sodium o-phenylphenate urinary bladder carcinogenicity in rats.
    Food Chem Toxicol 2002; 40: 715-22
    Abstract     Related articles   

  205. MOOG R, Burger AM, Brandl M, Schuler J, Schubert R, Unger C et al
    Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.
    Cancer Chemother Pharmacol 2002; 49: 356-66
    Abstract     Related articles   

  206. SIM DEL LC, Yeo WM, Chow VT
    The novel human HUEL (C4orf1) protein shares homology with the DNA- binding domain of the XPA DNA repair protein and displays nuclear translocation in a cell cycle-dependent manner.
    Int J Biochem Cell Biol 2002; 34: 487-504
    Abstract     Related articles   


  207. Can blood tests detect cancer early?
    Health News 2002; 8: 4
    Abstract     Related articles   

  208. WILKINSON EJ, Brown HM
    Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease.
    Hum Pathol 2002; 33: 549-54
    Abstract     Related articles   

  209. BROWN HM, Wilkinson EJ
    Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma.
    Hum Pathol 2002; 33: 545-8
    Abstract     Related articles   

  210. SWIERCZYNSKI SL, Epstein JI
    Prognostic significance of atypical papillary urothelial hyperplasia.
    Hum Pathol 2002; 33: 512-7
    Abstract     Related articles   

  211. DATTA SN, Allen GM, Evans R, Vaughton KC, Lucas MG
    Urinary tract ultrasonography in the evaluation of haematuria--a report of over 1,000 cases.
    Ann R Coll Surg Engl 2002; 84: 203-5
    Abstract     Related articles   

  212. XU K, Hou S, Du Z
    Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma.
    Chin Med J (Engl) 2002; : 743-5
    Abstract     Related articles   

  213. SONMEZER M, Ensari A, Ustun Y, Gungor M, Ortac F
    Primary lymphoma of the urinary bladder presenting as a large pelvic mass.
    J Pak Med Assoc 2002; 52: 228-30
    Abstract     Related articles   

  214. HENDSCH SA, Glover SD, Otis CN, Donovan JT
    Atypical glandular cells of undetermined significance from extramammary Paget’s of the bladder.
    Obstet Gynecol 2002; 99: 912-4
    Abstract     Related articles   

  215. VINCENZI B, Santini D, Spoto S, Finolezzi E, D’Angelillo RM, La Cesa A et al
    The antineoplastic treatment in the elderly.
    Clin Ter 2002; 153: 207-15
    Abstract     Related articles   

  216. THEANO T, Pelagia S, Konstantinos N, Petros K, Alfred B, Konstantinos D et al
    Lymphocyte activation by granulocyte macrophage-colony stimulating factor in human bladder cancer.
    J Exp Ther Oncol 2002; 2: 153-7
    Abstract     Related articles   

  217. MATVEEV BP, Figurin KM, Toktomushev AT
    [Results of organ-preserving therapy for invasive bladder cancer]
    Urologiia 2002; : 3-5
    Abstract     Related articles   

  218. CARRASCOSA LLORET C, Cremades Mira A, Sanchez Sanchis M, Rodrigo Guanter V, Beltran Armada JR, Sala Aznar A et al
    [Study of cathepsin D levels in invasive bladder cancer and its stroma. Correlation with tumor stage, cytological grade, lymph node metastasis and survival]
    Actas Urol Esp 2002; 26: 335-8
    Abstract     Related articles   

  219. CUESTA ALCALA JA, Ripa Saldias L, Aldave Villanueva J, Pascual Piedrola I, Solchaga Martinez A, Ponz Gonzalez M et al
    [Neuroendocrine small cell carcinoma of the bladder. Review of the literature and report of a case]
    Arch Esp Urol 2002; 55: 452-6.
    Abstract     Related articles   

  220. SEGURA MARTIN M, Salinas Sanchez A, Lorenzo Romero J, Hernandez Millan I, Gimenez Bachs JM, Virseda Rodriguez J
    [Complications after radical cystectomy in patients with bladder carcinoma]
    Arch Esp Urol 2002; 55: 383-93.
    Abstract     Related articles   

  221. FAUCONNET S, Lascombe I, Chabannes E, Adessi GL, Desvergne B, Wahli W et al
    Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells.
    J Biol Chem 2002; :
    Abstract     Related articles   

  222. REALE M, Intorno R, Tenaglia R, Feliciani C, Barbacane RC, Santoni A et al
    Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy.
    Cancer Immunol Immunother 2002; 51: 91-8
    Abstract     Related articles   

  223. SHARIEFF W
    Gall bladder cancer risk factors and genetic mutations in Pakistani women.
    Trop Doct 2002; 32: 122
    Abstract     Related articles   

  224. VECCHIONE A, Ishii H, Baldassarre G, Bassi P, Trapasso F, Alder H et al
    FEZ1/LZTS1 Is Down-Regulated in High-Grade Bladder Cancer, and Its Restoration Suppresses Tumorigenicity in Transitional Cell Carcinoma Cells.
    Am J Pathol 2002; 160: 1345-52
    Abstract     Related articles   


  225. Bladder Cancer.
    Harv Mens Health Watch 2002; 6: 3-6
    Abstract     Related articles   

  226. RODEL C, Grabenbauer GG, Kuhn R, Zorcher T, Papadopoulos T, Dunst J et al
    Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil.
    Int J Radiat Oncol Biol Phys 2002; 52: 1303-9
    Abstract     Related articles   

  227. ABU-NADER R, Terrell CL
    Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.
    Mayo Clin Proc 2002; 77: 393-7
    Abstract     Related articles   

  228. YAMADA H, Kuroda E, Matsumoto S, Matsumoto T, Yamada T, Yamashita U
    Prostaglandin E2 down-regulates viable Bacille Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro.
    Clin Exp Immunol 2002; 128: 52-8
    Abstract     Related articles   

  229. TSUKAMOTO M, Matsuyama H, Oba K, Yoshihiro S, Takahashi M, Naito K
    Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence.
    Cancer Genet Cytogenet 2002; 134: 41-5
    Abstract     Related articles   

  230. HANSON K
    BCG installations for bladder cancer and latent tuberculosis infection.
    Urol Nurs 2002; 22: 132-4
    Abstract     Related articles   

  231. EDWARDS J, Duncan P, Going JJ, Watters AD, Grigor KM, Bartlett JM
    Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
    J Pathol 2002; 196: 380-5
    Abstract     Related articles   

  232. TAKADA T, Honda M, Momohara C, Komori K, Fujioka H
    [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report]
    Hinyokika Kiyo 2002; 48: 239-42
    Abstract     Related articles   

  233. BLOOMFIELD DJ
    Bladder cancer--room for improvement.
    Clin Oncol (R Coll Radiol) 2002; : 139-40
    Abstract     Related articles   

  234. KURUMA H, Ao T, Murayama M, Mizoguchi H, Koshiba K
    [Subsequent upper urothelial cancer following bladder tumor]
    Hinyokika Kiyo 2002; 48: 199-202
    Abstract     Related articles   

  235. ADJEI AA
    Pemetrexed in the treatment of selected solid tumors.
    Semin Oncol 2002; 29: 50-3
    Abstract     Related articles   

  236. WOOLCOTT CG, King WD, Marrett LD
    Coffee and tea consumption and cancers of the bladder, colon and rectum.
    Eur J Cancer Prev 2002; 11: 137-45
    Abstract     Related articles   

  237. GRONAU S, Menz CK, Melzner I, Hautmann R, Moller P, Barth TF
    Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
    Virchows Arch 2002; 440: 436-40
    Abstract     Related articles   

  238. SEENATH MM, Parry DJ, Kessel D, Scott DJ
    Acute iliac stent thrombosis - an unusual complication following use of the Lloyd-Davies position.
    Eur J Vasc Endovasc Surg 2002; 23: 374-5
    Abstract     Related articles   

  239. WAX JR, Pinette MG, Blackstone J, Cartin A, McCrann DJ
    Nonbilharzial bladder carcinoma complicating pregnancy: review of the literature.
    Obstet Gynecol Surv 2002; 57: 236-44
    Abstract     Related articles   

  240. OTTO T, Luemmen G, Bex A, Suhr J, Goebell PJ, Raz A et al
    Tumor cell motility as a novel target in cancer--experimental and clinical results.
    Onkologie 2002; 25: 172-7
    Abstract     Related articles   

  241. LEISSNER J, Allhoff EP, Hohenfellner R, Wolf HK
    [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy]
    Zentralbl Chir 2002; 127: 315-21
    Abstract     Related articles   

  242. SCHAFFER M, Schaffer PM, Corti L, Gardiman M, Sotti G, Hofstetter A et al
    Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
    J Photochem Photobiol B 2002; 66: 157-64
    Abstract     Related articles   

  243. BORGAONKAR S, Jain A, Bollina P, McLaren DB, Tulloch D, Kerr GR et al
    Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.
    Clin Oncol (R Coll Radiol) 2002; : 141-7
    Abstract     Related articles   

  244. BOL MG, Baak JP, Janssen EA, Breeuwsma NG, de Bruin PC
    Further testing of morphometric grading in T(A,1) urothelial carcinomas of the urinary bladder and the additional value of p53 immunoquantitation.
    Anal Quant Cytol Histol 2002; 24: 114-20
    Abstract     Related articles   

  245. JAMES NJ, Ettelaie C, Bruckdorfer KR
    Inhibition of tissue factor activity reduces the density of cellular network formation in an in vitro model of angiogenesis.
    Biochem Soc Trans 2002; 30: 217-21
    Abstract     Related articles   

  246. CHAPMAN K
    The ProteinChip Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation.
    Biochem Soc Trans 2002; 30: 82-7
    Abstract     Related articles   

  247. MOHANTY NK, Malhotra V, Nayak RL, Arora RP
    Combined low-dose intravesical immunotherapy (BCG + interferon alpha- 2b) in the management of superficial transitional cell carcinoma of the urinary bladder: a five-year follow-up.
    J Chemother 2002; 14: 194-7
    Abstract     Related articles   

  248. CELIS JE, Celis P, Palsdottir H, Ostergaard M, Gromov P, Primdahl H et al
    Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas.
    Mol Cell Proteomics 2002; 1: 269-79
    Abstract     Related articles   

  249. FROST FJ, Chwirka J, Craun GF, Thomson B, Stomps J
    Physical injury risks associated with drinking water arsenic treatment.
    Risk Anal 2002; 22: 235-43
    Abstract     Related articles   

  250. BORRE S, Brustia D, Rosa F, Brondolo R, Rizzo G, Garavelli PL
    [Calmette-Guerin bacillus disseminated infection after intravesical instillation]
    Recenti Prog Med 2002; 93: 247-8
    Abstract     Related articles   

  251. VARO SOLIS C, Baez Perea JM, Garrido Insua S, Beltran Aguilar V
    [Signet-ring cell neoplasm. Unusual histologic variety as primary bladder tumor]
    Actas Urol Esp 2002; 26: 297-301.
    Abstract     Related articles   

  252. HERRERA PUERTO J, Barragan Casas JM, Galan Velasco JJ, Hoyos Fitto C, Pierna Manzano J, Isusquiza Garro I
    [Oat cell carcinoma of the bladder]
    Actas Urol Esp 2002; 26: 290-2.
    Abstract     Related articles   

  253. CID MOUTEIRA P, Ortiz Rey JA, Anton Badiola I, San Miguel Fraile P, Alvarez Alvarez C, Zungri Telo E et al
    [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness]
    Actas Urol Esp 2002; 26: 279-84.
    Abstract     Related articles   

  254. GARCIA LIGERO J, Navas Pastor J, Garcia Garcia F, Serrallach Orejas F, Sempere Gutierrez A, Rico Galiano JL et al
    [Acute hematuria as first manifestation of bladder urothelioma in a 17-year-old adolescent]
    Arch Esp Urol 2002; 55: 317-9.
    Abstract     Related articles   

  255. JAN CR, Lu YC, Jiann BP, Chang HT, Su W, Chen WC et al
    Novel effect of CP55,940, a CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels in bladder cancer cells.
    Chin J Physiol 2002; 45: 33-9
    Abstract     Related articles   

  256. LEE SJ, Cho SH, Park SK, Kim SW, Park MS, Choi HY et al
    Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk.
    Cancer Lett 2002; 177: 173-9
    Abstract     Related articles   

  257. ZAAK D
    [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier]
    MMW Fortschr Med 2002; 144: 24-6
    Abstract     Related articles   

  258. MIYAZAKI J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H
    Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells.
    FEMS Immunol Med Microbiol 2002; 33: 23-6
    Abstract     Related articles   

  259. FADL-ELMULA I, Kytola S, Leithy ME, Abdel-Hameed M, Mandahl N, Elagib A et al
    Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization.
    BMC Cancer 2002; 2: 5
    Abstract     Related articles   

  260. EROGLU M, Irmak S, Acar A, Denkbas EB
    Design and evaluation of a mucoadhesive therapeutic agent delivery system for postoperative chemotherapy in superficial bladder cancer.
    Int J Pharm 2002; 235: 51-9
    Abstract     Related articles   

  261. STIBOROVA M, Miksanova M, Havlicek V, Schmeiser HH, Frei E
    Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA.
    Mutat Res 2002; 500: 49-66
    Abstract     Related articles   

  262. GOLKA K, Prior V, Blaszkewicz M, Bolt HM
    The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
    Toxicol Lett 2002; 128: 229-41
    Abstract     Related articles   


  263. [Suspected bladder carcinoma. New rapid test with high sensitivity]
    MMW Fortschr Med 2002; 144: 65
    Abstract     Related articles   

  264. DAVIES BR, O’Donnell M, Durkan GC, Rudland PS, Barraclough R, Neal DE et al
    Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.
    J Pathol 2002; 196: 292-9
    Abstract     Related articles   

  265. GROAH SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF
    Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer.
    Arch Phys Med Rehabil 2002; 83: 346-51
    Abstract     Related articles   

  266. WANG ZP, Chen YR, Zheng RL, Lu JZ, Wang JJ
    Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
    Acta Pharmacol Sin 2002; 23: 257-262
    Abstract     Related articles   

  267. STAV K, Leibovici D, Siegel YI, Lindner A
    Leukemoid reaction associated with transitional cell carcinoma.
    Isr Med Assoc J 2002; 4: 223-4
    Abstract     Related articles   

  268. WEBSTER LR, McKenzie GH, Moriarty HT
    Organophosphate-based pesticides and genetic damage implicated in bladder cancer.
    Cancer Genet Cytogenet 2002; 133: 112-7
    Abstract     Related articles   

  269. ZHANG XM, Elhosseiny A, Melamed MR
    Plasmacytoid urothelial carcinoma of the bladder. A case report and the first description of urinary cytology.
    Acta Cytol 2002; 46: 412-6
    Abstract     Related articles   

  270. CHU YC, Han JY, Han HS, Kim JM, Suh JK
    Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings.
    Acta Cytol 2002; 46: 341-8
    Abstract     Related articles   

  271. BERTHELOT JM, Varin S, Caillon F, Prost A, Maugars Y
    Pseudomonas aeruginosa osteomyelitis of both ischia: a case report.
    J Bone Joint Surg Am 2002; 84-A: 441-4
    Abstract     Related articles   

  272. AZUMI M, Tokumitsu M, Saga Y, Hashimoto H, Kaneko S, Yachiku S et al
    [Nephrogenic adenoma of the bladder in children]
    Nippon Hinyokika Gakkai Zasshi 2002; 93: 495-8
    Abstract     Related articles   

  273. SCHATTNER A, Gilad A, Cohen J
    Systemic granulomatosis and hypercalcaemia following intravesical bacillus Calmette-Guerin immunotherapy.
    J Intern Med 2002; 251: 272-7
    Abstract     Related articles   

  274. NANAURA H, Yamada Y, Fukatsu H
    [A case of subcutaneous metastases from bladder cancer after radical cystouretherectomy]
    Hinyokika Kiyo 2002; 48: 179-81
    Abstract     Related articles   

  275. UEMURA M, Nishimura K, Hirai T, Kanno N, Mizutani S, Miyoshi S et al
    [Leiomyosarcoma and transitional cell carcinoma in the urinary bladder: a case report]
    Hinyokika Kiyo 2002; 48: 159-62
    Abstract     Related articles   

  276. DRISSI M, Amil T, Lebbar K, Amer A, Ben Ameur M
    [Inflammatory pseudo-tumor of the urachus: a case report]
    Ann Urol (Paris) 2002; : 138-41
    Abstract     Related articles   

  277. SAINT F, Salomon L, Quintela R, Cicco A, Abbou CC, Chopin DK
    [Classification, favorable characteristics, prevention and treatment of adverse side-effects associated with Bacillus Calmette-Guerin in the treatment of superficial bladder cancer]
    Ann Urol (Paris) 2002; : 120-31
    Abstract     Related articles   

  278. MARTIN SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC
    Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
    Am J Surg Pathol 2002; 26: 292-300
    Abstract     Related articles   

  279. SEIFERT P, Benedic M, Effert P
    Nerve fibers in tumors of the human urinary bladder.
    Virchows Arch 2002; 440: 291-7
    Abstract     Related articles   

  280. HELPAP B, Kloppel G
    Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
    Virchows Arch 2002; 440: 241-8
    Abstract     Related articles   

  281. VAN DEN BOSCH J, Kropman RF, Blok P, Wijermans PW
    Disappearance of a mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori.
    Eur J Haematol 2002; 68: 187-8
    Abstract     Related articles   

  282. BENIMETSKAYA L, Guzzo-Pernell N, Liu ST, Lai JC, Miller P, Stein CA
    Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells.
    Bioconjug Chem 2002; 13: 177-87
    Abstract     Related articles   

  283. CASOLI E, Di Fiore F, Longobardi S, Intilla O, Pone D
    [Metastatic penile lesions secondary to transitional cell carcinoma of the bladder: a rare cause of "malignant priapism"]
    Arch Ital Urol Androl 2002; 74: 48-9
    Abstract     Related articles   

  284. SIMEONE C, Tanello M, Rosini R, Botturi A, Tralce L, Sironi D et al
    ["Post-actinic pelvic disease" and the ureter: the post-actinic ureter]
    Arch Ital Urol Androl 2002; 74: 12-5
    Abstract     Related articles   

  285. GIACINTI L, Cauchi C
    [27th National Oncology Congress of the Italian Tumor Society. Part 2]
    Clin Ter 2002; 153: 79-83
    Abstract     Related articles   

  286. KREGE S, Hinke A, Otto T, Rubben H
    [Evaluation of ther complementary drug Factor AF2 as a supportive agent in management of advanced urothelial carcinoma. Prospective randomized multicenter study]
    Urologe A 2002; 41: 164-8
    Abstract     Related articles   

  287. TURK I, Davis JW, Deger S, Winkelmann B, Schonberger B, Schellhammer PF et al
    [Laparoscopic radical cystectomy with intracorporeal creation of a continent urinary diversion. Future or present?]
    Urologe A 2002; 41: 107-12
    Abstract     Related articles   

  288. CHOW SK, Looi LM, Loh CS, Yeap SS
    Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.
    Intern Med J 2002; 32: 114-6
    Abstract     Related articles   

  289. PU YS, Hour TC, Chen J, Huang CY, Guan JY, Lu SH
    Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
    Anticancer Drugs 2002; 13: 293-300
    Abstract     Related articles   

  290. ANDERSON CR, McNiel EA, Gillette EL, Powers BE, LaRue SM
    Late complications of pelvic irradiation in 16 dogs.
    Vet Radiol Ultrasound 2002; 43: 187-92
    Abstract     Related articles   

  291. KOMIAKOV BK, Gorelov SI, Novikov AI, Gorelov AI, Guliev BG, Idrisov ShN et al
    [Short-term outcomes of radical surgery for bladder cancer]
    Urologiia 2002; : 16-9
    Abstract     Related articles   

  292. QUEK P, Chin CM, Lim PH
    The role of BTA stat in clinical practice.
    Ann Acad Med Singapore 2002; 31: 212-6
    Abstract     Related articles   

  293. APAYDIN R, Gul U, Bahadir S, Siviloglu C, Ofluoglu I
    Dermatomyositis without muscle weakness associated with transitional cell carcinoma of the bladder.
    J Eur Acad Dermatol Venereol 2002; 16: 172-4
    Abstract     Related articles   

  294. KARAGAS MR, Stukel TA, Tosteson TD
    Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
    Int J Hyg Environ Health 2002; 205: 85-94
    Abstract     Related articles   


  295. New clinical data further supports accuracy of the Vysis UroVysion test.
    Expert Rev Mol Diagn 2002; 2: 93-4
    Abstract     Related articles   


  296. Fujirebio Diagnostics to develop cancer diagnostics.
    Expert Rev Mol Diagn 2002; 2: 93
    Abstract     Related articles   

  297. CHEN WC, Wu HC, Hsu CD, Chen HY, Tsai FJ
    p21 gene codon 31 polymorphism is associated with bladder cancer.
    Urol Oncol 2002; 7: 63-6.
    Abstract     Related articles   

  298. CHAMPETIER S, Fradet Y, Bachvarov D
    Identification of two genes differentially expressed upon different spatial configuration of the MGH-U3 human bladder cancer cells.
    Urol Oncol 2002; 7: 57-61.
    Abstract     Related articles   

  299. MIGNON F, Chevriere A, Mesurolle B, El Hajam M, Morel H, Lacombe P
    [Miliary induced by intravesical BCG immunotherapy for carcinoma of the bladder: CT Findings]
    J Radiol 2002; 83: 368-71.
    Abstract     Related articles   

  300. THIER R, Golka K, Bruning T, Ko Y, Bolt HM
    Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts.
    Toxicol Lett 2002; 127: 321-7
    Abstract     Related articles   

  301. FREITAS RN, Brasileiro-Filho G, Silva ME, Pena SD
    Bracken fern-induced malignant tumors in rats: absence of mutations in p53, H-ras and K-ras and no microsatellite instability.
    Mutat Res 2002; 499: 189-96
    Abstract     Related articles   

  302. ZHENG S, Zhang J, Di X, Xiao Z, Wang D, Li C et al
    [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder]
    Zhonghua Yi Xue Za Zhi 2002; 82: 161-3
    Abstract     Related articles   

  303. PRIMDAHL H, Wikman FP, von Der Maase H, Zhou Xg X, Wolf H, Orntoft TF
    Allelic Imbalances in Human Bladder Cancer: Genome-Wide Detection With High-Density Single-Nucleotide Polymorphism Arrays.
    J Natl Cancer Inst 2002; 94: 216-223
    Abstract     Related articles   

  304. SHARP JD, Hausladen DA, Maher MG, Wheeler MA, Altieri DC, Weiss RM
    Bladder cancer detection with urinary survivin, an inhibitor of apoptosis.
    Front Biosci 2002; 7: E36-E41
    Abstract     Related articles   

  305. LEVETT D, Flecknell PA, Rudland PS, Barraclough R, Neal DE, Mellon JK et al
    Transfection of S100A4 Produces Metastatic Variants of an Orthotopic Model of Bladder Cancer.
    Am J Pathol 2002; 160: 693-700
    Abstract     Related articles   

  306. COTHREN C, Ferucci P, Harken AH, Veve R, Finlayson CA, Johnson JL
    Urachal carcinoma: key points for the general surgeon.
    Am Surg 2002; 68: 201-3
    Abstract     Related articles   

  307. ZHANG DS, Lin GF, Ma QW, Shen JH
    Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population.
    Acta Pharmacol Sin 2002; 23: 188-92
    Abstract     Related articles   

  308. MCMAHON RF, Hunt CR
    In situ adenocarcinoma of the bladder: the role of the urachus.
    Am J Surg Pathol 2002; 26: 271-2
    Abstract     Related articles   

  309. OLIVA E, Amin MB, Jimenez R, Young RH
    Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Am J Surg Pathol 2002; 26: 190-7
    Abstract     Related articles   

  310. PAGES F, Lebel-Binay S, Vieillefond A, Deneux L, Cambillau M, Soubrane O et al
    Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer.
    Clin Exp Immunol 2002; 127: 303-309
    Abstract     Related articles   

  311. MITSUMORI K, Sato K, Kato T
    [Intra-arterial chemotherapy in urological cancer]
    Gan To Kagaku Ryoho 2002; 29: 197-203
    Abstract     Related articles   

  312. NAGUIB M, Caceres M, Thomas CR Jr, Herman TS, Eng TY
    Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature.
    Am J Clin Oncol 2002; 25: 42-4
    Abstract     Related articles   

  313. VON DER MAASE H
    Current and future perspectives in advanced bladder cancer: Is there a new standard?
    Semin Oncol 2002; 29: 3-14
    Abstract     Related articles   

  314. LEONARD C, Huret JL, Gfco
    [From cytogenetics to cytogenomics of bladder cancers]
    Bull Cancer 2002; 89: 166-173
    Abstract     Related articles   

  315. ZEEGERS MP, Goldbohm RA, van den Brandt PA
    A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).
    Cancer Causes Control 2002; 13: 83-90
    Abstract     Related articles   

  316. NOEL G, Mazeron JJ
    [Report on the 43rd Congress of the American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco, 4-8 November 2001]
    Cancer Radiother 2002; 6: 50-8
    Abstract     Related articles   

  317. NOWITZ A, Artru AA
    Air embolism during radical cystectomy with ileal conduit urinary diversion.
    Anesthesiology 2002; 96: 506-8
    Abstract     Related articles   

  318. HENNINGSOHN L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G
    Distressful symptoms after radical radiotherapy for urinary bladder cancer.
    Radiother Oncol 2002; 62: 215-25
    Abstract     Related articles   

  319. JAFFRAY JY, Giollant M, Perissel B, Vago P
    [From "monocolor" karyotype to "multicolor" karyotype: applications of M-Fish in hematology and oncology]
    Bull Cancer 2002; 89: 174-80
    Abstract     Related articles   

  320. VOGELZANG NJ
    Future directions for gemcitabine in the treatment of genitourinary cancer.
    Semin Oncol 2002; 29: 40-5
    Abstract     Related articles   

  321. MISSET JL
    Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.
    Semin Oncol 2002; 29: 36-9
    Abstract     Related articles   

  322. HUSSAIN M, Vaishampayan U, Smith DC
    Novel gemcitabine-containing triplets in the management of urothelial cancer.
    Semin Oncol 2002; 29: 20-4
    Abstract     Related articles   

  323. STADLER WM
    Gemcitabine doublets in advanced urothelial cancer.
    Semin Oncol 2002; 29: 15-9
    Abstract     Related articles   

  324. HAYES GM, Carpenito C, Davis PD, Dougherty ST, Dirks JF, Dougherty GJ
    Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
    Cancer Gene Ther 2002; 9: 133-41
    Abstract     Related articles   

  325. SEIBEL JL, Prasad S, Weiss RE, Bancila E, Epstein JI
    Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
    Hum Pathol 2002; 33: 236-41
    Abstract     Related articles   

  326. ALBERS P, Siener R, Hartlein M, Fallahi M, Haeutle D, Perabo FG et al
    Gemcitabine monotherapy as second-line treatment in cisplatin- refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life.
    Onkologie 2002; 25: 47-52
    Abstract     Related articles   

  327. LIU B, Zhang Y, Wang Z, Ding Q, Chen B, Wang J et al
    [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma]
    Zhonghua Wai Ke Za Zhi 2002; 40: 112-5
    Abstract     Related articles   

  328. MOYAD MA
    Potential lifestyle and dietary supplement options for the prevention and postdiagnosis of bladder cancer.
    Urol Clin North Am 2002; 29: 31-48, viii
    Abstract     Related articles   

  329. DROLLER MJ
    Current concepts of tumor markers in bladder cancer.
    Urol Clin North Am 2002; 29: 229-34
    Abstract     Related articles   

  330. KAMAT AM, Lamm DL
    Chemoprevention of bladder cancer.
    Urol Clin North Am 2002; 29: 157-68
    Abstract     Related articles   

  331. LI C, Chen CC, Yang TH, Tzai TS, Huang CH, Liou JT et al
    Establishment of a mini-gene expression database for bladder tumor.
    J Formos Med Assoc 2002; 101: 104-9
    Abstract     Related articles   

  332. PECTASIDES D, Glotsos J, Bountouroglou N, Kouloubinis A, Mitakidis N, Karvounis N et al
    Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.
    Ann Oncol 2002; 13: 243-50
    Abstract     Related articles   

  333. SANCHEZ ZALABARDO D, Rosell Costa D, Fernandez Montero JM, Lopez Ferrandis J, Arocena Garcia-Tapia J, Jimenez Garin S et al
    [Prognostic value of P53, Ki67, and Rb protein in infiltrating bladder tumors]
    Actas Urol Esp 2002; 26: 98-103.
    Abstract     Related articles   

  334. AU JL, Jang SH, Wientjes MG
    Clinical aspects of drug delivery to tumors.
    J Control Release 2002; 78: 81-95
    Abstract     Related articles   

  335. COLLIS SJ, Sangar VK, Tighe A, Roberts SA, Clarke NW, Hendry JH et al
    Development of a novel rapid assay to assess the fidelity of DNA double- strand-break repair in human tumour cells.
    Nucleic Acids Res 2002; 30: E1
    Abstract     Related articles   

  336. ZHANG Y, Mahendran R, Yap LL, Esuvaranathan K, Khoo HE
    The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells.
    Biochem Pharmacol 2002; 63: 273-282
    Abstract     Related articles   

  337. TAWADROS T, Formenton A, Dudler J, Thompson N, Nicod P, Leisinger HJ et al
    The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium.
    J Cell Sci 2002; 115: 385-93
    Abstract     Related articles   

  338. AKAZA H
    Developing therapies for advanced bladder cancer.
    Expert Opin Investig Drugs 2002; 11: 109-115
    Abstract     Related articles   

  339. LIOU LS, Pettay JD, Tubbs RR
    Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer.
    Front Biosci 2002; 7: E27-32
    Abstract     Related articles   

  340. RAO J
    Targeting actin remodeling profiles for the detection and management of urothelial cancers - a perspective for bladder cancer research.
    Front Biosci 2002; 7: E1-8
    Abstract     Related articles   

  341. SHAO ZM, Nguyen M
    Angiogenic factors and bladder cancer.
    Front Biosci 2002; 7: E33-5
    Abstract     Related articles   

  342. HAN KR KR, Pantuck AJ, Belldegrun AS, Rao JY
    Tumor markers for the early detection of bladder cancer.
    Front Biosci 2002; 7: E19-26
    Abstract     Related articles   

  343. MACLEOD RA, Dirks WG, Drexler HG
    Persistent use of misidentified cell lines and its prevention.
    Genes Chromosomes Cancer 2002; 33: 103-5
    Abstract     Related articles   

  344. LIM BK, Mahendran R, Lee YK, Bay BH
    Chemopreventive Effect of Lactobacillus rhamnosus on Growth of a Subcutaneously Implanted Bladder Cancer Cell Line in the Mouse.
    Jpn J Cancer Res 2002; 93: 36-41
    Abstract     Related articles   

  345. PELUCCHI C, Tavani A, Negri E, Franceschi S, La Vecchia C
    Tobacco smoking and bladder cancer in coffee non-drinkers.
    J Epidemiol Community Health 2002; 56: 78-9
    Abstract     Related articles   

  346. ALY MS, Khaled HM
    Chromosomal aberrations in early-stage bilharzial bladder cancer.
    Cancer Genet Cytogenet 2002; 132: 41-5
    Abstract     Related articles   

  347. KOREVAAR EW, Huizenga H, Lof J, Stroom JC, Leer JW, Brahme A
    Investigation of the added value of high-energy electrons in intensity- modulated radiotherapy: four clinical cases.
    Int J Radiat Oncol Biol Phys 2002; 52: 236-53
    Abstract     Related articles   

  348. HINOTSU S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T et al
    [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin]
    Gan To Kagaku Ryoho 2002; 29: 73-80
    Abstract     Related articles   

  349. HAGIWARA A, Sano M, Tanaka H, Kawabe M, Tamano S, Kadota T et al
    Lack of enhancing effect of two Kampo medicines, Sho-saiko-to (TJ-9) and Sairei-to (TJ-114), on rat urinary bladder carcinogenesis initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Teratog Carcinog Mutagen 2002; 22: 41-50
    Abstract     Related articles   

  350. DUNST J, Rodel C, Diestelhorst A, Heynemann H, Schrott KM, Sauer R
    Radiochemotherapy for T1G3 bladder cancer.
    Front Radiat Ther Oncol 2002; 36: 151-8
    Abstract     Related articles   

  351. MILLER K
    T1G3 bladder cancer--the case for TUR and BCG.
    Front Radiat Ther Oncol 2002; 36: 147-50
    Abstract     Related articles   

  352. RODEL C, Grabenbauer GG, Kuhn R, Dunst J, Papadopoulos T, Schrott KM et al
    Invasive bladder cancer: organ preservation by radiochemotherapy.
    Front Radiat Ther Oncol 2002; 36: 118-30
    Abstract     Related articles   

  353. GSCHWEND JE
    Outcome of patients undergoing radical cystectomy for invasive bladder cancer.
    Front Radiat Ther Oncol 2002; 36: 106-17
    Abstract     Related articles   

  354. DE BRAUD F, Maffezzini M, Vitale V, Bruzzi P, Gatta G, Hendry WF et al
    Bladder cancer.
    Crit Rev Oncol Hematol 2002; 41: 89-106
    Abstract     Related articles   

  355. SHELLEY MD, Barber J, Wilt T, Mason MD
    Surgery versus radiotherapy for muscle invasive bladder cancer (Cochrane Review).
    Cochrane Database Syst Rev 2002; : CD002079
    Abstract     Related articles   

  356. KADONO Y, Koizumi H
    [A case of transitional cell carcinoma of the bladder with active urinary tract tuberculosis]
    Nippon Hinyokika Gakkai Zasshi 2002; 93: 58-61
    Abstract     Related articles   

  357. RIEMENSBERGER J, Bohle A, Brandau S
    IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer.
    Clin Exp Immunol 2002; 127: 20-6
    Abstract     Related articles   

  358. INUI M, Fujita K, Ueda N, Takenaka I, Kakehi Y
    [A case of regionally metastatic pure squamous cell carcinoma of the urinary bladder successfully treated with radical chemoradiotherapy]
    Hinyokika Kiyo 2002; 48: 33-5
    Abstract     Related articles   

  359. NAGAHAMA K, Yamada T, Ichiyanagi N, Sakai Y, Kamata S, Fukuda H et al
    [Functional and urodynamic characteristics in patients with ileal neobladder]
    Hinyokika Kiyo 2002; 48: 1-6
    Abstract     Related articles   

  360. FEKAK H, Rabu R, Joual A, Bennani S, Moufid K, Sarf S et al
    [Intradiverticular bladder tumors. Three case reports]
    Ann Urol (Paris) 2002; : 53-7
    Abstract     Related articles   

  361. BELLAOUI H, Chefchaouni MC, Lazrak N, Khalfaoui LC, Yassine F, Elhamany Z
    [Flow cytometric DNA analysis and cytology in diagnosis and prognosis of bladder tumors: preliminary results of a comparative study of bladder lavage]
    Ann Urol (Paris) 2002; : 45-52
    Abstract     Related articles   

  362. LEBRET T
    [Treatment of bladder tumors]
    Rev Prat 2002; 52: 36-42
    Abstract     Related articles   

  363. RISCHMANN P
    [Diagnosis of bladder tumors]
    Rev Prat 2002; 52: 32-5
    Abstract     Related articles   

  364. ORLOW I, Cordon-Cardo C
    Evaluation of alterations in the tumor suppressor genes INK4A and INK4B in human bladder tumors.
    Methods Mol Biol 2002; 179: 43-59
    Abstract     Related articles   

  365. CHERTIN B, Reinus C, Koulikov D, Rosenmann E, Farkas A, Chertin B
    Post-chemotherapy microscopic residual prostate rhabdomyosarcoma: long- term conservative follow-up.
    Pediatr Surg Int 2002; 18: 68-9
    Abstract     Related articles   

  366. NORTIER J
    [Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)]
    Nephrologie 2002; 23: 37-8
    Abstract     Related articles   

  367. LOPEZ-BELTRAN A, Cheng L, Andersson L, Brausi M, de MA, Montironi R et al
    Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.
    Virchows Arch 2002; 440: 3-11
    Abstract     Related articles   

  368. HARA I, Miyake H, Hara S, Gotoh A, Okada H, Arakawa S et al
    Optimal timing of radical cystectomy for patients with invasive transitional cell carcinoma of the bladder.
    Jpn J Clin Oncol 2002; 32: 14-8
    Abstract     Related articles   

  369. LU HF, Wu HC, Hsia TC, Chen WC, Hung CF, Chung JG
    Effects of butylated hydroxyanisole and butylated hydroxytoluene on DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumour cells.
    J Appl Toxicol 2002; 22: 37-44
    Abstract     Related articles   

  370. STERNBERG CN, Calabro F
    The management of bladder cancer in the elderly.
    Tumori 2002; 88: S128-9
    Abstract     Related articles   

  371. AKIMOV OV, Chukin SE
    [Malignant carcinoid of the urinary bladder]
    Arkh Patol 2002; 64: 41-2
    Abstract     Related articles   

  372. COLECCHIA M, Dagrada GP, Poliani PL, Pilotti S
    Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder.
    Histopathology 2002; 40: 108-9
    Abstract     Related articles   

  373. BERNARDI D
    Is it possible to use anthracyclines in patients older than 70 years? Pro.
    Tumori 2002; 88: S133-5
    Abstract     Related articles   

  374. BENITEZ DEL ROSARIO MA, Feria M, Monton Alvarez FI
    Hallucinations in an elderly cancer patient: opioid neurotoxicity or dementia with Lewy bodies?
    Palliat Med 2002; 16: 71-2
    Abstract     Related articles   

  375. PETRINI B, Haggarth L, Stiernstedt SH
    Early PCR detection of Bacille Calmette-Guerin complications in bladder cancer therapy.
    Scand J Infect Dis 2002; 34: 233-4
    Abstract     Related articles   

  376. FRATER CJ, Mansberg VJ
    An unusual pattern of prostatic metastases.
    Clin Nucl Med 2002; 27: 50-2
    Abstract     Related articles   

  377. VINH PQ, Sugie S, Tanaka T, Hara A, Yamada Y, Katayama M et al
    Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl- N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Jpn J Cancer Res 2002; 93: 42-9
    Abstract     Related articles   

  378. ORTIZ GAMIZ A, Poyato Galan JM, Sanchez Sanchez E, Moyano Calvo JL, Arribas Gonzalez JM, Alvarez-Ossorio Fernandez JL et al
    [Bladder leiomyoma: diagnosis by imaging]
    Arch Esp Urol 2002; 55: 79-81
    Abstract     Related articles   

  379. ADRIAZOLA SEMINO M, Ortiz Cabria R, Garcia Cobo E, Tejeda Banez E, Alonso Villalba A, Romero Rodriguez F
    [Distal bone metastases of transitional-cell carcinoma of the bladder. Apropos of a case]
    Arch Esp Urol 2002; 55: 69-70
    Abstract     Related articles   

  380. HUGUET PEREZ J, Palou J, Millan Rodriguez F, Villavicencio Mavrich H, Rodriguez JV
    [Radical cystectomy for superficial tumors in the BCG era]
    Arch Esp Urol 2002; 55: 50-6
    Abstract     Related articles   

  381. FERNANDEZ GOMEZ JM, Garcia Rodriguez J, Escaf Barmadah S, Raigoso P, Rodriguez Martinez JJ, Allende MT et al
    [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma]
    Arch Esp Urol 2002; 55: 41-9
    Abstract     Related articles   

  382. KACZMAREK P, Blaszczyk J, Kowalski J, Niemirowicz J
    [Evaluation of side effects after intrabladder instillations of preparations in patients with superficial bladder carcinoma]
    Pol Merkuriusz Lek 2002; 12: 39-42
    Abstract     Related articles   

  383. MIRA E, Lacalle RA, Gomez-Mouton C, Leonardo E, Manes S
    Quantitative determination of tumor cell intravasation in a real-time polymerase chain reaction-based assay.
    Clin Exp Metastasis 2002; 19: 313-8
    Abstract     Related articles   

  384. XIAOTONG H, Hannocks MJ, Hampson I, Brunner G
    GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy.
    Clin Exp Metastasis 2002; 19: 291-9
    Abstract     Related articles   

  385. FOSSA SD, Skovlund E
    Selection of patients may limit the generalizability of results from cancer trials.
    Acta Oncol 2002; 41: 131-7
    Abstract     Related articles   


  386. Controversies in uro-oncology. Proceedings of the Fourth Meeting on Special Aspects of Radiotherapy. Berlin, Germany. June 2000.
    Front Radiat Ther Oncol 2002; 36: 1-196
    Abstract     Related articles   

  387. ZIETMAN AL
    Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy.
    Front Radiat Ther Oncol 2002; 36: 131-46
    Abstract     Related articles   

  388. CHOSIA M, Switala J, Domagala W
    Nephrogenic adenoma of the urinary bladder--a case report and review of the literature.
    Pol J Pathol 2002; 53: 91-5
    Abstract     Related articles   

  389. ORNTOFT TF, Thykjaer T, Waldman FM, Wolf H, Celis JE
    Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.
    Mol Cell Proteomics 2002; 1: 37-45
    Abstract     Related articles   

  390. NYLAND TG, Wallack ST, Wisner ER
    Needle-tract implantation following us-guided fine-needle aspiration biopsy of transitional cell carcinoma of the bladder, urethra, and prostate.
    Vet Radiol Ultrasound 2002; 43: 50-3
    Abstract     Related articles   

  391. NISHIYAMA T, Tanikawa T, Tomita Y, Takahasi K
    Neoadjuvant chemotherapy with sequential methotrexate and 5- Fluorouracil scheduling, epirubicin and Cisplatin for locally advanced bladder cancer.
    Oncology 2002; 63: 1-5
    Abstract     Related articles   

  392. GORELOV SI
    [Fluorescent cystoscopy in diagnosing and treating superficial cancer of the urinary bladder]
    Urologiia 2002; : 25-8
    Abstract     Related articles   

  393. BADAWI AF, Habib SL, Mohammed MA, Abadi AA, Michael MS
    Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer.
    Cancer Invest 2002; 20: 651-6
    Abstract     Related articles   

  394. HATCHER JF, Swaminathan S
    Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P- postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
    Environ Mol Mutagen 2002; 39: 314-22
    Abstract     Related articles   

  395. SALIGNAC S, Walter A, Feugier P, Lecompte T, Lesesve JF
    [Solid tumor in terminal phase: interpretation of biologic anomalies (hematologic tests)]
    Ann Biol Clin (Paris) 2002; : 96-100
    Abstract     Related articles   

  396. PETRYLAK DP
    Salvage therapy for platinum-refractory urothelial cancer: designing new clinical trials.
    Cancer Invest 2002; 20: 855-6
    Abstract     Related articles   

  397. BELLMUNT J, Cos J, Cleries R, Perez M, Ribas A, Eres N et al
    Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer.
    Cancer Invest 2002; 20: 673-85
    Abstract     Related articles   

  398. WESTER K, Sjostrom A, de la Torre M, Carlsson J, Malmstrom PU
    HER-2--a possible target for therapy of metastatic urinary bladder carcinoma.
    Acta Oncol 2002; 41: 282-8
    Abstract     Related articles   

  399. SAPI Z, Bodo M
    [FISH diagnostics]
    Magy Onkol 2002; 46: 25-32
    Abstract     Related articles   

  400. DODDAMANI D, Ansari MS, Gupta NP, Aron M, Singh I, Datta Gupta S
    Mesonephroid adenocarcinoma of the bladder and urethra: a case report.
    Int Urogynecol J Pelvic Floor Dysfunct 2002; 13: 47-9
    Abstract     Related articles   

  401. VALLEJO HERRADOR J, Sanchez de la Muela P, Diz Rodriguez R, Martin-Laborda F
    [Synchronous primary urologic triple neoplasia. Report of a new case and review of the literature]
    Actas Urol Esp 2002; 26: 57-9
    Abstract     Related articles   

  402. KHAITAN A, Seth A, Dinda AK, Singh I, Talwar M, Bandhu S
    Transurethral resection versus open surgery for leiomyoma of urinary bladder--a report of 2 cases.
    Int Urogynecol J Pelvic Floor Dysfunct 2002; 13: 270-3
    Abstract     Related articles   

  403. LIU WC, Ye G, Zhang RG
    In vivo HSV-TK gene transfer and the therapeutic effects of ganciclovir on bladder cancer in mice with HSV-TK gene transfer.
    Di Yi Jun Yi Da Xue Xue Bao 2002; 22: 41-2
    Abstract     Related articles   

  404. STERNBERG CN
    Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
    Ann Oncol 2002; 13 Suppl 4: 273-9
    Abstract     Related articles   

  405. RAITANEN M
    [Treatment and follow-up of superficial bladder cancer]
    Duodecim 2002; 118: 903-9
    Abstract     Related articles   

  406. RISSANEN AM, Pekonen M, Terho R, Krees R, Katila ML
    [Enlarged pelvic lymph nodes after immunotherapy in a patient with bladder cancer]
    Duodecim 2002; 118: 1029-32
    Abstract     Related articles   

  407. ROTTERUD R, Pettersen EO, Berner A, Holm R, Olsen DR, Fossa SD
    Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients.
    Acta Oncol 2002; 41: 463-70
    Abstract     Related articles   

  408. SAMOILOV AV, Naumkina SA
    [Postradiation intestinal phlegmon]
    Vestn Khir Im I I Grek 2002; 161: 100-1
    Abstract     Related articles   

  409. KOBAYASHI M, Wood PA, Hrushesky WJ
    Circadian chemotherapy for gynecological and genitourinary cancers.
    Chronobiol Int 2002; 19: 237-51
    Abstract     Related articles   

  410. GONTIJO AM, Marcondes JP, Elias FN, de Oliveira ML, de Lima RO, Salvadori DM et al
    DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.
    Environ Mol Mutagen 2002; 40: 190-9
    Abstract     Related articles   

  411. GOLDRICK M, Prescott J
    Detection of mutations in human cancer using nonisotopic RNase cleavage assay.
    Methods Mol Med 2002; 68: 141-55
    Abstract     Related articles   

  412. MCCULLOUGH LB
    Ethical issues in the use of tumor markers in clinical investigation of the management of bladder cancer.
    Urol Oncol 2002; 7: 35-7.
    Abstract     Related articles   

  413. VAN DER MEIJDEN AP
    The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified?
    Urol Oncol 2002; 7: 31-3.
    Abstract     Related articles   

  414. SENGELOV L, von der Maase H, Lundbeck F, Barlebo H, Colstrup H, Engelholm SA et al
    Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.
    Acta Oncol 2002; 41: 447-56.
    Abstract     Related articles   

  415. RESZKA E, Wasowicz W
    Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Minireview.
    Neoplasma 2002; 49: 209-16.
    Abstract     Related articles   

  416. PECZKOWSKA M, Gessek J, Januszewicz A, Neumann HP, Januszewicz M, Janaszek-Sitkowska H et al
    Pheochromocytoma of the urinary bladder coexisting with another extra-adrenal tumour--case report of a 19-year-old male patient.
    Blood Press 2002; 11: 101-5.
    Abstract     Related articles   

  417. WATERS SB, Akman SA
    A new assay to quantify in vivo repair of G:T mispairs by base excision repair.
    Mutat Res 2001; 487: 109-19
    Abstract     Related articles   

  418. DE WIT R
    [New developments in chemotherapy for metastasized bladder cancer]
    Ned Tijdschr Geneeskd 2001; 145: 2412-7
    Abstract     Related articles   

  419. TANAKA M, Grossman HB
    Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin.
    Hum Gene Ther 2001; 12: 2225-36
    Abstract     Related articles   

  420. ANDRES E, Gaunard A, Blickle JF, Kuhnert C, Goichot B, Schlienger JL et al
    Systemic reactions after intravesical BCG instillation for bladder cancer.
    QJM 2001; 94: 719
    Abstract     Related articles   

  421. VINEIS P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK et al
    Current Smoking, Occupation, N-Acetyltransferase-2 and Bladder Cancer: A Pooled Analysis of Genotype-based Studies.
    Cancer Epidemiol Biomarkers Prev 2001; 10: 1249-52
    Abstract     Related articles   

  422. PICH A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Navone R
    Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
    Am J Surg Pathol 2001; 25: 1528-33
    Abstract     Related articles   

  423. GUILLEMIN F, Cosserat-Gerardin I, Notter D, Vigneron C
    [Diagnosis and treatment of bladder tumors by photodynamic therapy]
    Pathol Biol (Paris) 2001; : 815-23
    Abstract     Related articles   

  424. CRESSWELL J, Robertson H, Neal DE, Griffiths TR, Kirby JA
    Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E- cadherin in normal human urothelium and bladder carcinomas.
    Clin Exp Immunol 2001; 126: 397-402
    Abstract     Related articles   

  425. CANNARD L, Lemelle JL, Gaconnet E, Champigneulle J, Mainard L, Claudon M
    Dynamic MR imaging of bladder haemangioma.
    Pediatr Radiol 2001; 31: 882-5
    Abstract     Related articles   

  426. GALIMBERTI S, Riccioni R, Azzara A, Testi R, Fazzi R, Testi C et al
    Unusual morphology in a case of large granular cell leukemia.
    Ann Hematol 2001; 80: 755-7
    Abstract     Related articles   

  427. POON KS, Moreira O, Jones EC, Treissman S, Gleave ME
    Inflammatory pseudotumor of the urinary bladder: a report of five cases and review of the literature.
    Can J Urol 2001; 8: 1409-15
    Abstract     Related articles   

  428. HERR HW, Schneider M
    Immediate versus delayed outpatient flexible cystoscopy: final report of a randomized study.
    Can J Urol 2001; 8: 1406-8
    Abstract     Related articles   

  429. TSUCHIYA F, Ikeda I, Kanda F, Fukuoka H
    [A case of bladder tumor producing granulocyte-colony stimulation factor and parathyroid hormone-related protein]
    Hinyokika Kiyo 2001; 47: 873-6
    Abstract     Related articles   

  430. MATSUOKA Y, Ishizaka K, Kobayashi T, Machida T, Oka K
    [Transitional cell carcinoma of the ureter with inverted proliferation accompanied with papillary bladder tumor: a case report]
    Hinyokika Kiyo 2001; 47: 861-3
    Abstract     Related articles   

  431. TOUYAMA H, Hokama S, Hatano T, Ogawa Y
    [Primary signet ring cell carcinoma of the urinary bladder: a case report]
    Hinyokika Kiyo 2001; 47: 853-5
    Abstract     Related articles   

  432. LOPEZ-BELTRAN A, Bollito E, Luque RJ, Montironi R
    A practical approach to bladder sampling and diagnostic reporting of pathological findings.
    Pathologica 2001; 93: 688-92
    Abstract     Related articles   

  433. CHUNG WB, Hong SH, Kim JA, Sohn YK, Kim BW, Kim JW
    Hypermethylation of tumor-related genes in genitourinary cancer cell lines.
    J Korean Med Sci 2001; 16: 756-61
    Abstract     Related articles   

  434. CUERVO PINNA MA, Cuervo Pinna C, Macias Castillo S, Bureo Dacal JC, Espada Alonso MJ, Pimentel Leo J
    [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder]
    An Med Interna 2001; 18: 641-3
    Abstract     Related articles   

  435. FILION MC, Phillips NC
    Therapeutic potential of mycobacterial cell wall-DNA complexes.
    Expert Opin Investig Drugs 2001; 10: 2157-65
    Abstract     Related articles   

  436. BOFFETTA P, Gridley G, Lindelof B
    Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden.
    J Invest Dermatol 2001; 117: 1531-7
    Abstract     Related articles   

  437. KUBO M, Van de Water L, Plantefaber LC, Mosesson MW, Simon M, Tonnesen MG et al
    Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair.
    J Invest Dermatol 2001; 117: 1369-81
    Abstract     Related articles   

  438. BONACRUZ KAZZI G
    Asymptomatic bladder phaeochromocytoma in a 7-year-old boy.
    J Paediatr Child Health 2001; 37: 600-2
    Abstract     Related articles   

  439. KACZMAREK P, Buczynski A, Niemirowicz J, Gnitecki W, Kocur E, Karpinski J
    [Lipids peroxidation in platelets in patients with bladder cancer treated with Mycobacterium suspension]
    Pol Merkuriusz Lek 2001; 11: 484-6
    Abstract     Related articles   

  440. SKACEL M, Pettay JD, Tsiftsakis EK, Procop GW, Biscotti CV, Tubbs RR
    Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides.
    Anal Quant Cytol Histol 2001; 23: 381-7
    Abstract     Related articles   

  441. GEN H, Yamamoto S, Morimura K, Min W, Mitsuhashi M, Murai T et al
    p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)- nitrosamine: different genetic alteration from urinary bladder carcinoma.
    Jpn J Cancer Res 2001; 92: 1278-83
    Abstract     Related articles   

  442. PAN Y, Lavelle JP, Bastacky SI, Meyers S, Pirtskhalaishvili G, Zeidel ML et al
    Detection of tumorigenesis in rat bladders with optical coherence tomography.
    Med Phys 2001; 28: 2432-40
    Abstract     Related articles   

  443. NUTTING CM, Huddart RA
    Retinoids in the prevention of bladder cancer.
    Expert Rev Anticancer Ther 2001; 1: 541-5
    Abstract     Related articles   

  444. ROSSER CJ, Benedict WF, Dinney CP
    Gene therapy for superficial bladder cancer.
    Expert Rev Anticancer Ther 2001; 1: 531-9
    Abstract     Related articles   

  445. SHACKLEY DC, Briggs C, Whitehurst C, Betts CD, O’Flynn KJ, Clarke NW et al
    Photodynamic therapy for superficial bladder cancer.
    Expert Rev Anticancer Ther 2001; 1: 523-30
    Abstract     Related articles   

  446. O’CONNOR RC, Alsikafi NF, Steinberg GD
    Therapeutic options and treatment of muscle invasive bladder cancer.
    Expert Rev Anticancer Ther 2001; 1: 511-22
    Abstract     Related articles   


  447. IDM confirms significant results in bladder cancer program.
    Expert Rev Anticancer Ther 2001; 1: 507
    Abstract     Related articles   

  448. BASSI P, Iafrate M, Spinadin R, Carando R, Iannello R, Repele M et al
    [Superficial bladder neoplasia unresponsive to endocavitary treatment: when should the treatment approach be changed?]
    Arch Ital Urol Androl 2001; 73: 181-6
    Abstract     Related articles   

  449. WU WJ, Liu LT, Huang CH, Chang SF, Chang LL
    Telomerase activity in human bladder tumors and bladder washing specimens.
    Kaohsiung J Med Sci 2001; 17: 602-9
    Abstract     Related articles   

  450. IMAMOGLU MA, Bakirtas H, Yigitbasi O, Ersoy H, Sertcelik AN
    Intravesical epirubicin treatment following TUR in superficial bladder tumours.
    Arch Esp Urol 2001; 54: 1147-53
    Abstract     Related articles   

  451. PAINEMAL DUARTE C, Gallardo J, Valdebenito JP, Gamargo C, Rubio B, Harbst H
    [MALT lymphoma of the bladder. Report of a case]
    Arch Esp Urol 2001; 54: 1138-40
    Abstract     Related articles   

  452. NAVAS PASTOR J, Garcia Ligero J, Garcia Garcia F, Tomas Ros M, Rico Galiano JL, Sempere Gutierrez A et al
    [Synchronous tumor of the upper urinary tract with bladder cancer. Opportunity for nephroureterectomy and block-cystectomy]
    Arch Esp Urol 2001; 54: 1095-102
    Abstract     Related articles   

  453. LEURAUD K, Benichou J
    A comparison of several methods to test for the existence of a monotonic dose-response relationship in clinical and epidemiological studies.
    Stat Med 2001; 20: 3335-51
    Abstract     Related articles   

  454. HEDELIN H, Boman H, Holmang S
    [When is it meaningful to investigate hematuria? Macroscopic hematuria-- investigate always. Microscopic hematuria--symptoms and age decide]
    Lakartidningen 2001; 98: 5498-500, 5503
    Abstract     Related articles   

  455. ALTWEIN JE
    [Dysuria. Typical symptoms for proper diagnosis]
    MMW Fortschr Med 2001; 143 Suppl: 121-30
    Abstract     Related articles   

  456. OZONO S, Hinotsu S, Tabata S, Takashima K, Fujimoto K, Okajima E et al
    Treated Natural History of Superficial Bladder Cancer.
    Jpn J Clin Oncol 2001; 31: 536-540
    Abstract     Related articles   

  457. KOSHIDA K, Imao T, Ito H, Miyagi T, Konaka H, Mizokami A et al
    [Prospects for molecular research in urological oncology: bladder cancer]
    Hinyokika Kiyo 2001; 47: 815-8
    Abstract     Related articles   

  458. IKEGAMI S, Yoshimura I, Tsuji A, Seta K, Kimura F, Odajima K et al
    [Immunohistochemical study of p53 and Ki-67 overexpression in grade 3 superficial bladder tumor in relationship to tumor recurrence and prognosis]
    Nippon Hinyokika Gakkai Zasshi 2001; 92: 656-65
    Abstract     Related articles   

  459. KUNZE E, Francksen B, Schulz H
    Expression of MUC5AC apomucin in transitional cell carcinomas of the urinary bladder and its possible role in the development of mucus- secreting adenocarcinomas.
    Virchows Arch 2001; 439: 609-15
    Abstract     Related articles   

  460. WILLIAMS SG, Buscarini M, Stein JP
    Molecular markers for diagnosis, staging, and prognosis of bladder cancer.
    Oncology (Huntingt) 2001; : 1469-70, 1473-4, 1476
    Abstract     Related articles   

  461. MIZUNO J, Sugimoto S, Iiyama T, Watanabe H, Ichikawa N, Machida K et al
    [Anesthetic management of a patient with von Recklinghausen disease complicated with spinal tumor and severe spinal deformity]
    Masui 2001; 50: 1246-9
    Abstract     Related articles   

  462. OHTANI M, Iwasaki A, Shiraiwa H
    [Urinary tumor marker for urothelial cancer]
    Gan To Kagaku Ryoho 2001; 28: 1933-7
    Abstract     Related articles   

  463. YANO A, Hashimoto K, Okuchi T, Mizoguchi H, Mutaguchi K, Nakamoto T et al
    [Dihydropyrimidine dehydrogenase activity in urothelial cancer-- influence of UFT administration on DPD activity]
    Gan To Kagaku Ryoho 2001; 28: 1877-83
    Abstract     Related articles   

  464. HURSTING SD, Perkins SN, Phang JM, Barrett JC
    Diet and cancer prevention studies in p53-deficient mice.
    J Nutr 2001; 131: 3092S-4S
    Abstract     Related articles   

  465. WANG HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J et al
    Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
    Am J Surg Pathol 2001; 25: 1380-7
    Abstract     Related articles   

  466. BOL MG, Baak JP, de Bruin PC, Rep S, Marx W, Bos S et al
    Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.
    J Clin Pathol 2001; 54: 854-9
    Abstract     Related articles   

  467. GREENBERG RS, Mandel JS, Pastides H, Britton NL, Rudenko L, Starr TB
    A meta-analysis of cohort studies describing mortality and cancer incidence among chemical workers in the United States and western Europe.
    Epidemiology 2001; 12: 727-40
    Abstract     Related articles   

  468. ONG F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA et al
    Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
    Radiother Oncol 2001; 61: 169-75
    Abstract     Related articles   

  469. TANAKA J, Marriott G, Higa T, Higa T
    Cacofurans A and B, new furanoditerpenes from a marine sponge.
    J Nat Prod 2001; 64: 1468-70
    Abstract     Related articles   

  470. VAIDYANATHAN S, Soni BM, Mansour P, Glass CA, Singh G, Bingley J et al
    Community-care waiting list for persons with spinal cord injury.
    Spinal Cord 2001; 39: 584-8
    Abstract     Related articles   

  471. DIBB MJ, Noble DJ, Peh WC, Lam CH, Yip KH, Li JH et al
    Ultrasonographic analysis of bladder tumors.
    Clin Imaging 2001; 25: 416-20
    Abstract     Related articles   

  472. MIYANAGA N, Akaza H
    [Bladder cancer]
    Nippon Rinsho 2001; 59 Suppl 7: 379-85
    Abstract     Related articles   

  473. MARTOV AG, Moskalev AIu, Gushchin BL, Saliukov RV, Al’-Musavi ShI, Amelin AV
    [Endoscopic treatment of bladder diverticula]
    Urologiia 2001; : 40-4
    Abstract     Related articles   

  474. RETZ M, Lehmann J, Wullich B, Stockle M
    [After-care of bladder carcinoma]
    Urologe A 2001; 40: 480-4
    Abstract     Related articles   

  475. WEISSBACH L
    [Palliation of urothelial carcinoma of the bladder]
    Urologe A 2001; 40: 475-9
    Abstract     Related articles   

  476. OTTO T, Rubben H
    [Treatment of metastases of urothelial carcinoma. Results of a prospective study of metastases surgery]
    Urologe A 2001; 40: 471-4
    Abstract     Related articles   

  477. RIEDMILLER H
    [Urinary drainage and urinary diversion. Patient selection and counseling]
    Urologe A 2001; 40: 468-70
    Abstract     Related articles   

  478. RUBBEN H, Otto T
    [Locally advanced or metastatic bladder carcinoma. Current aspects of therapy]
    Urologe A 2001; 40: 464-7
    Abstract     Related articles   

  479. JOCHAM D, Durek C
    [Treatment of superficial bladder tumor]
    Urologe A 2001; 40: 460-3
    Abstract     Related articles   

  480. HOLTL W
    [Diagnostic algorithm of urothelial tumor of the upper urinary tract]
    Urologe A 2001; 40: 451
    Abstract     Related articles   

  481. KALBLE T
    [Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer]
    Urologe A 2001; 40: 447-50
    Abstract     Related articles   

  482. VOGELI TA, Ackermann R
    [Prognostic factors in urothelial carcinoma]
    Urologe A 2001; 40: 442-6
    Abstract     Related articles   

  483. JAKSE G, Studer U, Rubben H
    [Urothelial carcinoma]
    Urologe A 2001; 40: 441
    Abstract     Related articles   

  484. BOSTROM PJ, Aaltonen V, Soderstrom KO, Uotila P, Laato M
    Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells.
    Pathology 2001; 33: 469-74
    Abstract     Related articles   

  485. SHIAU A L, Lin P R, Chang M Y, Wu C L
    Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer.
    Gene Ther 2001; 8: 1609-17
    Abstract     Related articles   

  486. AMBROSIO V, Borzacchiello G, Bruno F, Galati P, Roperto F
    Uroplakin expression in the urothelial tumors of cows.
    Vet Pathol 2001; 38: 657-60
    Abstract     Related articles   

  487. LU H, Zang Y, Liu L
    [Orthotopic detenia cecal-ascending colon urinary reservoir: report of 18 cases]
    Zhonghua Wai Ke Za Zhi 2001; 39: 848-9
    Abstract     Related articles   

  488. XU Y, Qiao Y, Sa Y
    [Enhanced continent mechanism of the tapered ileum in continent urinary reservoir]
    Zhonghua Wai Ke Za Zhi 2001; 39: 845-7
    Abstract     Related articles   

  489. ZHOU X, Mei H, Gao X
    [Clinical study of detenia cecal-ascending colon continent cutaneous urinary reservoir]
    Zhonghua Wai Ke Za Zhi 2001; 39: 842-4
    Abstract     Related articles   

  490. GOYA N, Ishikawa N, Tomizawa Y, Ryoji O, Ito F, Onitsuka S et al
    Electrovaporization using a rollerball electrode for flat or small papillary tumors of the bladder: basic study in dogs.
    J Endourol 2001; 15: 951-5
    Abstract     Related articles   

  491. GUY L, Giraud B, Boiteux JP
    Minimally invasive extraperitoneal lymphadenectomy: clinical validation of an original technique.
    J Endourol 2001; 15: 903-8
    Abstract     Related articles   

  492. CHETTY R, Clarke B
    Myxoid invasive papillary urothelial carcinoma of the bladder and urethra.
    Pathology 2001; 33: 515-8
    Abstract     Related articles   

  493. OJEA CALVO A, Nunez Lopez A, Alonso Rodrigo A, Rodriguez Iglesias B, Benavente Delgado J, Barros Rodriguez JM et al
    [Bladder leiomyoma]
    Actas Urol Esp 2001; 25: 759-63
    Abstract     Related articles   

  494. CUESTA ALCALA JA, Caballero Martinez MC, Amat Villegas I
    [Synchronous presentation of inverted papilloma with transitional carcinoma focus in right kidney pelvis and bladder urothelial carcinoma]
    Actas Urol Esp 2001; 25: 750-4
    Abstract     Related articles   

  495. SEGURA MARTIN M, Salinas Sanchez AS, Lorenzo Romero JG, Hernandez Millan I, Gimenez Bachs JM, Virseda Rodriguez JA
    [Survival in patients treated with radical cystectomy for bladder carcinoma]
    Actas Urol Esp 2001; 25: 737-45
    Abstract     Related articles   

  496. ARRIZABALAGA MORENO M, Garcia Gonzalez JI, Diez Rodriguez J, Perez Garnelo MJ, Navarro Sebastian J, Castro Pita M et al
    [Clinical course and mid- and long-term prognosis of superficial bladder tumors]
    Actas Urol Esp 2001; 25: 710-9
    Abstract     Related articles   

  497. ZHANG J, Zheng S, Di X, et Al
    [A further study on potential of microsatellite analysis of urine in diagnosis of bladder cancer]
    Zhonghua Yi Xue Za Zhi 2001; 81: 1224-6
    Abstract     Related articles   

  498. WU B, Pan C, Song G
    [Study on different responses of rats’ small intestine mucous membrane and bladder transitional epithelium in the same carcinogenic urine
    Zhonghua Yi Xue Za Zhi 2001; 81: 1227-9
    Abstract     Related articles   

  499. MASTERS JR
    Re: methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial.
    J Natl Cancer Inst 2001; 93: 1574-5
    Abstract     Related articles   

  500. UEMURA M, Nishimura K, Inoue H, Mizutani S, Miyoshi S
    [Late metastases of prostatic adenocarcinoma to urinary bladder after radical prostatectomy: a case report]
    Hinyokika Kiyo 2001; 47: 747-9
    Abstract     Related articles   

  501. KOROKU M, Tanda H, Katoh S, Onishi S, Nakajima H, Nanbu A et al
    [Small cell carcinoma of the urinary bladder: a case report]
    Hinyokika Kiyo 2001; 47: 743-5
    Abstract     Related articles   

  502. TORUNER GA, Akyerli C, Ucar A, Aki T, Atsu N, Ozen H et al
    Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
    Arch Toxicol 2001; 75: 459-64
    Abstract     Related articles   

  503. GROMOVA I, Gromov P, Celis JE
    A novel member of the glycosyltransferase family, beta 3 Gn-T2, highly downregulated in invasive human bladder transitional cell carcinomas.
    Mol Carcinog 2001; 32: 61-72
    Abstract     Related articles   

  504. ANTOS F, Serclova Z, Gilbert Z
    [Pelvic exenteration in the treatment of locally advanced tumors of surgical, gynaecological and urological origin]
    Zentralbl Chir 2001; 126: 777-9
    Abstract     Related articles   

  505. HOBOHM U
    Fever and cancer in perspective.
    Cancer Immunol Immunother 2001; 50: 391-6
    Abstract     Related articles   

  506. BINDELS EM, Vermey M, De Both NJ, van der Kwast TH
    Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines.
    Virchows Arch 2001; 439: 552-9
    Abstract     Related articles   

  507. HELPAP B
    Nonepithelial neoplasms of the urinary bladder.
    Virchows Arch 2001; 439: 497-503
    Abstract     Related articles   

  508. DHILLON SS, Singh DJ, Dass B, Schaub CR
    Transitional cell carcinoma manifesting as acute cor pulmonale: cause of microscopic tumor embolism.
    South Med J 2001; 94: 1030-2
    Abstract     Related articles   

  509. TORRICO ROMAN P, Mogollon Cano-Cortes T, Lopez-Rios Velasco J, Fernandez de Mera JJ, Blasco Huelva A
    [Bladder transitional cell carcinoma with metastasis to the maxillary sinus as first symptom]
    Acta Otorrinolaringol Esp 2001; 52: 622-4
    Abstract     Related articles   

  510. LATTERMANN R, Schricker T, Wachter U, Goertz A, Georgieff M
    Intraoperative epidural blockade prevents the increase in protein breakdown after abdominal surgery.
    Acta Anaesthesiol Scand 2001; 45: 1140-6
    Abstract     Related articles   

  511. RINKE K, Grunert R, Bednarski PJ
    New synthetic route to [bis-1,2- (aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Pharmazie 2001; 56: 763-9
    Abstract     Related articles   

  512. SCHMITZ SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B
    Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles.
    J Magn Reson Imaging 2001; 14: 355-61
    Abstract     Related articles   

  513. PUNTONI R, Merlo F, Borsa L, Reggiardo G, Garrone E, Ceppi M
    A historical cohort mortality study among shipyard workers in Genoa, Italy.
    Am J Ind Med 2001; 40: 363-70
    Abstract     Related articles   

  514. ICZKOWSKI KA, Shanks JH, Gadaleanu V, Cheng L, Jones EC, Neumann R et al
    Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
    Mod Pathol 2001; 14: 1043-51
    Abstract     Related articles   

  515. AUGUSTO D, Gosselin B, Leroy X
    An unusual tumor of the urinary bladder.
    Arch Pathol Lab Med 2001; 125: 1383-4
    Abstract     Related articles   

  516. OVERSTREET K, Haghighi P
    Urothelial and prostate carcinoma metastasizing to the same lymph node: a case report and review of the literature.
    Arch Pathol Lab Med 2001; 125: 1354-7
    Abstract     Related articles   

  517. SCHAFFER M, Schaffer PM, Corti L, Sotti G, Hofstetter A, Jori G et al
    Photofrin II as an efficient radiosensitizing agent in an experimental tumor.
    Onkologie 2001; 24: 482-5
    Abstract     Related articles   

  518. SUZUKI S, Shimada T
    Suicide gene therapy for bladder tumors.
    J Nippon Med Sch 2001; 68: 368-9
    Abstract     Related articles   

  519. AU WW
    Life style factors and acquired susceptibility to environmental disease.
    Int J Hyg Environ Health 2001; 204: 17-22
    Abstract     Related articles   

  520. CATERINO M, Finocchi V, Giunta S, De Carli P, Crecco M
    Bladder cancer within a direct inguinal hernia: CT demonstration.
    Abdom Imaging 2001; 26: 664-666
    Abstract     Related articles   

  521. TAN FE, Zeegers MP
    An asymptotically unbiased estimator of exposed versus non-exposed odds ratio from reported dose-response data.
    Stat Methods Med Res 2001; 10: 311-23
    Abstract     Related articles   

  522. DULEWICZ A, Pietka BD, Jaszczak P, Nechay A, Sawicki W, Pykalo R et al
    Computer identification of neoplastic urothelial nuclei from the bladder.
    Anal Quant Cytol Histol 2001; 23: 321-9
    Abstract     Related articles   

  523. TIMURKAAN N, Yener Z, Ycjksel H
    Leiomyoma of the urinary bladder in a goat.
    Aust Vet J 2001; 79: 708-9
    Abstract     Related articles   

  524. OZEN H, Ekici S, Uygur MC, Akbal C, Sahin A
    Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
    J Endourol 2001; 15: 863-7
    Abstract     Related articles   

  525. DREICER R
    Locally advanced and metastatic bladder cancer.
    Curr Treat Options Oncol 2001; 2: 431-6
    Abstract     Related articles   

  526. MOHAN H, Ahal S, Nada R, Jogai S, Attri AK
    Osteosarcoma of the bladder--a case report.
    Indian J Pathol Microbiol 2001; 44: 451-2
    Abstract     Related articles   

  527. XIAOXU L, Jianhong L, Jinfeng W, Klotz LH
    Bladder adenocarcinoma: 31 reported cases.
    Can J Urol 2001; 8: 1380-3
    Abstract     Related articles   

  528. DOHERTY A, Burkhard F, Holliger S, Studer U
    Bladder substitution in women.
    Curr Urol Rep 2001; 2: 350-6
    Abstract     Related articles   

  529. MASTROENI F, Aragona M, Caldarera E, Piccolo A, Rotondo S, Spinnato L et al
    Deep venous thrombosis in patients undergoing salvage radical cystectomy.
    Arch Esp Urol 2001; 54: 839-41
    Abstract     Related articles   

  530. SALINAS SANCHEZ AS, Segura Martin M, Lorenzo Romero JG, Hernandez Millan I, Fernandez Olano C, Virseda Rodriguez JA
    [Quality of life of patients after radical surgery of bladder cancer]
    Arch Esp Urol 2001; 54: 787-95
    Abstract     Related articles   

  531. NUNEZ MORA C, Chamorro Ramos L, Rendon Sanchez D, Rios Gonzalez E, Pastor Arquero T, Aguilera Bazan A et al
    [Clinical pathway for TUR of bladder neoplasms. Analysis of the first 2 years of its implementation]
    Arch Esp Urol 2001; 54: 777-86
    Abstract     Related articles   

  532. LEMA GRILLE J, Rodriguez Nunez H, Cimadevila Garcia A, Durana Tonder C, Blanco Parra M
    [Malignant vesico-prostatic fibrous histiocytoma]
    Actas Urol Esp 2001; 25: 664-7
    Abstract     Related articles   

  533. GIBANEL GARANTO R, Mallafre Sala JM, Rodriguez Casado A, Cetina Herrando A, Capdevila Querol S, Truan Cacho D et al
    [Bladder leiomyoma]
    Actas Urol Esp 2001; 25: 662-3
    Abstract     Related articles   

  534. ALVAREZ KINDELAN J, Lopez Beltran A, Anglada Curado F, Moreno Arcas P, Carazo Carazo JL, Regueiro Lopez JC et al
    [Clinico-pathologic differences between bladder neoplasm with low malignant potential and low-grade carcinoma]
    Actas Urol Esp 2001; 25: 645-50
    Abstract     Related articles   

  535. SIGNORELLO LB, Ye W, Fryzek JP, Lipworth L, Fraumeni JF Jr, Blot WJ et al
    Nationwide study of cancer risk among hip replacement patients in Sweden.
    J Natl Cancer Inst 2001; 93: 1405-10
    Abstract     Related articles   

  536. SUN HZ, Wu SF, Tu ZH
    Knockdown of IGF-IR by Antisense Oligodeoxynucleotide auguments the sensitivity of bladder cancer cells to mitomycin.
    Acta Pharmacol Sin 2001; 22: 841-6
    Abstract     Related articles   

  537. DEWAN M, Rasshid M, Elmalik EM, Ansari MA, Morad N
    Lessons to be learned: a case study approach. Paraganglioma of the urinary bladder.
    J R Soc Health 2001; 121: 193-8
    Abstract     Related articles   

  538. BOHLE A, Durek C
    [Use of BCG in superficial urinary bladder carcinoma]
    Urologe A 2001; 40: 403-9
    Abstract     Related articles   

  539. BUTTNER H, Feyerabend T, Bohle A
    [Radiochemotherapy of urothelial carcinoma]
    Urologe A 2001; 40: 380-3
    Abstract     Related articles   

  540. VACHA P, Buttner H, Bohle A, Feyerabend T
    [Radiotherapy of urothelial carcinomas of the urinary bladder]
    Urologe A 2001; 40: 376-9
    Abstract     Related articles   

  541. STENZL A, Ninkovic M, Ashammakhi N, Eder IE, Bartsch G
    [Reconstruction of the lower urinary tract. Developments at the beginning of a new century]
    Urologe A 2001; 40: 368-75
    Abstract     Related articles   

  542. HAUTMANN RE
    [15 years experience with the ileal neobladder. What have we learned?]
    Urologe A 2001; 40: 360-7
    Abstract     Related articles   

  543. CAIRO F, Rubino I, Rotundo R, Prato GP, Ficarra G
    Oral Acanthosis nigricans as a marker of internal malignancy. A case report.
    J Periodontol 2001; 72: 1271-5
    Abstract     Related articles   

  544. SANTOURLIDIS S, Warskulat U, Florl AR, Maas S, Pulte T, Fischer J et al
    Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma.
    Mol Carcinog 2001; 32: 36-43
    Abstract     Related articles   

  545. EVANS HK, Wylie AA, Murphy SK, Jirtle RL
    The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2.
    Genomics 2001; 77: 99-104
    Abstract     Related articles   

  546. FEDRIGA R, Gunelli R, Nanni O, Bacci F, Amadori D, Calistri D
    Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.
    Neoplasia 2001; 3: 446-50
    Abstract     Related articles   

  547. HUNCHAREK M, Kupelnick B
    Chemotherapeutic prophylaxis of superficial bladder tumors.
    Oncology (Huntingt) 2001; : 1106
    Abstract     Related articles   

  548. BECK SD, Koch MO
    Spiral ileal neobladder substitution with orthotopic ureteral reimplantation: early results.
    Tech Urol 2001; 7: 223-8
    Abstract     Related articles   

  549. BROMLEY B, Roberts DJ, Tracy EE, Greene MF, Shipp TD, Benacerraf BR
    Fibroepithelial bladder polyp and renal tubular dysgenesis: an unusual cause of third-trimester oligohydramnios.
    J Ultrasound Med 2001; 20: 1015-9
    Abstract     Related articles   

  550. LO PRESTI E, Sperati A, Rapiti E, Di Domenicantonio R, Forastiere F, Perucci CA
    [Cause of death among workers of a refinery in Rome]
    Med Lav 2001; 92: 327-37
    Abstract     Related articles   

  551. SUDA K, Rothen-Rutishauser B, Gunthert M, Wunderli-Allenspach H
    Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features.
    In Vitro Cell Dev Biol Anim 2001; 37: 505-14
    Abstract     Related articles   

  552. JEON SS, Kang I, Hong JH, Choi HY, Chai SE
    Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms.
    J Endourol 2001; 15: 753-9
    Abstract     Related articles   

  553. SUPERTI F, Longhi C, Di Biase AM, Tinari A, Marchetti M, Pisani S et al
    Herpes simplex virus type 2 modulates the susceptibility of human bladder cells to uropathogenic bacteria.
    Med Microbiol Immunol (Berl) 2001; : 201-8
    Abstract     Related articles   

  554. ZITO R
    Low doses and thresholds in genotoxicity: from theories to experiments.
    J Exp Clin Cancer Res 2001; 20: 315-25
    Abstract     Related articles   

  555. STIBOROVA M, Schmeiser HH, Breuer A, Frei E
    Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation.
    Gen Physiol Biophys 2001; 20: 267-79
    Abstract     Related articles   

  556. SANCHEZ ZALABARDO D, Lopez Ferrandis J, Arocena Garcia-Tapia J, Sanz Perez G, Zudaire Bergera J, Berian Polo JM
    [Recurrent urothelial tumor in orthotopic neobladder]
    Actas Urol Esp 2001; 25: 600-2
    Abstract     Related articles   

  557. VAZQUEZ BLANC S, Vazquez Navarrete S, Pinzon Bohorquez J, Goni Zurita MJ, Romero Maturana JM, Lahoz Romero E
    [Vesical cavernous hemangioma]
    Actas Urol Esp 2001; 25: 586-8
    Abstract     Related articles   

  558. SANCHEZ ZALABARDO D, Rodriguez Gonzalez J, Fernandez Montero JM, Lopez Ferrandis J, Arocena Garcia-Tapia J, Sanz Perez G et al
    [Primary bladder adenocarcinoma: our experience in the last 10 years]
    Actas Urol Esp 2001; 25: 573-7
    Abstract     Related articles   

  559. RODRIGUEZ-RUBIO CORTADELLAS FI, Garrido Insua S, Rivas Aguayo D, Hens Perez A, Bachiller Burgos J, Beltran Aguilar V et al
    [Second resection in patients with Ta-T1 bladder tumors]
    Actas Urol Esp 2001; 25: 553-8
    Abstract     Related articles   

  560. MARQUEZ MORENO AJ, Julve Villalta E, Alonso Dorrego JM, Rubio Garrido FJ, Blanes Berenguel A, Matilla Vicente A
    [Multiple bladder inverted papillomas]
    Arch Esp Urol 2001; 54: 692-4
    Abstract     Related articles   

  561. LI X, Sun D, Gao W
    [Intravesical instillation of cytotoxic T-lymphocytes induced by soluble tumor antigen in the prophylaxis of recurrence of bladder cancer]
    Zhonghua Wai Ke Za Zhi 2001; 39: 619-22
    Abstract     Related articles   

  562. MIZUNO K, Sasaki T, Saito Y, Itabashi Y, Miura H, Yodono H et al
    [Gadolinium-enhanced MR imaging, T2-weighted MR imaging, and transurethral ultrasonography]
    Nippon Igaku Hoshasen Gakkai Zasshi 2001; 61: 496-501
    Abstract     Related articles   

  563. SCHEPPACH W, Krenn V, Eck M, Menzel T, Burrows G, Langenfeld H
    [Tumor cell embolism to pulmonary arteries]
    Z Gastroenterol 2001; 39: 583-6
    Abstract     Related articles   

  564. FENNICHE S, Hassene H, Attia S, Fkih L, Bousnina S, Cheikh K et al
    [A rare complication of antineoplastic BCG therapy: pulmonary tuberculosis]
    Tunis Med 2001; 79: 467-70
    Abstract     Related articles   

  565. SYED HA, Biyani CS, Bryan N, Brough SJ, Powell CS
    Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience.
    J Endourol 2001; 15: 625-7
    Abstract     Related articles   

  566. BARROSO RELINQUE N, Lopez Ruiz T, Bozada Garcia JM, Belda Laguna O
    [Retroperitoneal cavity communicating with the duodenum found during the endoscopic evaluation of upper digestive hemorrhage]
    Rev Esp Enferm Dig 2001; 93: 481-3
    Abstract     Related articles   

  567. TROXEL DB
    Diagnostic errors in surgical pathology uncovered by a review of malpractice claims: part VI--urinary bladder and branchial cleft cyst.
    Int J Surg Pathol 2001; 9: 227-9
    Abstract     Related articles   

  568. SAZAWA A
    [Gelsolin gene therapy using adenovirus vector for orthotopically implanted human urinary bladder carcinoma in nude mice]
    Hokkaido Igaku Zasshi 2001; 76: 263-71
    Abstract     Related articles   

  569. MORITA K, Ishikawa R, Enami N, Kashiwagi A, Murayama M, Yamagami H et al
    Reconstruction of urinary tract utilizing transverse colon conduit for a cystectomized patient with post-ureterocutaneostomy complications and sigmoid colon cancer.
    Hokkaido Igaku Zasshi 2001; 76: 199-202
    Abstract     Related articles   

  570. MORITANI H, Sakamoto M, Yoshida Y, Nasu H, Nemoto R, Nakamura I
    Pheochromocytoma of the urinary bladder revealed with cerebral hemorrhage.
    Intern Med 2001; 40: 638-42
    Abstract     Related articles   

  571. BATY V, Ray-Coquard I, Roman S, Bory RM
    BCG therapy-related death and previous pelvic radiation.
    Ann Pharmacother 2001; 35: 963-4
    Abstract     Related articles   

  572. MOULY S, Berenbaum F, Kaplan G
    Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Guerin instillation.
    J Rheumatol 2001; 28: 1699-701
    Abstract     Related articles   

  573. DAWRA RK, Sharma OP, Somvanshi R
    A preliminary study on the carcinogenicity of the common fern Onychium contiguum.
    Vet Res Commun 2001; 25: 413-20
    Abstract     Related articles   

  574. MASUDA A, Minakmi S, Usui Y, Arihara K, Nagata Y, Kawamura N
    Advanced bladder cancer in a young female: a case report.
    Tokai J Exp Clin Med 2001; 26: 39-43
    Abstract     Related articles   

  575. FERNANDEZ MENA FJ, Moreno-Torres YC
    [Bladder cancer]
    Arch Esp Urol 2001; 54: 493-510
    Abstract     Related articles   

  576. RADOSAVLJEVIC V, Jankovic S, Markovic-Denic Lj
    [Risk factors for urinary bladder cancer]
    Srp Arh Celok Lek 2001; 129: 180-2
    Abstract     Related articles   

  577. CARR NJ, McLean AD
    A mucinous tumour of the urachus: adenoma or low grade mucinous cystic tumour of uncertain malignant potential?
    Adv Clin Path 2001; 5: 93-7
    Abstract     Related articles   

  578. SPYRIDONOS P, Ravazoula P, Cavouras D, Berberidis K, Nikiforidis G
    Computer-based grading of haematoxylin-eosin stained tissue sections of urinary bladder carcinomas.
    Med Inform Internet Med 2001; 26: 179-90
    Abstract     Related articles   

  579. ORELLANE C
    St John’s wort helps to fight bladder cancer.
    Lancet Oncol 2001; 2: 399
    Abstract     Related articles   

  580. ALIAEV IUG, Ternovoi SK, Sinitsyn VE, Rapoport LM, Vinarov AZ, Grigorian VA et al
    [Magnetic resonance urography: possibilities and prospects]
    Urologiia 2001; : 7-11
    Abstract     Related articles   

  581. KOZLOV VP, Zubarev AV, Grishin MA, Nasnikova IIu, Kovalev AA, Aristov AV
    [Diagnosis of bladder cancer]
    Urologiia 2001; : 36-9
    Abstract     Related articles   

  582. CATERINO M, Giunta S, Finocchi V, Giglio L, Mainiero G, Carpanese L et al
    Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques.
    Abdom Imaging 2001; 26: 433-8
    Abstract     Related articles   

  583. AMONKAR P, Murali G, Krishnamurthy S
    Schistosoma induced squamous cell carcinoma of the bladder.
    Indian J Pathol Microbiol 2001; 44: 363-4
    Abstract     Related articles   

  584. UDAWAT H, Nuwal P, Solanki RL
    Leiomyoma of urinary bladder--a case report.
    Indian J Pathol Microbiol 2001; 44: 347-8
    Abstract     Related articles   

  585. POWER RE, Kay EW, O’Connell F, Jaber AA, Donovan MG, Hickey DP et al
    Primary lymphoma of the bladder: a report of three cases.
    Ir J Med Sci 2001; 170: 196-7
    Abstract     Related articles   

  586. ZHANG Z, Zeng G, Zhang Z
    [Impact of extracellular gene of VEGF receptor KDR on growth of human bladder carcinoma in nude rats]
    Zhonghua Yi Xue Za Zhi 2001; 81: 684-6
    Abstract     Related articles   

  587. BIGOTTI G, Coli A, Prisco LA, Spina C, Russo F, Castri F et al
    Rare presentation of carcinosarcoma arising in bladder diverticulum.
    J Exp Clin Cancer Res 2001; 20: 301-4
    Abstract     Related articles   

  588. AGARWALA S, Hemal AK, Seth A, Gupta AK, Bhatnagar V, Mitra DK
    Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood.
    Eur J Pediatr Surg 2001; 11: 207-10
    Abstract     Related articles   

  589. BULBUL MA, Wazzan W, Nasr R, Hemady K
    The value of cystoscopy, prostate biopsy and frozen-section urethral biopsy prior to orthotopic neobladder substitution.
    Can J Urol 2001; 8: 1290-2
    Abstract     Related articles   

  590. ALBERT PS, McShane LM, Shih JH
    Latent class modeling approaches for assessing diagnostic error without a gold standard: with applications to p53 immunohistochemical assays in bladder tumors.
    Biometrics 2001; 57: 610-9
    Abstract     Related articles   

  591. CONDE REDONDO C, Estebanez Zarranz J, Rodriguez Tovez A, Amon Sesmero J, Alonso Fernandez D, Martinez Sagarra JM
    [Quality of life in patients treated with orthotopic bladder substitution versus cutaneous ileostomy]
    Actas Urol Esp 2001; 25: 435-44
    Abstract     Related articles   

  592. HITA ROSINO E, Jimenez Verdejo A, Mellado Mesa P, Lopez Hidalgo J, Sanchez Fornieles E, Grau Civit J
    [Descriptive study of bladder tumors in the district of Levante-Alto Almanzora]
    Actas Urol Esp 2001; 25: 415-21
    Abstract     Related articles   

  593. TAKAYAMA T, Kinuya S, Kobashi K, Onoguchi M, Mizukami Y, Koshida K et al
    Clinical approach to renal study incidental to 99mTc-MDP bone scintigraphy.
    Ann Nucl Med 2001; 15: 237-45
    Abstract     Related articles   

  594. PLISS GB, Mel’nikov AS, Malinin VV, Khavinson VK
    Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats.
    Bull Exp Biol Med 2001; 131: 558-60
    Abstract     Related articles   

  595. HAISFIELD-WOLFE ME
    Drug handling questioned.
    Urol Nurs 2001; 21: 200
    Abstract     Related articles   

  596. CHEUNG YL, Molassiotis A, Chang AM
    A pilot study on the effect of progressive muscle relaxation training of patients after stoma surgery.
    Eur J Cancer Care (Engl) 2001; : 107-14
    Abstract     Related articles   

  597. GILLOTEAUX J, Jamison JM, Arnold D, Taper HS, Summers JL
    Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells.
    Ultrastruct Pathol 2001; 25: 183-92
    Abstract     Related articles   

  598. SUN Y, Xu C, Qian S, Qu C, Zhao J, Ma Y
    Transurethral microwave needle ablation for bladder cancer.
    Chin Med J (Engl) 2001; : 546-7
    Abstract     Related articles   

  599. GUBAEV SZ, Burov NE, Osipov SA
    [Clinical and pharmacological characteristics of ropivacaine in sacral anesthesia]
    Anesteziol Reanimatol 2001; : 17-9
    Abstract     Related articles   

  600. SORINAS DELGADO N, Berne Manero JM, Bono Arino A, Garcia Prats MD, Sanz Velez JI
    [Leiomyosarcoma of the urinary bladder]
    Actas Urol Esp 2001; 25: 385-7
    Abstract     Related articles   

  601. GARCIA PEREZ M, Rico Lopez J, Camacho Martinez E
    [Radical cystectomy in superficial bladder carcinoma]
    Actas Urol Esp 2001; 25: 329-34
    Abstract     Related articles   

  602. ROSS JS, Cohen MB
    Detecting recurrent bladder cancer: new methods and biomarkers.
    Expert Rev Mol Diagn 2001; 1: 39-52
    Abstract     Related articles   

  603. ROOHULLAH, Nusrat J, Hamdani SR, Burdy GM, Khurshid A
    Cancer urinary bladder--5 year experience at Cenar, Quetta.
    J Ayub Med Coll Abbottabad 2001; 13: 14-6
    Abstract     Related articles   

  604. BONO ARINO A, Sanz Velez JI, Esclarin Duny MA, Berne Manero JM, Vera Alvarez J
    [Signet ring-cell adenocarcinoma in colocystoplasty]
    Actas Urol Esp 2001; 25: 312-4
    Abstract     Related articles   

  605. SOUSA ESCANDON MA, Perez Valcarcel J, Gonzalez Fernandez M, Gonzalez Rodriguez A, Lapena Villarroya JA, Uribarri Gonzalez C
    [Nephrogenic adenoma of the bladder: metaplasia or embryologic alteration?]
    Actas Urol Esp 2001; 25: 307-11
    Abstract     Related articles   

  606. PAEZ BORDA A, Lujan Galan M, Romero Cajigal I, Llanes Gonzalez L, Gomez de Vicente JM, Berenguer Sanchez A
    [Selective bladder sparing with transrectal resection of muscle- infiltrating tumors]
    Actas Urol Esp 2001; 25: 264-8
    Abstract     Related articles   

  607. MEDINA PEREZ M, Valero Puerta JA, Valpuesta Fernandez I, Sanchez Gonzalez M
    [Bladder adenocarcinoma with glandular cystitis areas]
    Arch Esp Urol 2001; 54: 254-6
    Abstract     Related articles   

  608. PIERAS AYALA E, Palou J, Rodriguez-Villamil L, Millan Rodriguez F, Salvador Bayarri J, Vicente Rodriguez J
    [Cytoscopic follow-up of initial G3T1 bladder tumors treated with BCG]
    Arch Esp Urol 2001; 54: 211-7
    Abstract     Related articles   

  609. SIDDIQUI FA, Amirkhosravi A, Amaya M, Meyer T, Biggerstaff J, Desai H et al
    Hemoglobin enhances tissue factor expression on human malignant cells.
    Blood Coagul Fibrinolysis 2001; 12: 171-7
    Abstract     Related articles   

  610. BROWN AL JR, Zietman AL, Shipley WU, Kaufman DS
    An organ-preserving approach to muscle-invading transitional cell cancer of the bladder.
    Hematol Oncol Clin North Am 2001; 15: 345-58, vii
    Abstract     Related articles   

  611. FERNANDEZ MA, Andreu R, Fortea JM, Aznar J
    The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
    Thromb Haemost 2001; 85: 743
    Abstract     Related articles   

  612. TONG Q, Zeng F, Zheng L, Zhao J, Lu G
    Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87.
    Chin Med J (Engl) 2001; : 402-6
    Abstract     Related articles   


  613. AFUD publicizes risks of cigarette smoking.
    Urol Nurs 2001; 21: 132
    Abstract     Related articles   

  614. FAN Z, Zhang J, Bai J
    [Deletion mapping of chromosome 18q and Smad proteins expression analysis in urinary bladder carcinomas]
    Zhonghua Zhong Liu Za Zhi 2001; 23: 135-7
    Abstract     Related articles   

  615. MCINTOSH J
    Analyzing counts, durations, and recurrences in clinical trials.
    J Biopharm Stat 2001; 11: 65-74
    Abstract     Related articles   

  616. LIN HY, Wu WJ, Jang MY, Shen JT, Tsai HN, Chou YH et al
    Cystitis glandularis mimics bladder cancer--three case reports and literature review.
    Gaoxiong Yi Xue Ke Xue Za Zhi 2001; 17: 102-6
    Abstract     Related articles   

  617. RANDALL S
    Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
    Urol Nurs 2001; 21: 30-1, 34-6
    Abstract     Related articles   

  618. KAMAT AM, Lamm DL
    Immunotherapy for bladder cancer.
    Curr Urol Rep 2001; 2: 62-9
    Abstract     Related articles   

  619. ROTTERUD R, Skomedal H, Berner A, Danielsen HE, Skovlund E, Fossa SD
    TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy.
    Acta Oncol 2001; 40: 644-52
    Abstract     Related articles   

  620. GRIFFITHS JR, McIntyre DJ, Howe FA, McSheehy PM, Ojugo ASE, Rodrigues LM et al
    Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatment.
    Acta Oncol 2001; 40: 609-14
    Abstract     Related articles   

  621. SANDLER H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D et al
    Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee.
    Int J Radiat Oncol Biol Phys 2001; 51: 28-38
    Abstract     Related articles   

  622. TOMOBE M, Shimazui T, Uchida K, Akaza H
    AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
    Anal Cell Pathol 2001; 22: 193-9
    Abstract     Related articles   

  623. FUJIMOTO H, Naito H, Terauchi M
    Skin rash in the hypogastric region during a regional chemotherapy for bladder carcinoma: CT and scintigraphic demonstration of a potential collateral pathway between the internal iliac and inferior epigastric arteries.
    Eur Radiol 2001; 11: 1838-40
    Abstract     Related articles   

  624. MACVILLE MV, Van der Laak JA, Speel EJ, Katzir N, Garini Y, Soenksen D et al
    Spectral imaging of multi-color chromogenic dyes in pathological specimens.
    Anal Cell Pathol 2001; 22: 133-42
    Abstract     Related articles   

  625. SCHNEIDER G, Ahlhelm F, Altmeyer K, Aliani S, Remberger K, Schoenhofen H et al
    Rare pseudotumors of the urinary bladder in childhood.
    Eur Radiol 2001; 11: 1024-9
    Abstract     Related articles   

  626. AMBROSIANI L, Declich P, Bellone S, Tavani E, Pacilli P, Guarneri A et al
    Thyroid metastases from renal clear cell carcinoma: a cyto-histological study of two cases.
    Adv Clin Path 2001; 5: 11-6
    Abstract     Related articles   

  627. RAITANEN MP, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T
    Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Ann Chir Gynaecol 2001; 90: 261-5
    Abstract     Related articles   

  628. RAITANEN MP, Aine R, Kylmala T, Kallio J, Liukkonen T, Tammela T
    The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
    Ann Chir Gynaecol 2001; 90: 256-9
    Abstract     Related articles   

  629. PLISS GB, Mel’nikov AS, Malinin VV, Khavinson VKh
    [Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats]
    Vopr Onkol 2001; 47: 601-7
    Abstract     Related articles   

  630. STARTSEV VIU
    [Diagnosis of recurrences of bladder cancer]
    Vopr Onkol 2001; 47: 536-43
    Abstract     Related articles   

  631. GORREA M, Lorente R, Roel J
    Seminal vesicle cyst associated with ipsilateral renal agenesis and papillary carcinoma of the bladder.
    Eur Radiol 2001; 11: 2500-3
    Abstract     Related articles   

  632. HUDDART RA, Lau FN, Guerrero-Urbano T, Jay G, Norman A, Horwich A et al
    Accelerated chemotherapy in the treatment of urothelial cancer.
    Clin Oncol (R Coll Radiol) 2001; : 279-83
    Abstract     Related articles   

  633. WURDINGER S, Schutz K, Fuchs D, Kaiser WA
    Two cases of metastases to the breast on MR mammography.
    Eur Radiol 2001; 11: 802-6
    Abstract     Related articles   

  634. KRUPSKI T, Theodorescu D
    Orthotopic neobladder following cystectomy: indications, management, and outcomes.
    J Wound Ostomy Continence Nurs 2001; 28: 37-46
    Abstract     Related articles   

  635. BAGROVA SG
    [Results of phase II clinical trial of cycloplatam in refractory solid tumors]
    Vopr Onkol 2001; 47: 752-6
    Abstract     Related articles   

  636. ZLATNIK EIU, Kapkina NN, Zaderin VP, Zakora GI
    [Immunocorrective effect of alternating magnetic field in the postoperative period in malignant bladder cancer]
    Vopr Onkol 2001; 47: 312-4
    Abstract     Related articles   

  637. CANNON SB
    Staging and terminology of superficial urinary bladder tumors.
    J Insur Med 2001; 33: 360-2
    Abstract     Related articles   

  638. GILLOTEAUX J, Jamison JM, Arnold D, Summers JL
    Autoschizis: another cell death for cancer cells induced by oxidative stress.
    Ital J Anat Embryol 2001; 106: 79-92
    Abstract     Related articles   

  639. MIODONSKI AJ, Litwin JA, Nowogrodzka-Zagorska M, Gorczyca J
    Vascular architecture of normal human urinary bladder and its remodeling in cancer, as revealed by corrosion casting.
    Ital J Anat Embryol 2001; 106: 221-8
    Abstract     Related articles   

  640. THIERY JP
    [Role of growth factor signaling in epithelial cell plasticity during development and in carcinogenesis]
    Bull Acad Natl Med 2001; 185: 1279-92
    Abstract     Related articles   

  641. KRAVCHICK S, Cytron S, Lobik L, Altshuler A, Kravchenko Y, Ben-Dor D
    Clot retention and spontaneous rupture with secondary pneumatosis of bladder wall following routine cystoscopy.
    Pathol Oncol Res 2001; 7: 301-2
    Abstract     Related articles   

  642. BERTETTO O, Bracada S, Tamburini M, Cortesi E
    Quality of life studies and genito-urinary tumors.
    Ann Oncol 2001; 12 Suppl 3: S43-8
    Abstract     Related articles   

  643. TAKACSI NAGY L, Paczelt F, Patyanik M, Mayer A
    [Radiochemotherapy of bladder cancer with/without tissue-organ protection]
    Magy Onkol 2001; 45: 331-333
    Abstract     Related articles   

  644. LAATO M, Ekfors T, Alanen A, Rajala P, Nurmi M
    Leiomyoma of the urinary bladder.
    Ann Chir Gynaecol Suppl 2001; : 55-7
    Abstract     Related articles   

  645. LAATO M, Ekfors T, Alanen A, Rajala P, Nurmi M
    Leiomyoma of the urinary bladder.
    Ann Chir Gynaecol 2001; 90 Suppl 215: 55-7
    Abstract     Related articles   

  646. SHISHKOV D
    [Orthotopic bladder from the small intestine following radical cystectomy according to Studer’s procedure]
    Khirurgiia (Sofiia) 2001; : 41-3
    Abstract     Related articles   

  647. ULLERAS E, Wilcock A, Miller SJ, Franklin GC
    The sequential activation and repression of the human PDGF-B gene during chronic hypoxia reveals antagonistic roles for the depletion of oxygen and glucose.
    Growth Factors 2001; 19: 233-45
    Abstract     Related articles   

  648. PAVLAKOVIC H, Havers W, Schweigerer L
    Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.
    Angiogenesis 2001; 4: 259-62
    Abstract     Related articles   

  649. OGAWA K, Hirose M, Sugiura S, Cui L, Imaida K, Ogiso T et al
    Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.
    Nutr Cancer 2001; 40: 134-9
    Abstract     Related articles   

  650. COSSERAT-GERARDIN I, Bezdetnaya L, Notter D, Vigneron C, Guillemin F
    Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells.
    J Photochem Photobiol B 2000; 59: 72-9
    Abstract     Related articles   

  651. ROODHOUSE A
    Management of bladder cancer: a nursing view.
    Prof Nurse 2000; 16: 987-90
    Abstract     Related articles   

  652. IZAWA JI, Grossman HB
    Localized bladder cancer.
    Curr Treat Options Oncol 2000; 1: 423-32
    Abstract     Related articles   

  653. OKABE S, Ishikawa T, Tanami S, Kuwabara H, Fukahara T, Udagawa M et al
    Lleosigmoid anastomosis with exclusion of transected ileal loop for intestinal fistula following total cystectomy of bladder cancer. Report of a case.
    J Med Dent Sci 2000; 47: 215-9
    Abstract     Related articles   

  654. ZANG Z, Xu H, Yu L, Yang D, Xie S, Shi Y et al
    Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer.
    Chin Med J (Engl) 2000; : 1002-6
    Abstract     Related articles   

  655. POSSATI L, Rocchetti R, Talevi S, Beatrici V, Margiotta C, Ferrante L et al
    The role of peroxisome proliferator-activated receptor gamma in bladder cancer in relation to angiogenesis and progression.
    Gen Pharmacol 2000; 35: 269-75
    Abstract     Related articles   

  656. FOULADI B, Sabatier L, Miller D, Pottier G, Murnane JP
    The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line.
    Neoplasia 2000; 2: 540-54
    Abstract     Related articles   

  657. ZHANG YF, Xie SS, Hou XP, Gao X, Zhang S, Chen ZS
    [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals]
    Yao Xue Xue Bao 2000; 35: 854-9
    Abstract     Related articles   

  658. QIU L, Cong X, Tan Y
    [Application of microsatellite alteration of urine sediment in the early diagnosis of bladder cancer]
    Zhonghua Zhong Liu Za Zhi 2000; 22: 483-6
    Abstract     Related articles   

  659. QIN Z, Mei H, Dai Y, et Al
    [Telomerase activity and cellular apoptosis of bladder cancer]
    Zhonghua Wai Ke Za Zhi 2000; 38: 697-699
    Abstract     Related articles   

  660. LI H, Zhang Z, Shang L, Li X, Wang T
    Carcinoma of the lung and multiple primary tumors.
    Chin Med J (Engl) 2000; : 799-801
    Abstract     Related articles   

  661. SANSOM C
    Proteomics may aid bladder cancer diagnosis.
    Lancet Oncol 2000; 1: 5
    Abstract     Related articles   

  662. LANGENSTROER P, See W
    The role of a second transurethral resection for high-grade bladder cancer.
    Curr Urol Rep 2000; 1: 204-7
    Abstract     Related articles   

  663. SUN H, Fan J, Tang X
    [Effect of IGF1 receptor gene antisense oligodeoxynucleotide on T24 urinary bladder cancer cells]
    Zhonghua Zhong Liu Za Zhi 2000; 22: 276-8
    Abstract     Related articles   

  664. GU Y, Hou S, Li Y, et Al
    [The invasive ability of bladder cancer]
    Zhonghua Wai Ke Za Zhi 2000; 38: 552-3
    Abstract     Related articles   

  665. ZHANG X, Yang H, Lu G
    [Establishment of MRP-overexpression subline of bladder carcinoma and its MDR phenotype]
    Zhonghua Zhong Liu Za Zhi 2000; 22: 273-5
    Abstract     Related articles   

  666. CUMISKY S
    BCG immunotherapy for carcinoma of the urinary bladder.
    Nurs Stand 2000; 14: 45-7
    Abstract     Related articles   

  667. WANG R, Zhang C, Yu L, Guo Y
    Clinical application of radioimmunoimaging with 99mTc-BDI-1 in the diagnosis of bladder cancer.
    Chin Med J (Engl) 2000; : 396-9
    Abstract     Related articles   

  668. XU A, Wang X, Yu M
    [Clinical study on super-selective camptothecin microsphere’s embolization of internal iliac artery for bladder carcinoma]
    Zhonghua Yi Xue Za Zhi 2000; 80: 358-9
    Abstract     Related articles   

  669. CUI X, Guo R, Xu Z, Wang B, Li C
    Relationship between metabolic phenotype of N-acetylation and bladder cancer.
    Chin Med J (Engl) 2000; : 303-5
    Abstract     Related articles   

  670. IAVARONE C, Forte F, Bronzetti E, Minocchi L, Mezzetti G, Greco L et al
    [Pseudosarcoma of the urinary bladder. Report of a case]
    Minerva Urol Nefrol 2000; 52: 45-8
    Abstract     Related articles   

  671. YANG X, Shen P, Yao K, Mi Z, Liu S, Zhang H et al
    High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.
    Chin Med J (Engl) 2000; : 117-9
    Abstract     Related articles   

  672. SLOJEWSKI M
    [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]
    Ann Acad Med Stetin 2000; 46: 217-29
    Abstract     Related articles   

  673. MOON DG, Cheon J, Yoon DH, Park HS, Kim HK, Kim JJ et al
    Allium sativum potentiates suicide gene therapy for murine transitional cell carcinoma.
    Nutr Cancer 2000; 38: 98-105
    Abstract     Related articles   

  674. WANG S, Xia T, Zhang Z, et Al
    [Expression of VEGF and tumor angiogenesis in bladder cancer]
    Zhonghua Wai Ke Za Zhi 2000; 38: 34-6
    Abstract     Related articles   

  675. SHOU J, Wang M, Ma J
    [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH]
    Zhonghua Zhong Liu Za Zhi 2000; 22: 36-8
    Abstract     Related articles   

  676. QHIU L, Cong X, Ja L
    [The expression and clinical significance of keratin 19, 20 mRNA in different tumor cell lines and tumor tissues]
    Zhonghua Zhong Liu Za Zhi 2000; 22: 32-5
    Abstract     Related articles   

  677. LAIDLER P, Gil D, Pituch-Noworolska A, Ciolczyk D, Ksiazek D, Przybylo M et al
    Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
    Acta Biochim Pol 2000; 47: 1159-70
    Abstract     Related articles   

  678. IRIE A, Kashani-Sabet M, Scanlon KJ, Uchida T, Baba S
    Hammerhead ribozymes as therapeutic agents for bladder cancer.
    Mol Urol 2000; 4: 61-6
    Abstract     Related articles   

  679. NAKAMURA K, Yamaguchi A, Namiki M, Ishihara H, Nagasu T, Kowalczyk JJ et al
    Antitumor activity of ER-51785, a new peptidomimetic inhibitor of farnesyl transferase: synergistic effect in combination with paclitaxel.
    Oncol Res 2000; 12: 477-84
    Abstract     Related articles   

  680. NASU Y, Kusaka N, Saika T, Tsushima T, Kumon H
    Suicide gene therapy for urogenital cancer: current outcome and prospects.
    Mol Urol 2000; 4: 67-71
    Abstract     Related articles   

  681. SHOU J, Ma J, Xu B
    [Adenocarcinoma of the urinary bladder: a report of 27 cases]
    Zhonghua Zhong Liu Za Zhi 1999; 21: 461-3
    Abstract     Related articles   

  682. RANADIVE NU, Trivedi VD, Gadgil NM
    Primary adenocarcinoma of the urinary bladder: a study of 6 cases from the pathologist’s point of view.
    Arch Esp Urol 1999; 52: 906-11
    Abstract     Related articles   

  683. MIZUTANI Y, Yoshida O
    Effect of anticancer agents on Fas-mediated cytotoxicity against bladder cancer cells.
    J Infect Chemother 1999; 5: 139-143
    Abstract     Related articles   

  684. YANG D, Li S, Wang H, et Al
    [Prevention of postoperative recurrence of bladder cancer: a clinical study]
    Zhonghua Wai Ke Za Zhi 1999; 37: 464-71
    Abstract     Related articles   

  685. ZHUANG L, Zhang Z, Guo Y
    Aberrant expression of growth factor Wnt-5A in six urinary malignant cell lines.
    Chin Med J (Engl) 1999; : 251-5
    Abstract     Related articles   

  686. WU Z, Lu H, Luo S
    [Transurethral microwave tissue coagulation therapy for carcinoma of urinary bladder: an analysis of 35 patients]
    Zhonghua Zhong Liu Za Zhi 1999; 21: 148-50
    Abstract     Related articles   

  687. PANCHEV P, Kumanov Kh, Ianev K, Georgiev M, Slavov Ch, Kirilov S
    [Continent derivation of urine (a Modo) Mainz II]
    Khirurgiia (Sofiia) 1999; : 16-8
    Abstract     Related articles   

  688. CHAKAROV S, Lazarov Z, Fachikov Ts, Rangelov S, Bechev R
    [Creation of an orthotopic urinary bladder from ileum - "St Anna’s" procedure]
    Khirurgiia (Sofiia) 1999; : 14
    Abstract     Related articles   

  689. PANCHEV P, Kumanov H, Petrov P, Slavov Ch, Georgiev M, Yanev K et al
    [Post-cystectomy derivations - a rule or control of technical skills?]
    Khirurgiia (Sofiia) 1999; : 20-2
    Abstract     Related articles   

  690. FAN J, Tang X, Zhang X, et Al
    [Detection of apoptosis exposed to 10-hydroxycamptothecin in T24 human urinary bladder cancer cells]
    Zhonghua Wai Ke Za Zhi 1999; 37: 57-59
    Abstract     Related articles   

  691. NEYKOV K, Donkov I, Mirchov R
    [Intravesical chemotherapy with mitomycin C after TUR for superficial bladder carcinoma]
    Khirurgiia (Sofiia) 1999; : 11-4
    Abstract     Related articles   

  692. CHEN L, Wang X, Mei H, et Al
    [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence]
    Zhonghua Wai Ke Za Zhi 1998; 36: 484-6
    Abstract     Related articles   

  693. JACOBS EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR et al
    Vitamin C and Vitamin E Supplement Use and Bladder Cancer Mortality in a Large Cohort of US Men and Women.
    Am J Epidemiol 2002; 156: 1002-10
    Abstract     Related articles   

  694. ENGEL LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q et al
    Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review.
    Am J Epidemiol 2002; 156: 95-109
    Abstract     Related articles   

  695. ROTH T, Eckert C, Fiebig HH, Jung M
    Comparative action of cobalt carbonyl complexes on cancer cells using human tumor xenografts.
    Anticancer Res 2002; 22: 2281-4
    Abstract     Related articles   

  696. TEI Y, Matsuyama H, Wada T, Kurisu H, Tahara M, Naito K
    In vitro antitumor activity of bropirimine against urinary bladder tumor cells.
    Anticancer Res 2002; 22: 1667-71
    Abstract     Related articles   

  697. MARQUEZ M, Du J, Edgren M, Nilsson S, Lennartsson L, Hiltunen J et al
    Development of dextran derivatives with cytotoxic effects in human urinary bladder cancer cell lines.
    Anticancer Res 2002; 22: 741-4
    Abstract     Related articles   

  698. GIBANEL R, Ribal MJ, Filella X, Ballesta AM, Molina R, Alcaraz A et al
    BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Anticancer Res 2002; 22: 1157-60
    Abstract     Related articles   

  699. STREETER EH, Crew JP
    Angiogenesis, angiogenic factor expression and prognosis of bladder cancer.
    Anticancer Res 2001; 21: 4355-63
    Abstract     Related articles   

  700. HIRANO Y, Kageyama S, Ushiyama T, Suzuki K, Fujita K
    Clinical usefulness of chemotherapy based on an in vitro chemosensitivity test in urothelial cancer patients.
    Anticancer Res 2001; 21: 4061-6
    Abstract     Related articles   

  701. ROGALA E, Skopinska-Rozewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I et al
    Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Anticancer Res 2001; 21: 4259-63
    Abstract     Related articles   

  702. MAHDY E, Pan Y, Wang N, Malmstrom PU, Ekman P, Bergerheim U
    Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
    Anticancer Res 2001; 21: 3167-73
    Abstract     Related articles   

  703. VATNE V, Litlekalsoey J, Thorsen F, Ness GO, Wentzel-Larsen T, Hostmark JG
    Characterization of cell lines originating from an invasive transitional cell carcinoma.
    Anticancer Res 2001; 21: 3199-207
    Abstract     Related articles   

  704. CURIGLIANO G, Ferretti G, Flamini G, Goldhirsch A, de Braud F, Calabro MG et al
    Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Anticancer Res 2001; 21: 3015-20
    Abstract     Related articles   

  705. BERNARDINI S, Adessi GL, Chezy E, Billerey C, Carbillet JP, Bittard H
    Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
    Anticancer Res 2001; 21: 3001-4
    Abstract     Related articles   

  706. MELCHIOR D, Hammer P, Fimmers R, Schuller H, Albers P
    Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
    Anticancer Res 2001; 21: 2989-93
    Abstract     Related articles   

  707. CHENG AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS et al
    Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
    Anticancer Res 2001; 21: 2895-900
    Abstract     Related articles   

  708. HARRIS NM, Duffy PM, Crook TJ, Anderson WR, Sharpe P, Hayes MC et al
    Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer.
    BJU Int 2002; 90: 957-64
    Abstract     Related articles   

  709. SHACKLEY DC, Haylett A, Whitehurst C, Betts CD, O’Flynn K, Clarke NW et al
    Comparison of the cellular molecular stress responses after treatments used in bladder cancer.
    BJU Int 2002; 90: 924-32
    Abstract     Related articles   

  710. BRYAN RT, Wallace DM
    ’Superficial’ bladder cancer - time to uncouple pT1 tumours from pTa tumours.
    BJU Int 2002; 90: 846-52
    Abstract     Related articles   

  711. LEWIN J, Cooper A, Birch B
    Progesterone: a novel adjunct to intravesical chemotherapy.
    BJU Int 2002; 90: 736-41.
    Abstract     Related articles   

  712. STREETER EH, Little DM, Cranston DW, Morris PJ
    The urological complications of renal transplantation: a series of 1535 patients.
    BJU Int 2002; 90: 627-34.
    Abstract     Related articles   

  713. GHANEM AN
    Experience with ’capsule sparing’ cystoprostadenectomy for orthotopic bladder replacement: overcoming the problems of
    BJU Int 2002; 90: 617-20
    Abstract     Related articles   

  714. KULKARNI JN, Gupta R
    Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guerin (Danish 1331 strain).
    BJU Int 2002; 90: 554-7
    Abstract     Related articles   

  715. LANE T, Oliver T
    A study comparing various non-invasive methods of detecting bladder cancer in urine.
    BJU Int 2002; 90: 477
    Abstract     Related articles   

  716. THEODORE C, Bayle C, Bernheim A, Wibault P
    Secondary leukaemia after treating advanced bladder cancer with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and radiotherapy.
    BJU Int 2002; 90: 470-1
    Abstract     Related articles   

  717. ASAHI H, Koshida K, Hori O, Ogawa S, Namiki M
    Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer.
    BJU Int 2002; 90: 462-6
    Abstract     Related articles   

  718. SOULIE M, Seguin P, Martel P, Vazzoler N, Mouly P, Plante P
    A modified intussuscepted nipple in the Kock pouch urinary diversion: assessment of perioperative complications and functional results.
    BJU Int 2002; 90: 397-402
    Abstract     Related articles   

  719. GUPTA NP, Gill IS, Fergany A, Nabi G
    Laparoscopic radical cystectomy with intracorporeal ileal conduit diversion: five cases with a 2-year follow-up.
    BJU Int 2002; 90: 391-6
    Abstract     Related articles   

  720. MANSSON A, Davidsson T, Hunt S, Mansson W
    The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?
    BJU Int 2002; 90: 386-90
    Abstract     Related articles   

  721. KHAN MA, Shaw G, Paris AM
    Is microscopic haematuria a urological emergency?
    BJU Int 2002; 90: 355-7
    Abstract     Related articles   

  722. AVEYARD P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF
    Does smoking status influence the prognosis of bladder cancer? A systematic review.
    BJU Int 2002; 90: 228-239
    Abstract     Related articles   

  723. BERNUES M, Casadevall C, Caballin MR, Egozcue J, Miro R
    DNA hypermethylation at the D17S5 locus is not a frequent event in human urothelial cancer.
    BJU Int 2002; 90: 332-5
    Abstract     Related articles   

  724. HONG JH, Lee E, Hong J, Shin YJ, Ahn H
    Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines.
    BJU Int 2002; 90: 113-7
    Abstract     Related articles   

  725. MARINO G, Laudi M
    Ileal T-pouch as a urinary continent cutaneous diversion: clinical and urodynamic evaluation.
    BJU Int 2002; 90: 47-50
    Abstract     Related articles   

  726. TAYLOR JM, Pearce I, O’Flynn KJ
    Nurse-led cystoscopy: the next step.
    BJU Int 2002; 90: 45-6
    Abstract     Related articles   

  727. WALLACE DM, Bryan RT, Dunn JA, Begum G, Bathers S
    Delay and survival in bladder cancer.
    BJU Int 2002; 89: 868-78
    Abstract     Related articles   

  728. KANEKO T, Kurimoto S, Kume H, Kitamura T
    Accidental resection of bilateral ureteric orifices in a patient with ureterosigomoidostomy.
    BJU Int 2002; 89: 969-70
    Abstract     Related articles   

  729. YOSHIMURA K, Ichioka K, Terada N, Matsuta Y, Okubo K, Arai Y
    Retroperitoneoscopic tubeless cutaneous ureterostomy.
    BJU Int 2002; 89: 964-6
    Abstract     Related articles   

  730. MARTINEZ-PINEIRO JA, Flores N, Isorna S, Solsona E, Sebastian JL, Pertusa C et al
    Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer.
    BJU Int 2002; 89: 671-680
    Abstract     Related articles   

  731. SHACKLEY DC, Briggs C, Gilhooley A, Whitehurst C, O’Flynn KJ, Betts CD et al
    Photodynamic therapy for superficial bladder cancer under local anaesthetic.
    BJU Int 2002; 89: 665-70
    Abstract     Related articles   

  732. D’HALLEWIN MA, Kamuhabwa AR, Roskams T, De Witte PA, Baert L
    Hypericin-based fluorescence diagnosis of bladder carcinoma.
    BJU Int 2002; 89: 760-3
    Abstract     Related articles   

  733. LIPINSKI M, Jeromin L
    Comparison of the bladder tumour antigen test with photodynamic diagnosis in patients with pathologically confirmed recurrent superficial urinary bladder tumours.
    BJU Int 2002; 89: 757-9
    Abstract     Related articles   

  734. MALMSTROM PU
    A randomized comparative dose-ranging study of interferon-alpha and mitomycin-C as an internal control in primary or recurrent superficial transitional cell carcinoma of the bladder.
    BJU Int 2002; 89: 681-6
    Abstract     Related articles   

  735. BORKOWSKI A
    Superficial bladder cancer T1G3: the choice of treatment.
    BJU Int 2002; 89: 623-7
    Abstract     Related articles   

  736. KOLODZIEJ A, Dembowski J, Zdrojowy R, Wozniak P, Lorenz J
    Treatment of high-risk superficial bladder cancer with maintenance bacille Calmette-Guerin therapy: preliminary results.
    BJU Int 2002; 89: 620-2
    Abstract     Related articles   

  737. KOLACZYK W, Dembowski J, Lorenz J, Dudek K
    Evaluation of the influence of systemic neoadjuvant chemotherapy on the survival of patients treated for invasive bladder cancer.
    BJU Int 2002; 89: 616-9
    Abstract     Related articles   

  738. COOKE PW
    Evaluation of the cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment.
    BJU Int 2002; 89: 635
    Abstract     Related articles   

  739. YIOU R, Patard JJ, Benhard H, Abbou CC, Chopin DK
    Outcome of radical cystectomy for bladder cancer according to the disease type at presentation.
    BJU Int 2002; 89: 374-8
    Abstract     Related articles   

  740. SAAD A, Hanbury DC, McNicholas TA, Boustead GB, Morgan S, Woodman AC
    A study comparing various noninvasive methods of detecting bladder cancer in urine.
    BJU Int 2002; 89: 369-73
    Abstract     Related articles   

  741. CICCO A, de la Taille A, Saint F, Salomon L, Chopin DK, Abbou CC
    Appendicular abscess presenting as an infiltrating bladder tumour.
    BJU Int 2002; 89: 462-3
    Abstract     Related articles   

  742. YANAI H, Kubota Y, Nakada T
    Effects of electropermeabilization after the administration of anticancer drugs on transitional cell carcinoma.
    BJU Int 2002; 89: 438-42
    Abstract     Related articles   

  743. GAITONDE K, Goyal A, Nagaonkar S, Patil N, Singh DR, Srinivas V
    Retrospective review and long-term follow-up of radical cystectomy in a developing country.
    BJU Int 2002; 89 Suppl 1: 57-61
    Abstract     Related articles   

  744. GHONEIM MA
    Bilharziasis of the genitourinary tract.
    BJU Int 2002; 89 Suppl 1: 22-30
    Abstract     Related articles   

  745. DRYHURST DJ, Fowler CG
    A new small-calibre diagnostic flexible cystoscope.
    BJU Int 2002; 89: 194-6
    Abstract     Related articles   

  746. NAKAMURA K, Fujiyama C, Tokuda Y, Sugihara H, Masaki Z
    Bladder cancer cell implantation in reconstructed bladder in vitro: a model of tumour recurrence.
    BJU Int 2002; 89: 119-25
    Abstract     Related articles   

  747. HARA I, Miyake H, Hara S, Gotoh A, Nakamura I, Okada H et al
    Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement.
    BJU Int 2002; 89: 10-3
    Abstract     Related articles   

  748. EL-SOBKY E, Gomha M, El-Baz M, Abol-Enein H, Shaaban AA
    Prognostic significance of tumour angiogenesis in schistosoma- associated adenocarcinoma of the urinary bladder.
    BJU Int 2002; 89: 126-32
    Abstract     Related articles   

  749. EL-SHEIKH SS, Madaan S, Alhasso A, Abel P, Stamp G, Lalani EN
    Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer.
    BJU Int 2001; 88: 921-7
    Abstract     Related articles   

  750. POULAKIS V, Witzsch U, De Vries R, Altmannsberger H M, Manyak M J, Becht E
    A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
    BJU Int 2001; 88: 692-701
    Abstract     Related articles   

  751. SIMMS M S, Perkins A C, Price M R, Scholfield D P, Bishop M C
    99mTechnetium-C595 radioimmunoscintigraphy: a potential staging tool for bladder cancer.
    BJU Int 2001; 88: 686-91
    Abstract     Related articles   

  752. HERR H W
    Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?
    BJU Int 2001; 88: 683-5
    Abstract     Related articles   

  753. SAINT F, Patard JJ, Groux Muscatelli B, Lefrere Belda MA, Gil Diez de Medina S, Abbou CC et al
    Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment.
    BJU Int 2001; 88: 602-10
    Abstract     Related articles   

  754. MICHAUD DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D
    Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study.
    Br J Cancer 2002; 87: 960-5
    Abstract     Related articles   

  755. WATTERS AD, Latif Z, Forsyth A, Dunn I, Underwood MA, Grigor KM et al
    Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer.
    Br J Cancer 2002; 87: 654-8
    Abstract     Related articles   

  756. VALDIMARSDOTTIR U, Helgason AR, Furst CJ, Adolfsson J, Steineck G
    The unrecognised cost of cancer patients’ unrelieved symptoms:a nationwide follow-up of their surviving partners.
    Br J Cancer 2002; 86: 1540-5
    Abstract     Related articles   

  757. DANGLES V, Lazar V, Validire P, Richon S, Wertheimer M, Laville V et al
    Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.
    Br J Cancer 2002; 86: 1283-9
    Abstract     Related articles   

  758. TURNER KJ, Crew JP, Wykoff CC, Watson PH, Poulsom R, Pastorek J et al
    The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer.
    Br J Cancer 2002; 86: 1276-1282
    Abstract     Related articles   

  759. GARCIA DEL MURO X, Marcuello E, Guma J, Paz-Ares L, Climent MA, Carles J et al
    Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer.
    Br J Cancer 2002; 86: 326-30
    Abstract     Related articles   

  760. EDWARDS J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM
    Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Br J Cancer 2001; 85: 1894-9
    Abstract     Related articles   

  761. KIMURA F, Florl AR, Seifert HH, Louhelainen J, Maas S, Knowles MA et al
    Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
    Br J Cancer 2001; 85: 1887-93
    Abstract     Related articles   

  762. FAITHFULL S, Corner J, Meyer L, Huddart R, Dearnaley D
    Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy.
    Br J Cancer 2001; 85: 1853-64
    Abstract     Related articles   

  763. LE FRERE-BELDA MA, Cappellen D, Daher A, Gil-Diez-de-Medina S, Besse F, Abbou CC et al
    p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
    Br J Cancer 2001; 85: 1515-21
    Abstract     Related articles   

  764. CATTAN N, Rochet N, Mazeau C, Zanghellini E, Mari B, Chauzy C et al
    Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors.
    Br J Cancer 2001; 85: 1412-7
    Abstract     Related articles   

  765. WANNAMETHEE SG, Shaper AG, Walker M
    Physical activity and risk of cancer in middle-aged men.
    Br J Cancer 2001; 85: 1311-6
    Abstract     Related articles   

  766. TRIPATHI A, Folsom AR, Anderson KE
    Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women’s Health Study.
    Cancer 2002; 95: 2316-23.
    Abstract     Related articles   

  767. EHSAN A, Sommer F, Schmidt A, Klotz T, Koslowski J, Niggemann S et al
    Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.
    Cancer 2002; 95: 2293-301.
    Abstract     Related articles   

  768. RICCI S, Galli L, Chioni A, Iannopollo M, Antonuzzo A, Francesca F et al
    Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.
    Cancer 2002; 95: 1444-50
    Abstract     Related articles   

  769. HELPAP B
    Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Cancer 2002; 95: 1415-20
    Abstract     Related articles   

  770. RAO J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K et al
    Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
    Cancer 2002; 95: 1247-57
    Abstract     Related articles   

  771. YAN Y, Andriole GL, Humphrey PA, Kibel AS
    Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors.
    Cancer 2002; 95: 1239-46
    Abstract     Related articles   

  772. ZAAK D, Hungerhuber E, Schneede P, Stepp H, Frimberger D, Corvin S et al
    Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.
    Cancer 2002; 95: 1234-8
    Abstract     Related articles   

  773. VAUGHN DJ, Manola J, Dreicer R, See W, Levitt R, Wilding G
    Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): a trial of the Eastern Cooperative Oncology Group.
    Cancer 2002; 95: 1022-7
    Abstract     Related articles   

  774. GANDOUR-EDWARDS R, Lara PN Jr, Folkins AK, LaSalle JM, Beckett L, Li Y et al
    Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Cancer 2002; 95: 1009-15
    Abstract     Related articles   

  775. PICH A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Comino A et al
    Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
    Cancer 2002; 95: 784-90
    Abstract     Related articles   

  776. HSUEH SF, Lai MT, Yang CC, Chung YC, Hsu CP, Peng CC et al
    Association of overexpressed proline-directed protein kinase F(A) with chemoresistance, invasion, and recurrence in patients with bladder carcinoma.
    Cancer 2002; 95: 775-83
    Abstract     Related articles   

  777. BELLMUNT J, Albanell J, Paz-Ares L, Climent MA, Gonzalez-Larriba JL, Carles J et al
    Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.
    Cancer 2002; 95: 751-7
    Abstract     Related articles   

  778. HERR HW
    Pathologic evaluation of radical cystectomy specimens.
    Cancer 2002; 95: 668-9
    Abstract     Related articles   

  779. LOKESHWAR VB, Schroeder GL, Selzer MG, Hautmann SH, Posey JT, Duncan RC et al
    Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.
    Cancer 2002; 95: 61-72
    Abstract     Related articles   

  780. CURRY JL, Wojcik EM
    The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Cancer 2002; 96: 140-5
    Abstract     Related articles   

  781. NISMAN B, Barak V, Shapiro A, Golijanin D, Peretz T, Pode D
    Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Cancer 2002; 94: 2914-22
    Abstract     Related articles   

  782. OKAMURA K, Ono Y, Kinukawa T, Matsuura O, Yamada S, Ando T et al
    Randomized study of single early instillation of (2"R)-4’-O- tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
    Cancer 2002; 94: 2363-8
    Abstract     Related articles   

  783. WIENER HG, Remkes GW, Birner P, Pycha A, Schatzl G, Susani M et al
    DNA profiles and numeric histogram classifiers in nephrogenic adenoma.
    Cancer 2002; 96: 117-22
    Abstract     Related articles   

  784. RODRIGUEZ-ALONSO A, Pita-Fernandez S, Gonzalez-Carrero J, Nogueira-March JL
    Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma.
    Cancer 2002; 94: 1677-84
    Abstract     Related articles   

  785. NUMAHATA K, Satoh M, Handa K, Saito S, Ohyama C, Ito A et al
    Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma.
    Cancer 2002; 94: 673-85
    Abstract     Related articles   

  786. DIMOPOULOU I, Galani H, Dafni U, Samakovii A, Roussos C, Dimopoulos MA
    A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Cancer 2002; 94: 452-8
    Abstract     Related articles   

  787. CHENG L, Gu J, Ulbright TM, MacLennan GT, Sweeney CJ, Zhang S et al
    Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor.
    Cancer 2002; 94: 104-10
    Abstract     Related articles   

  788. STERNBERG CN, Calabro F, Pizzocaro G, Marini L, Schnetzer S, Sella A
    Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
    Cancer 2001; 92: 2993-8
    Abstract     Related articles   

  789. SHARIAT SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY et al
    Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.
    Cancer 2001; 92: 2985-92
    Abstract     Related articles   

  790. SANCHEZ-CARBAYO M, Urrutia M, Gonzalez de Buitrago JM, Navajo JA
    Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma.
    Cancer 2001; 92: 2820-8
    Abstract     Related articles   

  791. SANCHEZ-CARBAYO M, Ciudad J, Urrutia M, Navajo JA, Orfao A
    Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma.
    Cancer 2001; 92: 2811-9
    Abstract     Related articles   

  792. KIMURA T, Suzuki H, Ohashi T, Asano K, Kiyota H, Eto Y
    The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.
    Cancer 2001; 92: 2555-61
    Abstract     Related articles   

  793. STRONATI L, Gensabella G, Lamberti C, Barattini P, Frasca D, Tanzarella C et al
    Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma.
    Cancer 2001; 92: 2484-92
    Abstract     Related articles   

  794. KIM JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, Wheeler TM et al
    Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.
    Cancer 2001; 92: 1475-83
    Abstract     Related articles   

  795. SANCHEZ-CARBAYO M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G et al
    Molecular Profiling of Bladder Cancer Using cDNA Microarrays: Defining Histogenesis and Biological Phenotypes.
    Cancer Res 2002; 62: 6973-6980
    Abstract     Related articles   

  796. NGUYEN CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G et al
    Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2’-deoxycytidine.
    Cancer Res 2002; 62: 6456-61.
    Abstract     Related articles   

  797. GILDEA JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA et al
    RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
    Cancer Res 2002; 62: 6418-23.
    Abstract     Related articles   

  798. BESARATINIA A, Bates SE, Pfeifer GP
    Mutational Signature of the Proximate Bladder Carcinogen N-Hydroxy-4- acetylaminobiphenyl: Inconsistency with the p53 Mutational Spectrum in Bladder Cancer.
    Cancer Res 2002; 62: 4331-8
    Abstract     Related articles   

  799. TADA Y, Wada M, Taguchi K, Mochida Y, Kinugawa N, Tsuneyoshi M et al
    The Association of Death-associated Protein Kinase Hypermethylation with Early Recurrence in Superficial Bladder Cancers.
    Cancer Res 2002; 62: 4048-53
    Abstract     Related articles   

  800. CHENG J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT et al
    Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
    Cancer Res 2002; 62: 4157-63
    Abstract     Related articles   

  801. WATANABE R, Ohyama C, Aoki H, Takahashi T, Satoh M, Saito S et al
    Ganglioside g(m3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.
    Cancer Res 2002; 62: 3850-4
    Abstract     Related articles   

  802. ZHANG J, Ramesh N, Chen Y, Li Y, Dilley J, Working P et al
    Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
    Cancer Res 2002; 62: 3743-50
    Abstract     Related articles   

  803. THOMPSON TE, Rogan PK, Risinger JI, Taylor JA
    Splice Variants but not Mutations of DNA Polymerase beta Are Common in Bladder Cancer.
    Cancer Res 2002; 62: 3251-3256
    Abstract     Related articles   

  804. VELICESCU M, Weisenberger DJ, Gonzales FA, Tsai YC, Nguyen CT, Jones PA
    Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Cancer Res 2002; 62: 2378-84
    Abstract     Related articles   

  805. LIANG G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T
    Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2’-deoxycytidine.
    Cancer Res 2002; 62: 961-6
    Abstract     Related articles   

  806. GILDEA JJ, Harding MA, Seraj MJ, Gulding KM, Theodorescu D
    The role of Ral A in epidermal growth factor receptor-regulated cell motility.
    Cancer Res 2002; 62: 982-5
    Abstract     Related articles   

  807. HARTMANN A, Schlake G, Zaak D, Hungerhuber E, Hofstetter A, Hofstaedter F et al
    Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
    Cancer Res 2002; 62: 809-18
    Abstract     Related articles   

  808. MOHAMMED SI, Bennett PF, Craig BA, Glickman NW, Mutsaers AJ, Snyder PW et al
    Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
    Cancer Res 2002; 62: 356-8
    Abstract     Related articles   

  809. MARUYAMA R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S et al
    Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.
    Cancer Res 2001; 61: 8659-63
    Abstract     Related articles   

  810. HOGLUND M, Sall T, Heim S, Mitelman F, Mandahl N, Fadl-Elmula I
    Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
    Cancer Res 2001; 61: 8241-6
    Abstract     Related articles   

  811. FENG Z, Hu W, Rom WN, Beland FA, Tang MS
    4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene.
    Carcinogenesis 2002; 23: 1721-7
    Abstract     Related articles   

  812. WEI M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G et al
    Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
    Carcinogenesis 2002; 23: 1387-97
    Abstract     Related articles   

  813. MEISEL P
    Cancer, genes and gender.
    Carcinogenesis 2002; 23: 1087-8
    Abstract     Related articles   

  814. AIROLDI L, Orsi F, Magagnotti C, Coda R, Randone D, Casetta G et al
    Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies.
    Carcinogenesis 2002; 23: 861-866
    Abstract     Related articles   

  815. WANG L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y et al
    Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
    Carcinogenesis 2002; 23: 257-64
    Abstract     Related articles   

  816. IZAWA JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW et al
    Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by Interferon-beta Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis.
    Clin Cancer Res 2002; 8: 1258-1270
    Abstract     Related articles   

  817. DOMINGUEZ G, Carballido J, Silva J, Silva JM, Garcia JM, Menendez J et al
    p14ARF Promoter Hypermethylation in Plasma DNA as an Indicator of Disease Recurrence in Bladder Cancer Patients.
    Clin Cancer Res 2002; 8: 980-5
    Abstract     Related articles   

  818. TANNOCK IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ
    Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
    Clin Cancer Res 2002; 8: 878-84
    Abstract     Related articles   

  819. ONITA T, Ji PG, Xuan JW, Sakai H, Kanetake H, Maxwell PH et al
    Hypoxia-induced, Perinecrotic Expression of Endothelial Per?ARNT?Sim Domain Protein-1/Hypoxia-inducible Factor-2? Correlates with Tumor Progression, Vascularization, and Focal Macrophage Infiltration in Bladder Cancer.
    Clin Cancer Res 2002; 8: 471-480
    Abstract     Related articles   

  820. CHAN MW, Chan LW, Tang NL, Tong JH, Lo KW, Lee TL et al
    Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients.
    Clin Cancer Res 2002; 8: 464-470
    Abstract     Related articles   

  821. O’SHAUGHNESSY JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ et al
    Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
    Clin Cancer Res 2002; 8: 314-46
    Abstract     Related articles   

  822. LU ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z et al
    Impact of Alterations Affecting the p53 Pathway in Bladder Cancer on Clinical Outcome, Assessed by Conventional and Array-based Methods.
    Clin Cancer Res 2002; 8: 171-9
    Abstract     Related articles   

  823. UTTING M, Werner W, Dahse R, Schubert J, Junker K
    Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.
    Clin Cancer Res 2002; 8: 35-40
    Abstract     Related articles   

  824. GAZZANIGA P, Gradilone A, Frati L, Agliano AM
    Epidermal growth factor receptor mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure.
    Clin Cancer Res 2001; 7: 4288-9
    Abstract     Related articles   

  825. MIYAKE H, Hara I, Kamidono S, Gleave ME
    Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Clin Cancer Res 2001; 7: 4245-52
    Abstract     Related articles   

  826. DURKAN GC, Nutt JE, Rajjayabun PH, Neal DE, Lunec J, Mellon JK
    Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Clin Cancer Res 2001; 7: 3450-6
    Abstract     Related articles   

  827. STENMAN UH
    Tumor-associated trypsin inhibitor.
    Clin Chem 2002; 48: 1206-9
    Abstract     Related articles   

  828. CALABRO F, Sternberg CN
    High-risk metastatic urothelial cancer: chances for cure?
    Curr Opin Urol 2002; 12: 441-8
    Abstract     Related articles   


  829. Bibliography. Current world literature. Oncology: bladder and testis.
    Curr Opin Urol 2002; 12: 453-8
    Abstract     Related articles   

  830. TIGUERT R, Fradet Y
    New diagnostic and prognostic tools in bladder cancer.
    Curr Opin Urol 2002; 12: 239-43
    Abstract     Related articles   

  831. MEARINI E, Romani R, Mearini L, Antognelli C, Zucchi A, Baroni T et al
    Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas.
    Eur J Cancer 2002; 38: 1946-50
    Abstract     Related articles   

  832. WATTERS AD, Going JJ, Grigor KM, Bartlett JM
    Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours.
    Eur J Cancer 2002; 38: 1593-9
    Abstract     Related articles   

  833. STERNBERG CN
    Current perspectives in muscle invasive bladder cancer.
    Eur J Cancer 2002; 38: 460-7
    Abstract     Related articles   

  834. MONFARDINI S
    Medical oncology.
    Eur J Cancer 2001; 37 Suppl 7: S253-5
    Abstract     Related articles   

  835. VALENZUELA MT, Galisteo R, Zuluaga A, Villalobos M, Nunez MI, Oliver FJ et al
    Assessing the Use of p16(INK4a) Promoter Gene Methylation in Serum for Detection of Bladder Cancer.
    Eur Urol 2002; 42: 622-30.
    Abstract     Related articles   

  836. PLACER J, Espinet B, Salido M, Sole F, Gelabert-Mas A
    Clinical Utility of a Multiprobe FISH Assay in Voided Urine Specimens for the Detection of Bladder Cancer and its Recurrences, Compared with Urinary Cytology.
    Eur Urol 2002; 42: 547-52.
    Abstract     Related articles   

  837. GODDARD JC, Sutton CD, Jones JL, O’Byrne KJ, Kockelbergh RC
    Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer.
    Eur Urol 2002; 42: 464-8
    Abstract     Related articles   

  838. D’HALLEWIN MA, Bezdetnaya L, Guillemin F
    Fluorescence detection of bladder cancer: a review.
    Eur Urol 2002; 42: 417-25
    Abstract     Related articles   

  839. LEBRET T, Herve J, Yonneau L, Molinie V, Barre P, Lugagne P et al
    After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer?
    Eur Urol 2002; 42: 344
    Abstract     Related articles   

  840. KAASINEN E, Rintala E, Hellstrom P, Viitanen J, Juusela H, Rajala P et al
    Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma.
    Eur Urol 2002; 42: 167-74
    Abstract     Related articles   

  841. HARRIS NM, Crook TJ, Dyer JP, Solomon LZ, Bass P, Cooper AJ et al
    Intravesical meglumine gamma-linolenic Acid in superficial bladder cancer: an efficacy study.
    Eur Urol 2002; 42: 39-42
    Abstract     Related articles   

  842. HOTAKAINEN K, Haglund C, Paju A, Nordling S, Alfthan H, Rintala E et al
    Chorionic Gonadotropin beta-Subunit and Core Fragment in Bladder Cancer: mRNA and Protein Expression in Urine, Serum and Tissue.
    Eur Urol 2002; 41: 677-85
    Abstract     Related articles   

  843. PATARD JJ, Rodriguez A, Leray E, Rioux-Leclercq N, Guille F, Lobel B
    Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours.
    Eur Urol 2002; 41: 635-41
    Abstract     Related articles   

  844. BERGER AP, Parson W, Stenzl A, Steiner H, Bartsch G, Klocker H
    Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue.
    Eur Urol 2002; 41: 532-9
    Abstract     Related articles   

  845. BRAUSI M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA et al
    Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.
    Eur Urol 2002; 41: 523-31
    Abstract     Related articles   

  846. GSCHWEND JE, Dahm P, Fair WR
    Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy.
    Eur Urol 2002; 41: 440-8
    Abstract     Related articles   

  847. ARDELT P, Bohle A
    Molecular Aspects of Bladder Cancer IV: Gene Therapy of Bladder Cancer.
    Eur Urol 2002; 41: 372-81
    Abstract     Related articles   

  848. RAITANEN MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H et al
    Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis.
    Eur Urol 2002; 41: 284-9
    Abstract     Related articles   

  849. BASAKCI A, Kirkali Z, Tuzel E, Yorukoglu K, Mungan MU, Sade M
    Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder.
    Eur Urol 2002; 41: 342-5.
    Abstract     Related articles   

  850. KORKOLOPOULOU P, Lazaris ACh, Konstantinidou AE, Kavantzas N, Patsouris E, Christodoulou P et al
    Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.
    Eur Urol 2002; 41: 274-83.
    Abstract     Related articles   

  851. SATOH E, Miyao N, Tachiki H, Fujisawa Y
    Prediction of muscle invasion of bladder cancer by cystoscopy.
    Eur Urol 2002; 41: 178-81
    Abstract     Related articles   

  852. OOSTERLINCK W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C
    Guidelines on bladder cancer.
    Eur Urol 2002; 41: 105-12
    Abstract     Related articles   

  853. RODRIGUEZ-ALONSO A, Pita-Fernandez S, Gonzalez-Carrero J, Nogueira-March JL
    p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.
    Eur Urol 2002; 41: 182-8
    Abstract     Related articles   

  854. STENZL A, Bartsch G, Rogatsch H
    The remnant urothelium after reconstructive bladder surgery.
    Eur Urol 2002; 41: 124-31
    Abstract     Related articles   

  855. KAUSCH I, Bohle A
    Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer.
    Eur Urol 2002; 41: 15-29
    Abstract     Related articles   

  856. BABJUK M, Kostirova M, Mudra K, Pecher S, Smolova H, Pecen L et al
    Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.
    Eur Urol 2002; 41: 34-9
    Abstract     Related articles   

  857. SALVADOR-BAYARRI J, Rodriguez-Villamil L, Imperatore V, Palou Redorta J, Villavicencio-Mavrich H, Vicente-Rodriguez J
    Bladder neoplasms after nephroureterectomy: does the surgery of the lower ureter, transurethral resection or open surgery, influence the evolution?
    Eur Urol 2002; 41: 30-3
    Abstract     Related articles   

  858. DUGGAN BJ, Cotter FE, Kelly JD, Hamilton PW, McCallion K, Harkin D et al
    Antisense Bcl-2 oligonucleotide uptake in human transitional cell carcinoma.
    Eur Urol 2001; 40: 685-95
    Abstract     Related articles   

  859. JONSSON O, Olofsson G, Lindholm E, Tornqvist H
    Long-time experience with the Kock ileal reservoir for continent urinary diversion.
    Eur Urol 2001; 40: 632-40
    Abstract     Related articles   

  860. GERHARZ EW, Kohl UN, Melekos MD, Bonfig R, Weingartner K, Riedmiller H
    Ten years’ experience with the submucosally embedded in situ appendix in continent cutaneous diversion.
    Eur Urol 2001; 40: 625-31
    Abstract     Related articles   

  861. MARBERGER M, Stockle M, Pansadoro V, Sternberg CN
    Management and outcome in invasive and locally advanced bladder cancer.
    Eur Urol 2001; 40: 601-9
    Abstract     Related articles   

  862. OOSTERLINCK W, Bono AV, Mack D, Hall R, Sylvester R, de Balincourt C et al
    Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions.
    Eur Urol 2001; 40: 515-7
    Abstract     Related articles   

  863. VAN DIJK B, van Houwelingen KP, Witjes JA, Schalken JA, Kiemeney LA
    Alcohol Dehydrogenase Type 3 (ADH3) and the Risk of Bladder Cancer.
    Eur Urol 2001; 40: 509-14
    Abstract     Related articles   

  864. FRIEDRICH MG, Blind C, Milde-Langosch K, Erbersdobler A, Conrad S, Loning T et al
    Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
    Eur Urol 2001; 40: 518-24
    Abstract     Related articles   

  865. HOFER C, Kubler H, Hartung R, Breul J, Avril N
    Diagnosis and monitoring of urological tumors using positron emission tomography.
    Eur Urol 2001; 40: 481-7
    Abstract     Related articles   

  866. RAITANEN MP, Hellstrom P, Marttila T, Korhonen H, Talja M, Ervasti J et al
    Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test.
    Eur Urol 2001; 40: 422-6
    Abstract     Related articles   

  867. CHAHAL R, Darshane A, Browning AJ, Sundaram SK
    Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder.
    Eur Urol 2001; 40: 415-20
    Abstract     Related articles   

  868. POPOV I, Jelic S, Radosavljevic D, Nikolic-Tomasevic Z
    Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: a phase-II study.
    Eur Urol 2001; 40: 324-9
    Abstract     Related articles   

  869. BLANCHET P, Droupy S, Eschwege P, Viellefond A, Paradis V, Pichon MF et al
    Prospective evaluation of Ki-67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinoma.
    Eur Urol 2001; 40: 169-75
    Abstract     Related articles   

  870. SAGOL O, Yorukoglu K, Tuna B, Ozer E, Sis B, Guray M et al
    Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas.
    Eur Urol 2001; 40: 163-8
    Abstract     Related articles   

  871. JAKSE G, Hall R, Bono A, Holtl W, Carpentier P, Spaander JP et al
    Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861.
    Eur Urol 2001; 40: 144-50
    Abstract     Related articles   

  872. KRUGER S, Weitsch G, Buttner H, Matthiensen A, Bohmer T, Marquardt T et al
    HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications.
    Int J Cancer 2002; 102: 514-8.
    Abstract     Related articles   

  873. BISSON JF, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F
    A new method of implanting orthotopic rat bladder tumor for experimental therapies.
    Int J Cancer 2002; 102: 280-5
    Abstract     Related articles   

  874. KASSEM HSH, Sangar V, Cowan R, Clarke N, Margison GP
    A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer.
    Int J Cancer 2002; 101: 454-60
    Abstract     Related articles   

  875. AMIRA N, Mourah S, Rozet F, Teillac P, Fiet J, Aubin P et al
    Non-invasive molecular detection of bladder cancer recurrence.
    Int J Cancer 2002; 101: 293-7
    Abstract     Related articles   

  876. KOCHER T, Zheng M, Bolli M, Simon R, Forster T, Schultz-Thater E et al
    Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study.
    Int J Cancer 2002; 100: 702-5
    Abstract     Related articles   

  877. VAN GILS CH, Conway K, Li Y, Taylor JA
    HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.
    Int J Cancer 2002; 100: 414-8
    Abstract     Related articles   

  878. KNIGHT A, Askling J, Ekbom A
    Cancer incidence in a population-based cohort of patients with Wegener’s granulomatosis.
    Int J Cancer 2002; 100: 82-5
    Abstract     Related articles   

  879. SEDDIGHZADEH M, Steineck G, Larsson P, Wijkstrom H, Norming U, Onelov E et al
    Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms.
    Int J Cancer 2002; 99: 721-6
    Abstract     Related articles   

  880. LANG K, Niggemann B, Zanker KS, Entschladen F
    Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop.
    Int J Cancer 2002; 99: 673-80
    Abstract     Related articles   

  881. HEMMINKI K, Li X
    Cancer risks in second-generation immigrants to Sweden.
    Int J Cancer 2002; 99: 229-37
    Abstract     Related articles   

  882. REIHER FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J et al
    Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
    Int J Cancer 2002; 98: 682-9
    Abstract     Related articles   

  883. OHANA P, Bibi O, Matouk I, Levy C, Birman T, Ariel I et al
    Use of H19 regulatory sequences for targeted gene therapy in cancer.
    Int J Cancer 2002; 98: 645-50
    Abstract     Related articles   

  884. TADA Y, Wada M, Migita T, Nagayama J, Hinoshita E, Mochida Y et al
    Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
    Int J Cancer 2002; 98: 630-5
    Abstract     Related articles   

  885. GROMOVA I, Gromov P, Celis JE
    bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.
    Int J Cancer 2002; 98: 539-46
    Abstract     Related articles   

  886. DANGLES V, Validire P, Wertheimer M, Richon S, Bovin C, Zeliszewski D et al
    Impact of human bladder cancer cell architecture on autologous T- lymphocyte activation.
    Int J Cancer 2002; 98: 51-56
    Abstract     Related articles   

  887. WANG L, Habuchi T, Takahashi T, Kamoto T, Zuo T, Mitsumori K et al
    No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
    Int J Cancer 2002; 97: 787-90
    Abstract     Related articles   

  888. SGAMBATO A, Migaldi M, Faraglia B, De Aloysio G, Ferrari P, Ardito R et al
    Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
    Int J Cancer 2002; 97: 671-8
    Abstract     Related articles   

  889. KAMUHABWA AA, Cosserat-Gerardin I, Didelon J, Notter D, Guillemin F, Roskams T et al
    Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.
    Int J Cancer 2002; 97: 253-60
    Abstract     Related articles   

  890. ZOUHAIR A, Ozsahin M, Schneider D, Bauer J, Jichlinski P, Roth A et al
    Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin.
    Int J Cancer 2001; 96: 350-5
    Abstract     Related articles   

  891. GAGO-DOMINGUEZ M, Chan KK, Ross RK, Yu MC
    Permanent hair dyes and bladder cancer risk.
    Int J Cancer 2001; 94: 905-906
    Abstract     Related articles   

  892. HENLEY SJ, Thun MJ
    Use of permanent hair dyes and bladder-cancer risk.
    Int J Cancer 2001; 94: 903-904
    Abstract     Related articles   

  893. MILLER AB, Bartsch H
    Hair dye use and bladder cancer.
    Int J Cancer 2001; 94: 901-902
    Abstract     Related articles   

  894. SERIPA D, Parrella P, Gallucci M, Gravina C, Papa S, Fortunato P et al
    Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine.
    Int J Cancer 2001; 95: 364-9
    Abstract     Related articles   

  895. HEMMINKI K, Li X
    Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden.
    Int J Cancer 2001; 94: 444-8
    Abstract     Related articles   

  896. KAWAMURA S, Ohyama C, Watanabe R, Satoh M, Saito S, Hoshi S et al
    Glycolipid composition in bladder tumor: a crucial role of GM3 ganglioside in tumor invasion.
    Int J Cancer 2001; 94: 343-7
    Abstract     Related articles   

  897. STOEHR R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D et al
    No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Int J Oncol 2002; 20: 905-11
    Abstract     Related articles   

  898. JUNKER K, Kania K, Fiedler W, Hartmann A, Schubert J, Werner W
    Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.
    Int J Oncol 2002; 20: 647-53
    Abstract     Related articles   

  899. DAHSE R, Utting M, Werner W, Schimmel B, Claussen U, Junker K
    TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Int J Oncol 2002; 20: 107-15
    Abstract     Related articles   

  900. NOMURA T, Nakagawa M, Fujita Y, Hanada T, Mimata H, Nomura Y
    Clinical significance of thymidylate synthase expression in bladder cancer.
    Int J Urol 2002; 9: 368-76
    Abstract     Related articles   

  901. OGISHIMA T, Kawachi Y, Saito A, Suzuki F, Ishi K, Tanaka T
    Sarcomatoid carcinoma and carcinosarcoma of the urinary bladder.
    Int J Urol 2002; 9: 354-8
    Abstract     Related articles   

  902. KUROKAWA K, Suzuki K, Okazaki H, Ito K, Shiono A, Fukabori Y et al
    Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results.
    Int J Urol 2002; 9: 237-40
    Abstract     Related articles   

  903. IWASAKI A, Kawai K, Hayashi H, Ikeda N, Toida I, Ohtani M et al
    Immunological protection induced by bacillus Calmette-Guerin treatment in a murine bladder tumor model.
    Int J Urol 2002; 9: 219-24
    Abstract     Related articles   

  904. MUROTA T, Komai Y, Danno S, Fujita I, Kawakita M, Matsuda T
    Endoscopic partial cystectomy for bladder leiomyoma using retroperitoneoscopic and transurethral procedures.
    Int J Urol 2002; 9: 190-2
    Abstract     Related articles   

  905. SOUSA-ESCANDON A, Vazquez S, Quintero-Aldana G, Picallo JA, Neira J, Garcia-Novio F et al
    Neo-adjuvant treatment of infiltrating transitional-cell carcinoma of the bladder with paclitaxel and cisplatin: a phase II trial.
    Int J Urol 2002; 9: 162-6
    Abstract     Related articles   

  906. KURODA M, Meguro N, Maeda O, Saiki S, Kinouchi T, Usami M et al
    Stage specific follow-up strategy after cystectomy for carcinoma of the bladder.
    Int J Urol 2002; 9: 129-33
    Abstract     Related articles   

  907. MATSUI Y, Fujikawa K, Iwamura H, Oka H, Fukuzawa S, Takeuchi H
    Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel.
    Int J Urol 2002; 9: 122-4
    Abstract     Related articles   

  908. NAKAMURA E, Terachi T, Kamoto T, Okuno H, Terai A, Kakehi Y et al
    Retroperitoneoscopic ureterocutaneostomy for obstructive uropathy with advanced bladder cancer: A case report.
    Int J Urol 2002; 9: 60-62
    Abstract     Related articles   

  909. KAWAKAMI M, Ishikawa M, Kontani K, Iijima K, Kobayashi S, Nishizawa O
    Flexible video cystoscope with built-in high-frequency cauterizing element for transurethral resection of bladder tumor.
    Int J Urol 2001; 8: 713-4
    Abstract     Related articles   

  910. HONDA N, Yamada Y, Okada M, Aoki S, Kamijyo A, Taki T et al
    Clinical study of transitional cell carcinoma of the prostate associated with bladder transitional cell carcinoma.
    Int J Urol 2001; 8: 662-8
    Abstract     Related articles   

  911. FUJITA K, Nishimura K, Nonomura N, Hirota S, Okuyama A
    Early stage small cell carcinoma of the urinary bladder.
    Int J Urol 2001; 8: 643-4
    Abstract     Related articles   

  912. SEKINE H, Ohya K, Kojima SI, Igarashi K, Fukui I
    Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder.
    Int J Urol 2001; 8: 483-6
    Abstract     Related articles   

  913. CAM K, Yildirim A, Ozveri H, Turkeri L, Akdas A
    The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.
    Int Urol Nephrol 2002; 33: 49-52
    Abstract     Related articles   

  914. BAYRAKTAR Z, Sevin G, Gurbuz G, Tasci AI
    Ileal orthotopic neobladder in women: the first experiences from Turkey and our modifications.
    Int Urol Nephrol 2001; 32: 371-5
    Abstract     Related articles   

  915. TEKIN A, Aki FT, Ozen H
    Radical cystectomy versus alternative treatments for muscle-confined bladder cancer.
    Int Urol Nephrol 2001; 33: 357-62
    Abstract     Related articles   

  916. GOEL A, Goel A
    Carcinoma urinary bladder presenting as acute abdomen.
    Int Urol Nephrol 2001; 33: 491-2
    Abstract     Related articles   

  917. PALOU J, Rodriguez-Villamil L, Andreu-Crespo A, Salvador-Bayarri J, Vicente-Rodriguez J
    Intravesical treatment of severe bacillus Calmette-Guerin cystitis.
    Int Urol Nephrol 2001; 33: 485-9
    Abstract     Related articles   

  918. STAVROPOULOS NE, Filliadis I, Ioachim E, Michael M, Mermiga E, Hastazeris K et al
    CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors.
    Int Urol Nephrol 2001; 33: 479-83
    Abstract     Related articles   

  919. YENIYOL CO, Suelozgen T, Vardar E, Sural S, Postaci H, Ayder AR
    The relation of mutant p53 accumulation in transitional cell carcinoma of bladder with pathological stage, grade, recurrence and survival.
    Int Urol Nephrol 2001; 33: 473-8
    Abstract     Related articles   

  920. PIERAS-AYALA E, Palou-Redorta J, Tomero-Ruiz JI, Montlleo-Gonzalez M, Salvador-Bayarri J, Vicente-Rodriguez J
    Prognostic value of cystocopically pseudotumoral lesions (inflammation/granuloma) in primary stage T1 grade 3 bladder tumors treated with BCG.
    Int Urol Nephrol 2001; 33: 469-72
    Abstract     Related articles   

  921. SINGH I, Seth A
    Pedunculated prolapsing bladder hematoma (pseudotumor) mimicking an anterior vaginal polyp--a clinical curiosity and rare complication of transurethral resection of bladder tumor.
    Int Urol Nephrol 2001; 33: 467-8
    Abstract     Related articles   

  922. AYAN S, Gokce G, Kilicarslan H, Ozdemir O, Yildiz E, Gultekin EY
    K-RAS mutation in transitional cell carcinoma of urinary bladder.
    Int Urol Nephrol 2001; 33: 363-7.
    Abstract     Related articles   

  923. KARAKOK M, Aydin A, Bakir K, Ucak R, Korkmaz C
    AgNOR/P53 expression compared with different grades in bladder carcinoma.
    Int Urol Nephrol 2001; 33: 353-5.
    Abstract     Related articles   

  924. ANSARI MS, Goel A, Goel S, Durairajan LN, Seth A
    Malignant paraganglioma of the urinary bladder. A case report.
    Int Urol Nephrol 2001; 33: 343-5.
    Abstract     Related articles   

  925. DALBAGNI G, Russo P, Sheinfeld J, Mazumdar M, Tong W, Rabbani F et al
    Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin- refractory transitional-cell carcinoma of the bladder.
    J Clin Oncol 2002; 20: 3193-8
    Abstract     Related articles   

  926. CRAWFORD ED
    Intravesical therapy for superficial cancer: need for more options.
    J Clin Oncol 2002; 20: 3185-6
    Abstract     Related articles   

  927. RODEL C, Grabenbauer GG, Kuhn R, Papadopoulos T, Dunst J, Meyer M et al
    Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.
    J Clin Oncol 2002; 20: 3061-71
    Abstract     Related articles   

  928. GOSPODAROWICZ M
    Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?
    J Clin Oncol 2002; 20: 3048-50
    Abstract     Related articles   

  929. CHENG HL, Trink B, Tzai TS, Liu HS, Chan SH, Ho CL et al
    Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation.
    J Clin Oncol 2002; 20: 1544-50
    Abstract     Related articles   

  930. KUBALL J, Wen SF, Leissner J, Atkins D, Meinhardt P, Quijano E et al
    Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation.
    J Clin Oncol 2002; 20: 957-65
    Abstract     Related articles   

  931. VAUGHN DJ, Broome CM, Hussain M, Gutheil JC, Markowitz AB
    Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer.
    J Clin Oncol 2002; 20: 937-40
    Abstract     Related articles   

  932. OSCIER D, Bramble J, Hodges E, Wright D
    Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy.
    J Clin Oncol 2002; 20: 882
    Abstract     Related articles   

  933. VOGELZANG NJ
    Neoadjuvant MVAC: the long and winding road is getting shorter and straighter.
    J Clin Oncol 2001; 19: 4003-4
    Abstract     Related articles   

  934. XIAO Z, Brown K, Tulip J, Moore RB
    Whole Bladder Photodynamic Therapy for Orthotopic Superficial Bladder Cancer in Rats: A Study of Intravenous and Intravesical Administration of Photosensitizers.
    J Urol 2003; 169: 352-356.
    Abstract     Related articles   

  935. YOSSEPOWITCH O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW et al
    Orthotopic Urinary Diversion After Cystectomy For Bladder Cancer: Implications For Cancer Control And Patterns Of Disease Recurrence.
    J Urol 2003; 169: 177-181.
    Abstract     Related articles   

  936. STEIN JP
    Editorial: contemporary concepts of radical cystectomy and the treatment of bladder cancer.
    J Urol 2003; 169: 116-7.
    Abstract     Related articles   

  937. SHAHIN O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE, Herr HW
    A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival.
    J Urol 2003; 169: 96-100.
    Abstract     Related articles   

  938. BOHLE A, Jocham D, Bock PR
    Intravesical bacillus calmette-guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity.
    J Urol 2003; 169: 90-5.
    Abstract     Related articles   

  939. BOHM M, Wieland I, Schmidt C, Rubben H, Allhoff EP
    Loss of Heterozygosity on Chromosome 5p13-12 Predicts Adverse Prognosis in Advanced Bladder Cancer Independent of Tumor Stage and Grade.
    J Urol 2002; 168: 2655-2658
    Abstract     Related articles   

  940. MIZUTANI Y, Kamoi K, Ukimura O, Kawauchi A, Miki T
    Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
    J Urol 2002; 168: 2650-4.
    Abstract     Related articles   

  941. VALLANCIEN G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G, Guillonneau B
    Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience.
    J Urol 2002; 168: 2413-7.
    Abstract     Related articles   

  942. THIOUNN N, Pages F, Mejean A, Descotes JL, Fridman WH, Romet-Lemonne JL
    Adoptive Immunotherapy For Superficial Bladder Cancer With Autologous Macrophage Activated Killer Cells.
    J Urol 2002; 168: 2373-2376
    Abstract     Related articles   

  943. YOSHIMURA I, Ikegami S, Suzuki S, Tadakuma T, Hayakawa M
    Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system.
    J Urol 2002; 168: 2659-64.
    Abstract     Related articles   

  944. WRIGHT KO, Messing EM, Reeder JE
    Increased expression of the acid sphingomyelinase-like protein ASML3a in bladder tumors.
    J Urol 2002; 168: 2645-9.
    Abstract     Related articles   

  945. BEX A, Vooijs M, Horenblas S, Berns A
    Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.
    J Urol 2002; 168: 2641-4.
    Abstract     Related articles   

  946. KINDERS RJ, Landicho H
    Re: The BTA stat test is nonspecific for hematuria: an experimental hematuria model.
    J Urol 2002; 168: 2556
    Abstract     Related articles   

  947. SPRANGER R, Steiner H, Berger A, Horninger W, Bartsch G
    Intravesical free-floating prostate.
    J Urol 2002; 168: 2543-4.
    Abstract     Related articles   

  948. YAKOUT HH, Bissada NK, Picklesimer FL
    Recurrent superficial papillary adenocarcinoma of the bladder.
    J Urol 2002; 168: 2538-9.
    Abstract     Related articles   

  949. SHIOJI Y, Muraishi O, Tokue A
    A deserosalized muscle layer covering method for antireflux ureteroileostomy: a preliminary clinical trial.
    J Urol 2002; 168: 2521-3.
    Abstract     Related articles   

  950. PAREKH DJ, Clark T, O’Connor J, Jung C, Chang SS, Cookson M et al
    Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions.
    J Urol 2002; 168: 2454-6.
    Abstract     Related articles   

  951. SEOW SW, Rahmat JN, Mohamed AA, Mahendran R, Lee YK, Bay BH
    Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin).
    J Urol 2002; 168: 2236-9
    Abstract     Related articles   

  952. KUMAR A, Dubey D, Bansal P, Mandhani A, Naik S
    Urinary interleukin-8 predicts the response of standard and low dose intravesical bacillus Calmette-Guerin (modified Danish 1331 strain) for superficial bladder cancer.
    J Urol 2002; 168: 2232-5
    Abstract     Related articles   

  953. SAGA Y, Hashimoto H, Yachiku S, Tokumitsu M, Kaneko S
    Immunohistochemical expression of metallothionein in human bladder cancer: correlation with histopathological parameters and patient survival.
    J Urol 2002; 168: 2227-31
    Abstract     Related articles   

  954. SHIINA H, Igawa M, Shigeno K, Terashima M, Deguchi M, Yamanaka M et al
    Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer.
    J Urol 2002; 168: 2220-6
    Abstract     Related articles   

  955. SYLVESTER RJ, van der MEIJDEN AP, Lamm DL
    Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.
    J Urol 2002; 168: 1964-70
    Abstract     Related articles   

  956. BOMAN H, Hedelin H, Jacobsson S, Holmang S
    Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status.
    J Urol 2002; 168: 1955-9
    Abstract     Related articles   

  957. SAROSDY MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L et al
    Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
    J Urol 2002; 168: 1950-4
    Abstract     Related articles   

  958. DROLLER MJ
    Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
    J Urol 2002; 168: 2308-9
    Abstract     Related articles   

  959. DROLLER MJ
    Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.
    J Urol 2002; 168: 2307-8
    Abstract     Related articles   

  960. DROLLER MJ
    A study comparing various noninvasive methods of detecting bladder cancer in urine.
    J Urol 2002; 168: 2303-4
    Abstract     Related articles   

  961. DROLLER MJ
    Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions.
    J Urol 2002; 168: 2303
    Abstract     Related articles   

  962. MALMSTROM PU, Ren ZP, Sherif A, de la Torre M, Wester K, Thorn M
    Early metastatic progression of bladder carcinoma: molecular profile of primary tumor and sentinel lymph node.
    J Urol 2002; 168: 2240-4
    Abstract     Related articles   

  963. UESUGI T, Uno S, Hayashi K
    Colonic adenocarcinoma associated with dysplastic lesions in an indiana pouch.
    J Urol 2002; 168: 2117
    Abstract     Related articles   

  964. JESCHKE K, Wakonig J, Winzely M, Henning K
    Laparoscopic partial cystectomy for leiomyoma of the bladder wall.
    J Urol 2002; 168: 2115-6
    Abstract     Related articles   

  965. PETERSON AC, Lance RS, Ahuja S
    Laparoscopic hand assisted radical cystectomy with ileal conduit urinary diversion.
    J Urol 2002; 168: 2103-5
    Abstract     Related articles   

  966. THOENY HC, Sonnenschein MJ, Madersbacher S, Vock P, Studer UE
    Is ileal orthotopic bladder substitution with an afferent tubular segment detrimental to the upper urinary tract in the long term?
    J Urol 2002; 168: 2030-4
    Abstract     Related articles   

  967. XU YM, Qiao Y, Wu DL, Sa YL, Chen Z, Chen R et al
    Efferent tube suspension as a continent diversion mechanism: a preliminary report of a clinical study.
    J Urol 2002; 168: 2027-9
    Abstract     Related articles   

  968. PORTER MP, Voigt LF, Penson DF, Weiss NS
    Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States.
    J Urol 2002; 168: 1960-3
    Abstract     Related articles   

  969. ISURUGI K, Suzuki Y, Tanji S, Fujioka T
    Detection Of The Presence Of Catalytic Subunit Mrna Associated With Telomerase Gene In Exfoliated Urothelial Cells From Patients With Bladder Cancer.
    J Urol 2002; 168: 1574-1577
    Abstract     Related articles   

  970. WHEELER MA, Hausladen DA, Yoon JH, Weiss RM
    Prostaglandin E2 Production and Cyclooxygenase-2 Induction in Human Urinary Tract Infections and Bladder Cancer.
    J Urol 2002; 168: 1568-1573
    Abstract     Related articles   

  971. WILKINSON BA, Smallwood RH, Keshtar A, Lee JA, Hamdy FC
    Electrical impedance spectroscopy and the diagnosis of bladder pathology: a pilot study.
    J Urol 2002; 168: 1563-7
    Abstract     Related articles   

  972. KLAUSNER AP, Unger P, Fine EM
    Recurrent prostatic stromal proliferation of uncertain malignant potential: a therapeutic challenge.
    J Urol 2002; 168: 1493-4
    Abstract     Related articles   

  973. SEKINE H, Ohya K, Kojima S, Mizuguchi K
    Dermatomyositis associated with urachal adenocarcinoma.
    J Urol 2002; 168: 1488-9
    Abstract     Related articles   

  974. CHIU W, Radhakrishnan V, Lin CH, Huan SK, Wu MP
    Internal bladder retractor for laparoscopic cystectomy in the female patient.
    J Urol 2002; 168: 1479-81
    Abstract     Related articles   

  975. CHANG SS, Cole E, Cookson MS, Peterson M, Smith JA Jr
    Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results.
    J Urol 2002; 168: 1442-5
    Abstract     Related articles   

  976. THALMANN GN, Markwalder R, Walter B, Studer UE
    Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    J Urol 2002; 168: 1381-5
    Abstract     Related articles   

  977. SAZAWA A, Watanabe T, Tanaka M, Haga K, Fujita H, Harabayashi T et al
    Adenovirus Mediated Gelsolin Gene Therapy for Orthotopic Human Bladder Cancer in Nude Mice.
    J Urol 2002; 168: 1182-1187
    Abstract     Related articles   

  978. URAKAMI S, Igawa M, Shiina H, Shigeno K, Kikuno N, Yoshino T
    Recurrent transitional cell carcinoma in a child with the Costello syndrome.
    J Urol 2002; 168: 1133-4
    Abstract     Related articles   

  979. MANGIAROTTI B, Trinchieri A, Marconato R, Pisani E
    Skin abscess after intravesical instillation of bacillus Calmette- Guerin for prophylactic treatment of transitional cell carcinoma.
    J Urol 2002; 168: 1094-5
    Abstract     Related articles   

  980. GABOARDI F, Simonato A, Galli S, Lissiani A, Gregori A, Bozzola A
    Minimally invasive laparoscopic neobladder.
    J Urol 2002; 168: 1080-3
    Abstract     Related articles   

  981. HERR HW, Donat SM, Dalbagni G
    Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.
    J Urol 2002; 168: 978-80
    Abstract     Related articles   

  982. ROMANENKO A, Morimura K, Wei M, Zaparin W, Vozianov A, Fukushima S
    DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine.
    J Urol 2002; 168: 973-7
    Abstract     Related articles   

  983. MURPHY WM, Takezawa K, Maruniak NA
    Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care.
    J Urol 2002; 168: 968-72
    Abstract     Related articles   

  984. POOK SH, Esuvaranathan K, Mahendran R
    N-Acetylcysteine Augments The Cellular Redox Changes and Cytotoxic Activity of Internalized Mycobacterium Bovis in Human Bladder Cancer Cells.
    J Urol 2002; 168: 780-785
    Abstract     Related articles   

  985. KRIEGMAIR M, Zaak D, Rothenberger KH, Rassweiler J, Jocham D, Eisenberger F et al
    Transurethral Resection For Bladder Cancer Using 5-Aminolevulinic Acid Induced Fluorescence Endoscopy Versus White Light Endoscopy.
    J Urol 2002; 168: 475-478
    Abstract     Related articles   

  986. EISSA S, Swellam M, Sadek M, Mourad MS, Ahmady OE, Khalifa A
    Comparative Evaluation of the Nuclear Matrix Protein, Fibronectin, Urinary Bladder Cancer Antigen and Voided Urine Cytology in the Detection of Bladder Tumors.
    J Urol 2002; 168: 465-469
    Abstract     Related articles   

  987. RATLIFF TL
    bc10: a novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.
    J Urol 2002; 168: 884-5
    Abstract     Related articles   

  988. DROLLER MJ
    Risk of continued intravesical therapy and delayed cystectomy in the BCG-refractory superficial bladder cancer: an investigational approach.
    J Urol 2002; 168: 858-9
    Abstract     Related articles   

  989. DROLLER MJ
    Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer.
    J Urol 2002; 168: 854
    Abstract     Related articles   

  990. DUREK C, Jurczok A, Werner H, Jocham D, Bohle A
    Optimal treatment of systemic bacillus Calmette-Guerin infection: investigations in an animal model.
    J Urol 2002; 168: 826-31
    Abstract     Related articles   

  991. CHEN FH, Crist SA, Zhang GJ, Iwamoto Y, See WA
    Interleukin-6 production by human bladder tumor cell lines is up- regulated by bacillus Calmette-Guerin through nuclear factor-kappaB and Ap-1 via an immediate early pathway.
    J Urol 2002; 168: 786-97
    Abstract     Related articles   

  992. STEINBERG GD, Rinker-Schaeffer CW, Sokoloff MH, Brendler CB
    Highlights of the Society of Urologic Oncology meeting, June 2, 2001.
    J Urol 2002; 168: 653-9
    Abstract     Related articles   

  993. PATEL HR, Albehussi S, Arya M, Miller RA
    Can oxybutynin cause peripheral neuropathy?
    J Urol 2002; 168: 646
    Abstract     Related articles   

  994. LIN JT, Wang WH, Yen CC, Yu IT, Chen PM
    Prurigo nodularis as initial presentation of metastatic transitional cell carcinoma of the bladder.
    J Urol 2002; 168: 631-2
    Abstract     Related articles   

  995. ALI-EL-DEIN B, Gomha M, Ghoneim MA
    Critical evaluation of the problem of chronic urinary retention after orthotopic bladder substitution in women.
    J Urol 2002; 168: 587-92
    Abstract     Related articles   

  996. FRIEDRICH MG, Hellstern A, Hautmann SH, Graefen M, Conrad S, Huland E et al
    Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
    J Urol 2002; 168: 470-4
    Abstract     Related articles   

  997. VAN DER POEL HG, Molenaar B, Van BEUSECHEM VW, Haisma HJ, Rodriguez R, Curiel DT et al
    Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.
    J Urol 2002; 168: 266-72
    Abstract     Related articles   

  998. GOEBELL PJ, Otto T, Suhr J, Rubben H
    Evaluation of an Unconventional Treatment Modality with Mistletoe Lectin to Prevent Recurrence of Superficial Bladder Cancer: A Randomized Phase ii Trial.
    J Urol 2002; 168: 72-75
    Abstract     Related articles   

  999. LILIEN OM
    Re: 25-year experience with replacement of the human bladder (Camey procedure).
    J Urol 2002; 168: 203
    Abstract     Related articles   

  1000. BRANDAU S, Bohle A
    Re: Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2.
    J Urol 2002; 168: 199-200
    Abstract     Related articles   

  1001. WOODS SD, Reisner GS
    Ureteral stenting via an ileal conduit using a gastroscope.
    J Urol 2002; 168: 185
    Abstract     Related articles   

  1002. HENNINGSOHN L, Steven K, Kallestrup EB, Steineck G
    Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population.
    J Urol 2002; 168: 168-74
    Abstract     Related articles   

  1003. DUTTA SC, Chang SC, Coffey CS, Smith JA Jr, Jack G, Cookson MS
    Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder.
    J Urol 2002; 168: 164-7
    Abstract     Related articles   

  1004. CHANG SS, Cole E, Smith JA Jr, Cookson MS
    Pathological findings of gynecologic organs obtained at female radical cystectomy.
    J Urol 2002; 168: 147-9
    Abstract     Related articles   

  1005. FILBECK T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W
    Clinically relevant improvement of recurrence-free survival with 5- aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
    J Urol 2002; 168: 67-71
    Abstract     Related articles   

  1006. YOSSEPOWITCH O, Dalbagni G
    Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome.
    J Urol 2002; 168: 61-6
    Abstract     Related articles   

  1007. GILL IS, Kaouk JH, Meraney AM, Desai MM, Ulchaker JC, Klein EA et al
    Laparoscopic radical cystectomy and continent orthotopic ileal neobladder performed completely intracorporeally: the initial experience.
    J Urol 2002; 168: 13-8
    Abstract     Related articles   

  1008. WARD JN, Dong WF, Pitts WR Jr
    Lymphoepithelioma-like carcinoma of the bladder.
    J Urol 2002; 167: 2523-4
    Abstract     Related articles   

  1009. MASTER VA, Meng MV, Koppie TM, Carroll PR, Grossfeld GD
    Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization.
    J Urol 2002; 167: 2521-2
    Abstract     Related articles   

  1010. MAHMOUD-AHMED AS, Suh JH, Kupelian PA, Klein EA, Peereboom DM, Dreicer R et al
    Brain metastases from bladder carcinoma: presentation, treatment and survival.
    J Urol 2002; 167: 2419-22
    Abstract     Related articles   

  1011. DE LA ROSA F, Garcia-Carbonero R, Passas J, Rosino A, Lianes P, Paz-Ares L
    Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
    J Urol 2002; 167: 2413-8
    Abstract     Related articles   

  1012. GRIFFITHS TR, Charlton M, Neal DE, Powell PH
    Treatment of carcinoma in situ with intravesical bacillus Calmette- Guerin without maintenance.
    J Urol 2002; 167: 2408-12
    Abstract     Related articles   

  1013. MARUNIAK NA, Takezawa K, Murphy WM
    Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling.
    J Urol 2002; 167: 2404-7
    Abstract     Related articles   

  1014. DROLLER MJ
    Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.
    J Urol 2002; 167: 2297-8
    Abstract     Related articles   

  1015. KAASINEN ES, Harju LM, Timonen TT
    Inhibition of natural, interleukin-2 stimulated and bacillus Calmette- Guerin enhanced cytotoxicity with anti-CD16 antibodies.
    J Urol 2002; 167: 2209-14
    Abstract     Related articles   

  1016. HIRASAWA K, Kitamura T, Oka T, Matsushita H
    Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein.
    J Urol 2002; 167: 2130
    Abstract     Related articles   

  1017. DENG DY, Meng MV, Grossfeld GD, Stoller ML
    Simultaneous laparoscopic management of 3 urological malignancies.
    J Urol 2002; 167: 2125-6
    Abstract     Related articles   

  1018. WAMMACK R, Wricke C, Hohenfellner R
    Long-term results of ileocecal continent urinary diversion in patients treated with and without previous pelvic irradiation.
    J Urol 2002; 167: 2058-62
    Abstract     Related articles   

  1019. CHANG SS, Cookson MS, Baumgartner RG, Wells N, Smith JA Jr
    Analysis of early complications after radical cystectomy: results of a collaborative care pathway.
    J Urol 2002; 167: 2012-6
    Abstract     Related articles   

  1020. SOLSONA E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S
    Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    J Urol 2002; 167: 2007-11
    Abstract     Related articles   

  1021. HALLING KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL et al
    A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    J Urol 2002; 167: 2001-6
    Abstract     Related articles   

  1022. HOLMANG S, Johansson SL
    Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression.
    J Urol 2002; 167: 1634-7
    Abstract     Related articles   

  1023. GRONLUND-PAKKANEN S, Wahlfors J, Makinen K, Pakkanen TM, Talja M, Ala-Opas M et al
    The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
    J Urol 2002; 167: 1848-53
    Abstract     Related articles   

  1024. COLOMBO R
    Re: sexuality preserving cystectomy and neobladder: initial results.
    J Urol 2002; 167: 1803
    Abstract     Related articles   

  1025. CLARK T, Chang SS, Cookson MS
    Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
    J Urol 2002; 167: 1795
    Abstract     Related articles   

  1026. O’CONNOR RC, Hollowell CM, Laven BA, Yang XJ, Steinberg GD, Zagaja GP
    Recurrent giant cell carcinoma of the bladder.
    J Urol 2002; 167: 1784
    Abstract     Related articles   

  1027. YAP RL, Weiser A, Ozer O, Pazona J, Schaeffer A
    Adenocarcinoma arising from a defunctionalized bladder.
    J Urol 2002; 167: 1782-3
    Abstract     Related articles   

  1028. HANNA NH, Ulbright TM, Einhorn LH
    Primary choriocarcinoma of the bladder with the detection of isochromosome 12p.
    J Urol 2002; 167: 1781
    Abstract     Related articles   

  1029. SOLOWAY MS, Sofer M, Vaidya A
    Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    J Urol 2002; 167: 1573-83
    Abstract     Related articles   

  1030. JONES A, Fujiyama C, Turner K, Cranston D, Williams K, Stratford I et al
    ROLE OF THYMIDINE PHOSPHORYLASE IN AN IN VITRO MODEL OF HUMAN BLADDER CANCER INVASION.
    J Urol 2002; 167: 1482-1486
    Abstract     Related articles   

  1031. ANDREWS B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP
    PREOPERATIVE PLASMA LEVELS OF INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR PREDICT DISEASE RECURRENCE AND SURVIVAL OF PATIENTS WITH BLADDER CANCER.
    J Urol 2002; 167: 1475-1481
    Abstract     Related articles   

  1032. REIHER F, Ozer O, Pins M, Jovanovic BD, Eggener S, Campbell SC
    p53 AND MICROVESSEL DENSITY IN PRIMARY RESECTION SPECIMENS OF SUPERFICIAL BLADDER CANCER.
    J Urol 2002; 167: 1469-1474
    Abstract     Related articles   

  1033. SOULI M, Straub M, Gam X, Seguin P, De Petriconi R, Plante P et al
    A MULTICENTER STUDY OF THE MORBIDITY OF RADICAL CYSTECTOMY IN SELECT ELDERLY PATIENTS WITH BLADDER CANCER.
    J Urol 2002; 167: 1325-1328
    Abstract     Related articles   

  1034. HERR HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF
    IMPACT OF THE NUMBER OF LYMPH NODES RETRIEVED ON OUTCOME IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER.
    J Urol 2002; 167: 1295-1298
    Abstract     Related articles   

  1035. ARANHA O, Zhu L, Alhasan S, Wood DP Jr, Kuo TH, Sarkar FH
    ROLE OF MITOCHONDRIA IN CIPROFLOXACIN INDUCED APOPTOSIS IN BLADDER CANCER CELLS.
    J Urol 2002; 167: 1288-1294
    Abstract     Related articles   

  1036. NEVES M, Ciofu C, Larousserie F, Fleury J, Sibony M, Flahault A et al
    PROSPECTIVE EVALUATION OF GENETIC ABNORMALITIES AND TELOMERASE EXPRESSION IN EXFOLIATED URINARY CELLS FOR BLADDER CANCER DETECTION.
    J Urol 2002; 167: 1276-1281
    Abstract     Related articles   

  1037. ZAGAYNOVA EV, Streltsova OS, Gladkova ND, Snopova LB, Gelikonov GV, Feldchtein FI et al
    In vivo optical coherence tomography feasibility for bladder disease.
    J Urol 2002; 167: 1492-6
    Abstract     Related articles   

  1038. LOKESHWAR VB, Soloway MS
    Re: Urine based markers of urological malignancy.
    J Urol 2002; 167: 1406-7
    Abstract     Related articles   

  1039. FURUHASHI M, Suganuma N
    Recurrent bladder leiomyoma with ovarian steroid hormone receptors.
    J Urol 2002; 167: 1399-400
    Abstract     Related articles   

  1040. MEARINI E, Zucchi A, Costantini E, Fornetti P, Tiacci E, Mearini L
    Primary Burkitt’s lymphoma of bladder in patient with AIDS.
    J Urol 2002; 167: 1397-8
    Abstract     Related articles   

  1041. CHANG SS, Cookson MS, Hassan JM, Wells N, Smith JA Jr
    Routine postoperative intensive care monitoring is not necessary after radical cystectomy.
    J Urol 2002; 167: 1321-4
    Abstract     Related articles   

  1042. OGE O, Kozaci D, Gemalmaz H
    The BTA stat test is nonspecific for hematuria: an experimental hematuria model.
    J Urol 2002; 167: 1318-9
    Abstract     Related articles   

  1043. MIYAKE H, Eto H, Arakawa S, Kamidono S, Hara I
    Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    J Urol 2002; 167: 1282-7
    Abstract     Related articles   

  1044. NEULANDER EZ, Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN et al
    Re: pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    J Urol 2002; 167: 651
    Abstract     Related articles   

  1045. EHMANN UK, Terris MK
    Juxtacrine stimulation of normal and malignant human bladder epithelial cell proliferation.
    J Urol 2002; 167: 735-41
    Abstract     Related articles   

  1046. YANO A, Nakamoto T, Hashimoto K, Usui T
    Localization and expression of tissue inhibitor of metalloproteinase-1 in human urothelial cancer.
    J Urol 2002; 167: 729-34
    Abstract     Related articles   

  1047. TORTI SV, Golden-Fleet M, Willingham MC, Ma R, Cline M, Sakimoto Y et al
    Use of green fluorescent protein to measure tumor growth in an implanted bladder tumor model.
    J Urol 2002; 167: 724-8
    Abstract     Related articles   

  1048. PAISS T, Wohr G, Hautmann RE, Mattfeldt T, Muller M, Haeussler J et al
    Some tumors of the bladder are polyclonal in origin.
    J Urol 2002; 167: 718-23
    Abstract     Related articles   

  1049. NIMEH T, Kuang W, Levin HS, Klein EA
    Sarcomatoid transitional cell carcinoma of bladder managed with transurethral resection alone.
    J Urol 2002; 167: 641-2
    Abstract     Related articles   

  1050. RANKIN WR, Herman JR
    Rapidly progressive transitional cell carcinoma associated with dermatomyositis.
    J Urol 2002; 167: 639-40
    Abstract     Related articles   

  1051. FIELDING JR, Hoyte LX, Okon SA, Schreyer A, Lee J, Zou KH et al
    Tumor detection by virtual cystoscopy with color mapping of bladder wall thickness.
    J Urol 2002; 167: 559-62
    Abstract     Related articles   

  1052. ATSU N, Ekici S, Oge O O, Ergen A, Hascelik G, Ozen H
    False-positive results of the NMP22 test due to hematuria.
    J Urol 2002; 167: 555-8
    Abstract     Related articles   

  1053. NIXON RG, Chang SS, Lafleur BJ, Smith JA JA, Cookson MS
    Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.
    J Urol 2002; 167: 502-5
    Abstract     Related articles   

  1054. DAVIS JW, Sheth SI, Doviak MJ, Schellhammer PF
    Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup.
    J Urol 2002; 167: 494-500
    Abstract     Related articles   

  1055. MORALES A, Eidinger D, Bruce AW
    Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. 1976.
    J Urol 2002; 167: 891-3
    Abstract     Related articles   

  1056. HARRISON JH, Botsford TW, Tucker MR
    The use of the smear of the urinary sediment in the diagnosis and management of neoplasm of the kidney and bladder. 1951.
    J Urol 2002; 167: 864-71
    Abstract     Related articles   

  1057. SAINT F, Patard JJ, Maille P, Soyeux P, Hoznek A, Salomon L et al
    PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER.
    J Urol 2002; 167: 364-367
    Abstract     Related articles   

  1058. SORIA JC, Morat L, Durdux C, Housset M, Cortez A, Blaise R et al
    THE MOLECULAR DETECTION OF CIRCULATING TUMOR CELLS IN BLADDER CANCER USING TELOMERASE ACTIVITY.
    J Urol 2002; 167: 352-356
    Abstract     Related articles   

  1059. BOHLE A, Jurczok A, Ardelt P, Wulf T, Ulmer AJ, Jocham D et al
    Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo.
    J Urol 2002; 167: 357-63
    Abstract     Related articles   

  1060. UEDA T, Tamaki M, Ogawa O, Yoshimura N
    Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma.
    J Urol 2002; 167: 347-51
    Abstract     Related articles   

  1061. MATLAGA BR, Veys JA, Thacker CC, Assimos DG
    Prostate abscess following intravesical bacillus Calmette-Guerin treatment.
    J Urol 2002; 167: 251
    Abstract     Related articles   

  1062. TAVOLINI IM, Gardiman M, Benedetto G, Bassi P
    Unmanageable fever and granulomatous renal mass after intracavitary upper urinary tract bacillus Calmette-Guerin therapy.
    J Urol 2002; 167: 244-5
    Abstract     Related articles   

  1063. CHANG SS, Baumgartner RG, Wells N, Cookson MS, Smith JA Jr
    Causes of increased hospital stay after radical cystectomy in a clinical pathway setting.
    J Urol 2002; 167: 208-11
    Abstract     Related articles   

  1064. BOMAN H, Hedelin H, Holmang S
    Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
    J Urol 2002; 167: 80-3
    Abstract     Related articles   

  1065. LOTAN Y, Roehrborn CG
    Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.
    J Urol 2002; 167: 75-9
    Abstract     Related articles   

  1066. GARCIA-FERNANDEZ MO, Solano RM, Sanchez-Chapado M, Ruiz-Villaespesa A, Prieto JC, Carmena MJ
    Low expression of Galpha protein subunits in human prostate cancer.
    J Urol 2001; 166: 2512-7
    Abstract     Related articles   

  1067. TAKAHASHI T, Kushiro A, Nomoto K, Uchida K, Morotomi M, Yokokura T et al
    Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2.
    J Urol 2001; 166: 2506-11
    Abstract     Related articles   

  1068. LI D, Gan Y, Wientjes MG, Badalament RA, Au JL
    Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors.
    J Urol 2001; 166: 2500-5
    Abstract     Related articles   

  1069. DUVDEVANI M, Nass D, Neumann Y, Leibovitch I, Ramon J, Mor Y
    Pure rhabdoid tumor of the bladder.
    J Urol 2001; 166: 2337
    Abstract     Related articles   

  1070. BOCHNER BH, Herr HW, Reuter VE
    Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.
    J Urol 2001; 166: 2295-6
    Abstract     Related articles   

  1071. TIGUERT R, Bianco FJ Jr, Oskanian P, Li Y, Grignon DJ, Wood DP Jr et al
    Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.
    J Urol 2001; 166: 2155-60
    Abstract     Related articles   

  1072. SAITO S
    Transurethral en bloc resection of bladder tumors.
    J Urol 2001; 166: 2148-50
    Abstract     Related articles   

  1073. LAGUNA MP, de la Rosette JJ
    The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor.
    J Urol 2001; 166: 2017-22
    Abstract     Related articles   

  1074. SINDHWANI P, Hampton JA, Baig MM, Keck R, Selman SH
    Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.
    J Urol 2001; 166: 1498-501
    Abstract     Related articles   

  1075. EGGENER SE, Hairston J, Rubenstein JN, Gonzalez CM
    Bladder lipoma.
    J Urol 2001; 166: 1395
    Abstract     Related articles   

  1076. GIESSING M, Turk I, Schoenberger B, Loening SA
    Orthotopic neobladder after kidney transplantation in a male patient with recurring urothelial carcinoma and renal cancer.
    J Urol 2001; 166: 1383
    Abstract     Related articles   

  1077. SMITH E, Yoon J, Theodorescu D
    Evaluation of urinary continence and voiding function: early results in men with neo-urethral modification of the Hautmann orthotopic neobladder.
    J Urol 2001; 166: 1346-9
    Abstract     Related articles   

  1078. HERR HW, Sogani PC
    Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
    J Urol 2001; 166: 1296-9
    Abstract     Related articles   

  1079. HU YC, Sidransky D, Ahrendt SA
    Molecular detection approaches for smoking associated tumors.
    Oncogene 2002; 21: 7289-97
    Abstract     Related articles   

  1080. DANAEE H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T et al
    Microsatellite instability at tetranucleotide repeats in skin and bladder cancer.
    Oncogene 2002; 21: 4894-9
    Abstract     Related articles   

  1081. SIMON R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H et al
    Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.
    Oncogene 2002; 21: 2476-83
    Abstract     Related articles   

  1082. BOYER B, Bourgeois Y, Poupon MF
    Src kinase contributes to the metastatic spread of carcinoma cells.
    Oncogene 2002; 21: 2347-56
    Abstract     Related articles   

  1083. KRUTOVSKIKH VA, Piccoli C, Yamasaki H
    Gap junction intercellular communication propagates cell death in cancerous cells.
    Oncogene 2002; 21: 1989-99
    Abstract     Related articles   

  1084. MULLER M
    Telomerase: its clinical relevance in the diagnosis of bladder cancer.
    Oncogene 2002; 21: 650-5
    Abstract     Related articles   

  1085. PRIMDAHL H, von der Maase H, Christensen M, Wolf H, Orntoft TF
    Allelic deletions of Rb and L-myc in urine sediments from patients with bladder tumors or carcinoma in situ.
    Oncol Rep 2002; 9: 551-5
    Abstract     Related articles   

  1086. MIZUTANI Y, Wada H, Yoshida O, Fukushima M, Bonavida B, Kawauchi A et al
    Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.
    Oncol Rep 2002; 9: 289-92
    Abstract     Related articles   

  1087. MATSUSHIMA H, Kawabe K, Fujime M, Kitamura T, Homma Y, Kishi H et al
    Treatment of patients with superficial bladder cancer by intravesical instillation of anticancer drugs plus oral chemotherapy following TUR- Bt: A randomized controlled trial.
    Oncol Rep 2002; 9: 283-8
    Abstract     Related articles   

  1088. UCHIDA T, Minei S, Gao JP, Wang C, Satoh T, Baba S
    Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
    Oncol Rep 2002; 9: 253-9
    Abstract     Related articles   

  1089. JEON SH, Lee SJ, Chang SG
    Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors.
    Oncol Rep 2001; 8: 1265-7
    Abstract     Related articles   

  1090. LACROIX B, Rusch P, Cerisier A, Pages A, Armand C, Tostain J
    [Prognostic factors of invasive bladder cancer with lymph node invasion]
    Prog Urol 2002; 12: 615-20.
    Abstract     Related articles   

  1091. CLIPPE C, Clippe S, Yzebe D, Flechon A, Droz JP
    [Bladder cancer chemotherapy practice study]
    Prog Urol 2002; 12: 609-14.
    Abstract     Related articles   

  1092. DEBOIS H, Loupi E, Saliou P
    [Surveillance of the safety of intravesical BCG therapy in France: quantitative analysis of serious adverse events notified over a period of five years]
    Prog Urol 2002; 12: 604-8.
    Abstract     Related articles   

  1093. SAIDI R, Lefi M, Touffahi M, Farhane S, Saad H
    [Leiomyoma of the urinary bladder]
    Prog Urol 2002; 12: 493-6
    Abstract     Related articles   

  1094. MONDET F, Chartier-Kastler E, Yonneau L, Bohin D, Barrou B, Richard F
    [Epidemiology of urological emergencies in a teaching hospital]
    Prog Urol 2002; 12: 437-42
    Abstract     Related articles   

  1095. BENCHEKROUN A, Zannoud M, Nouini Y, Bernoussi Z, Kamouni M, Faik M
    [Pseudo-tumoral colic metaplasia of the urinary bladder]
    Prog Urol 2002; 12: 325-8
    Abstract     Related articles   

  1096. DE LA TAILLE A, Thiounn N, Tissier F, Vieillefond A, Flam T, Zerbib M et al
    [Fibromyxoid tumor of the bladder: report of 3 cases]
    Prog Urol 2002; 12: 321-4
    Abstract     Related articles   

  1097. GASTAUD O, Demailly M, Guilbert E, Colombat M, Petit J
    [Lympho-epithelioma of the bladder. Discussion of pathogenesis]
    Prog Urol 2002; 12: 318-20
    Abstract     Related articles   

  1098. EL SANDID M, Peraldi R, Pernin F
    [Linitis plastica type of primary signet cell adenocarcinoma of the bladder]
    Prog Urol 2002; 12: 313-7
    Abstract     Related articles   

  1099. GAME X, Soulie M, Fontanilles AM, Benoit JM, Corberand JX, Plante P
    [Can urinary corpuscular volume using automated hematology contribute the diagnostic etiology of hematuric microscopy?]
    Prog Urol 2002; 12: 248-52
    Abstract     Related articles   

  1100. RIGAUD J, Karam G, Braud G, Glemain P, Buzelin JM, Bouchot O
    [T1 bladder tumors: value of a second endoscopic resection]
    Prog Urol 2002; 12: 27-30.
    Abstract     Related articles   

  1101. BONNAL JL
    [Practical impact of pharmacologic and clinical data on early post-operative instillation of mitomycin C]
    Prog Urol 2002; 12: 118-23.
    Abstract     Related articles   

  1102. ZINI L, Amara N, Graziana JP, Villers A, Biserte J, Mazeman E
    [Klippel-Trenaunay syndrome and multiple vesical hemangiomas: treatment with Neodymium:YAG laser]
    Prog Urol 2001; 11: 1282-4
    Abstract     Related articles   

  1103. SAINT F, Irani J, Salomon L, Legrand P, Abbou CC, Chopin D
    [Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with endovesical BCG, for the prophylaxis of superficial bladder tumors]
    Prog Urol 2001; 11: 1242-50
    Abstract     Related articles   


  1104. [Superficial bladder tumors. Report of the 2001 Congress of the French Association of Urology]
    Prog Urol 2001; 11: 785-1190
    Abstract     Related articles   

  1105. GATTEGNO B, Chopin D
    [Diagnosis of superficial bladder tumors]
    Prog Urol 2001; 11: 993-1019
    Abstract     Related articles   

  1106. GATTEGNO B, Chopin D
    [Natural history of superficial bladder tumors]
    Prog Urol 2001; 11: 963-90
    Abstract     Related articles   

  1107. CHOPIN D, Gattegno B
    [Descriptive epidemiology of superficial bladder tumors]
    Prog Urol 2001; 11: 955-60
    Abstract     Related articles   

  1108. CHOPIN D, Vordos D, Gattegno B
    [Etiologies of superficial bladder tumors]
    Prog Urol 2001; 11: 927-52
    Abstract     Related articles   

  1109. FONTANIERE B, Ranchere-Vince D, Landry JL, Colombel M, Chopin D, Gattegno B
    [Quality criteria in urinary cytology for tumor diagnosis]
    Prog Urol 2001; 11: 867-75
    Abstract     Related articles   

  1110. BILLEREY C, Sibony M, Gattegno B, Chopin D
    [Pathologic anatomy of superficial tumors of the bladder]
    Prog Urol 2001; 11: 805-63
    Abstract     Related articles   

  1111. GATTEGNO B, Ciofu C, Chopin D
    [Survey on superficial bladder tumors with members of the French Association of Urology]
    Prog Urol 2001; 11: 1177-90
    Abstract     Related articles   

  1112. GATTEGNO B, Chopin D
    [Management of superficial bladder tumors]
    Prog Urol 2001; 11: 1161-74
    Abstract     Related articles   

  1113. GATTEGNO B, Chopin D
    [Surveillance of superficial bladder tumors]
    Prog Urol 2001; 11: 1151-7
    Abstract     Related articles   

  1114. GATTEGNO B, Chopin D
    [Bladder diverticulum and superficial bladder tumors]
    Prog Urol 2001; 11: 1145-8
    Abstract     Related articles   

  1115. GATTEGNO B, Chopin D
    [Cystectomy for superficial bladder tumors]
    Prog Urol 2001; 11: 1127-41
    Abstract     Related articles   

  1116. GATTEGNO B, Chopin D
    [Photodynamic therapy for superficial bladder tumors]
    Prog Urol 2001; 11: 1119-24
    Abstract     Related articles   

  1117. CHOPIN D, Saint F, Gattegno B
    [Endovesical immunotherapy: Calmette-Guerin bacillus]
    Prog Urol 2001; 11: 1067-115
    Abstract     Related articles   

  1118. CHOPIN D, Gattegno B
    [Endovesical chemotherapy for superficial bladder tumors]
    Prog Urol 2001; 11: 1047-64
    Abstract     Related articles   

  1119. GATTEGNO B, Chopin D
    [Assessment of loco-regional extension of superficial bladder tumors]
    Prog Urol 2001; 11: 1033-44
    Abstract     Related articles   

  1120. GATTEGNO B, Chopin D
    [Endoscopic diagnosis and treatment of superficial bladder tumors]
    Prog Urol 2001; 11: 1023-30
    Abstract     Related articles   

  1121. PFISTER C
    [Re: "Usefulness of p53 in the clinical management of bladder tumors", by S. Bernardini, E. Chabannes, H. Bittard. Prog. Urol., (2001), 11, 201-208]
    Prog Urol 2001; 11: 761
    Abstract     Related articles   

  1122. PALASCAK R, Game X, Milcent S, Camparo P, Berlizot P, Houlgatte A
    [Verrucous epidermoid carcinoma of the bladder unrelated to schistosomiasis]
    Prog Urol 2001; 11: 695-9
    Abstract     Related articles   

  1123. SAINT F, Irani J, Salomon L, Debois H, Abbou CC, Chopin D
    [Tolerance and efficiency of intravesical instillation of Calmette- Guerin in the prophylactic treatment of superficial bladder tumors, using a maintenance treatment]
    Prog Urol 2001; 11: 647-56
    Abstract     Related articles   

  1124. LACHAND AT, Texier J, Texier P
    [Surveillance and prognosis of "T1" superficial tumors of the bladder. Homogeneous series of 88 cases followed for 1 to 22 years]
    Prog Urol 2001; 11: 472-7
    Abstract     Related articles   

  1125. LACHAND AT, Texier J, Texier P
    [Surveillance and prognosis of "Ta" superficial tumors of the bladder. Homogeneous series of 138 cases followed for 1 to 18 years]
    Prog Urol 2001; 11: 466-71
    Abstract     Related articles   

  1126. CHABANNES E, Bernardini S, Wallerand H, Bittard H
    [Angiogenesis in bladder: prognosis indicator and therapeutic target]
    Prog Urol 2001; 11: 417-27
    Abstract     Related articles   

  1127. TURKOLMEZ K, Baltaci S, Beduk Y, Muftuoglu YZ, Gogus O
    DNA ploidy and S-phase fraction as predictive factors of response and outcome following neoadjuvant methotrexate, vinblastine, epirubicin and cisplatin (M-VEC) chemotherapy for invasive bladder cancer.
    Scand J Urol Nephrol 2002; 36: 46-51
    Abstract     Related articles   

  1128. EL-ABBADY AA, Shoukry MS, Hanno AG, Younis LK, Abdel-Rahman M
    Repeated transurethral resection of recurrent superficial bladder tumors--does it affect the spread and stage of the tumor?
    Scand J Urol Nephrol 2002; 36: 60-4
    Abstract     Related articles   

  1129. ZIEGER K, Olsen PR, Wolf H, Hojgaard K
    Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia--recurrence and progression.
    Scand J Urol Nephrol 2002; 36: 52-9
    Abstract     Related articles   

  1130. ZARGOOSHI J
    Psoas abscess as the initial presentation of bladder cancer.
    Scand J Urol Nephrol 2002; 36: 154-5
    Abstract     Related articles   

  1131. STAVROPOULOS NE, Hastazeris K, Filiadis I, Mihailidis I, Ioachim E, Liamis Z et al
    Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer.
    Scand J Urol Nephrol 2002; 36: 218-22
    Abstract     Related articles   

  1132. RAITANEN MP, Aine RA, Kaasinen ES, Liukkonen TJ, Kylmala TM, Huhtala H et al
    Suspicious Urine Cytology (Class III) in Patients with Bladder Cancer: Should it be Considered as Negative or Positive?
    Scand J Urol Nephrol 2002; 36: 213-7
    Abstract     Related articles   

  1133. HUANG HY, Chen WJ, Sung MT, Huang CC
    Atypical leiomyoma of the urinary bladder--a rare tumor occurring in a young female with concurrent breast carcinoma--an influence of sex steroid hormone?
    Scand J Urol Nephrol 2002; 36: 231-3
    Abstract     Related articles   

  1134. RIZK DE, Raaschou T, Mason N, Berg B
    Evidence of progesterone receptors in the mucosa of the urinary bladder.
    Scand J Urol Nephrol 2001; 35: 305-9
    Abstract     Related articles   

  1135. OLSSON H, Zackrisson B
    ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma.
    Scand J Urol Nephrol 2001; 35: 280-2
    Abstract     Related articles   

  1136. BILLIS A, Carvalho RB, Mattos AC, Negretti F, Nogueira CR, Oliveira MC et al
    Tumor grade heterogeneity in urothelial bladder carcinoma--proposal of a system using combined numbers.
    Scand J Urol Nephrol 2001; 35: 275-9
    Abstract     Related articles   

  1137. MOTTA L, Porcaro AB, Ficarra V, D’Amico A, Piubello Q, Comunale L
    Leiomyosarcoma of the bladder fourteen years after cyclophosphamide therapy for retinoblastoma.
    Scand J Urol Nephrol 2001; 35: 248-9
    Abstract     Related articles   

  1138. HOLMANG S, Johansson SL
    The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis.
    Scand J Urol Nephrol 2001; 35: 102-5
    Abstract     Related articles   

  1139. MOYAD MA
    An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Semin Urol Oncol 2001; 19: 306-16
    Abstract     Related articles   

  1140. MOULDER SL, Roth BJ
    Systemic chemotherapy for urothelial transitional cell carcinoma: an overview of toxicity.
    Semin Urol Oncol 2001; 19: 194-201
    Abstract     Related articles   

  1141. BOGDANOVIC J, Marusic G, Djozic J, Sekulic V V, Budakov P, Dejanovic N et al
    The Management of T1G3 Bladder Cancer.
    Urol Int 2002; 69: 263-265
    Abstract     Related articles   

  1142. ACIKBAS I, Keser I, Kilic S, Bagci H, Karpuzoglu G, Luleci G
    Detection of LOH of the RB1 Gene in Bladder Cancers by PCR-RFLP.
    Urol Int 2002; 68: 189-92
    Abstract     Related articles   

  1143. TORABI-POUR N, Nouri AM, Saffie R, Oliver RT
    Comparative Study of Peptides Isolated from Class I Antigen Groove of Urological Specimens. a further step toward the future of peptide therapy in bladder cancer patients.
    Urol Int 2002; 68: 183-188
    Abstract     Related articles   

  1144. IIZUMI T, Hariu K, Sato M, Sato S, Shimizu H, Tomomasa H et al
    Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase in Bladder Cancer.
    Urol Int 2002; 68: 122-125
    Abstract     Related articles   

  1145. TORABI-POUR N, Nouri AM, Saffie R, Oliver RT
    Comparative study between direct mild acid extraction and immunobead purification technique for isolation of HLA class I-associated peptides.
    Urol Int 2002; 68: 38-43
    Abstract     Related articles   

  1146. BEARDO P, Manasia P, Corral JM, Truan D, Alcover JB, Micali F
    Rare secondary carcinoma from bladder to testis.
    Urol Int 2002; 68: 204-5
    Abstract     Related articles   

  1147. NISHIYAMA T, Terunuma M, Takeda M, Katayama Y
    Renography as a measure of renal and neobladder function in patients with ileal bladder substitution.
    Urol Int 2002; 68: 168-71
    Abstract     Related articles   

  1148. OHASHI Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N et al
    Habitual intake of lactic Acid bacteria and risk reduction of bladder cancer.
    Urol Int 2002; 68: 273-80
    Abstract     Related articles   

  1149. BASSI PF, Spinadin R, Longo F, Saraeb S, Pappagallo GL, Zattoni F et al
    Delayed High-Dose Intravesical Epirubicin Therapy of Superficial Bladder Cancer. a way to reduce the side effects and increase the efficacy - a phase 2 trial.
    Urol Int 2002; 68: 216-9
    Abstract     Related articles   

  1150. ZAAK D, Hofstetter A
    The current diagnosis of superficial bladder cancer must be reconsidered.
    Urol Int 2002; 69: 85-90
    Abstract     Related articles   

  1151. YANG CC, Chu KC, Chen HY, Chen WC
    Expression of p16 and Cyclin D1 in Bladder Cancer and Correlation in Cancer Progression.
    Urol Int 2002; 69: 190-4
    Abstract     Related articles   

  1152. KALAFATIS P, Kavantzas N, Pavlopoulos PM, Agapitos E, Politou M, Kranides A
    Malignant peripheral nerve sheath tumor of the urinary bladder in von Recklinghausen disease.
    Urol Int 2002; 69: 156-9
    Abstract     Related articles   

  1153. CAPPELLO F, Aragona F, Serretta V, Randazzo G, Melloni D
    Sarcomatoid carcinoma of urinary bladder: immunohistochemical study of an uncommon case.
    Urol Int 2002; 69: 141-4
    Abstract     Related articles   

  1154. YU DS, Chen HI, Chang SY
    Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
    Urol Int 2002; 69: 129-35
    Abstract     Related articles   

  1155. DOMINICI A, Nesi G, Mondaini N, Amorosi A, Rizzo M
    Skin involvement from micropapillary bladder carcinoma as the first clinical manifestation of metastatic disease.
    Urol Int 2001; 67: 173-4
    Abstract     Related articles   

  1156. KOGA F, Nagamatsu H, Ishimaru H, Mizuo T, Yoshida K
    Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract.
    Urol Int 2001; 67: 135-41
    Abstract     Related articles   

  1157. ASCI R, Yildiz L, Sarikaya S, Buyukalpelli R, Yilmaz AF, Kandemir B
    p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder.
    Urol Int 2001; 67: 34-40
    Abstract     Related articles   

  1158. WATTERS AD, Stacey MW, Going JJ, Grigor KM, Cooke TG, Sim E et al
    Genetic aberrations of NAT2 and chromosome 8: their association with progression in transitional cell carcinoma of the urinary bladder.
    Urol Int 2001; 67: 235-9
    Abstract     Related articles   

  1159. IORI F, De Dominicis C, Liberti M, Frioni D, Vahedi M, Leonardo C et al
    Superficial bladder tumors in patients under 40 years of age: clinical, prognostic and cytogenetic aspects.
    Urol Int 2001; 67: 224-7
    Abstract     Related articles   

  1160. BASSI P, Iafrate M, Longo F, Iannello A, Mostaccio G, Ingrassia A et al
    Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract. A review of the literature.
    Urol Int 2001; 67: 189-94
    Abstract     Related articles   

  1161. GIANNOPOULOU I, Nakopoulou L, Zervas A, Lazaris AC, Stravodimos C, Giannopoulos A et al
    Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications.
    Urol Res 2002; 30: 342-5
    Abstract     Related articles   

  1162. YUAN SY, Hsu SL, Tsai KJ, Yang CR
    Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells.
    Urol Res 2002; 30: 282-8
    Abstract     Related articles   

  1163. SHINOHARA N, Koyanagi T
    Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
    Urol Res 2002; 30: 273-81
    Abstract     Related articles   

  1164. SUTTMANN H, Jocham D, Bohle A, Brandau S
    The role of LFA-1 in the lysis of bladder cancer cells by bacillus Calmette-Guerin and interleukin 2-activated killer cells.
    Urol Res 2002; 30: 233-9
    Abstract     Related articles   

  1165. DUGGAN BJ, Gray S, Johnston SR, Williamson K, Miyaki H, Gleave M
    The role of antisense oligonucleotides in the treatment of bladder cancer.
    Urol Res 2002; 30: 137-47
    Abstract     Related articles   

  1166. NOMURA T, Yamamoto H, Mimata H, Shitashige M, Shibasaki F, Miyamoto E et al
    Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells.
    Urol Res 2002; 30: 102-11
    Abstract     Related articles   

  1167. CROOK TJ, Dyer JP, McCormick RI, Birch BR, Cooper AJ
    The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer.
    Urol Res 2002; 30: 59-65
    Abstract     Related articles   

  1168. TSAI FJ, Lu HF, Yeh LS, Hsu CD, Chen WC
    Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients.
    Urol Res 2001; 29: 412-6
    Abstract     Related articles   

  1169. JICHLINSKI P, Leisinger HJ
    Photodynamic therapy in superficial bladder cancer: past, present and future.
    Urol Res 2001; 29: 396-405
    Abstract     Related articles   

  1170. TORUNER GA, Ucar A, Tez M, Cetinkaya M, Ozen H, Ozcelik T
    P53 codon 72 polymorphism in bladder cancer--no evidence of association with increased risk or invasiveness.
    Urol Res 2001; 29: 393-5
    Abstract     Related articles   

  1171. YANG CC, Chung JG
    Sulindac inhibited gene expression and activity of arylamine N- acetyltransferase and DNA-2-aminofluorene adduct formation in T24 human bladder tumor cells.
    Urol Res 2001; 29: 406-11
    Abstract     Related articles   

  1172. GONTERO P, Tizzani A, Muir GH, Caldarera E, Macaluso MP
    The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value.
    Urol Res 2001; 29: 377-87
    Abstract     Related articles   

  1173. LIN SS, Hung CF, Tyan YS, Yang CC, Hsia TC, Yang MD et al
    Ellagic [correction of ellagica] acid inhibits arylamine N- acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).
    Urol Res 2001; 29: 371-6
    Abstract     Related articles   

  1174. YANG WH, Liebert M, Price RE, Cromeens DM, Lin JS, Grossman HB
    Extravesical cryosurgical approach for VX2 bladder tumor in rabbits.
    Urol Res 2001; 29: 345-9
    Abstract     Related articles   

  1175. SAIKAWA S, Kanamura H, Noriki S, Matsukawa S, Okada K
    The effects of organ resection on rat urinary bladder carcinogenesis.
    Urol Res 2001; 29: 210-5
    Abstract     Related articles   

  1176. ZAAK D, Stepp H, Baumgartner R, Schneede P, Waidelich R, Frimberger D et al
    Ultraviolet-excited (308 nm) autofluorescence for bladder cancer detection.
    Urology 2002; 60: 1029-33.
    Abstract     Related articles   

  1177. KIM WJ, Kim H, Kim CH, Lee MS, Oh BR, Lee HM et al
    GSTT1-null genotype is a protective factor against bladder cancer.
    Urology 2002; 60: 913-8
    Abstract     Related articles   

  1178. DALBAGNI G, Herr HW, Reuter VE
    Impact of a second transurethral resection on the staging of T1 bladder cancer.
    Urology 2002; 60: 822-4
    Abstract     Related articles   

  1179. KIM SI, Kwon SM, Kim YS, Hong SJ
    Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer.
    Urology 2002; 60: 816-21
    Abstract     Related articles   

  1180. SACHS M, Rauen K, Ramamurthy M, Dodson J, De Marzo A, Putzi M et al
    Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
    Urology 2002; 60: 531
    Abstract     Related articles   

  1181. PU YS, Hour TC, Chen J, Huang CY, Guan JY, Lu SH
    Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Urology 2002; 60: 346-50
    Abstract     Related articles   

  1182. AKI H, Baslar Z, Uygun N, Ozguroglu M, Tuzuner N
    Primary granulocytic sarcoma of the urinary bladder: case report and review of the literature.
    Urology 2002; 60: 345
    Abstract     Related articles   

  1183. SAMARATUNGA H, Makarov DV, Epstein JI
    Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.
    Urology 2002; 60: 315-9
    Abstract     Related articles   

  1184. DASH A, Sanda MG, Yu M, Taylor JM, Fecko A, Rubin MA
    Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on Cancer.
    Urology 2002; 60: 276-80
    Abstract     Related articles   

  1185. NICKEL JC, Ardern D, Downey J
    Cytologic evaluation of urine is important in evaluation of chronic prostatitis.
    Urology 2002; 60: 225-7
    Abstract     Related articles   

  1186. SHIPLEY WU, Kaufman DS, Zehr E, Heney NM, Lane SC, Thakral HK et al
    Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.
    Urology 2002; 60: 62-7
    Abstract     Related articles   

  1187. CHIU AW, Huang YL, Huan SK, Wang YC, Ju JP, Chen MF et al
    Potential molecular marker for detecting transitional cell carcinoma.
    Urology 2002; 60: 181-5
    Abstract     Related articles   

  1188. PAREKH DJ, Jung C, O’Conner J, Dutta S, Smith ER Jr
    Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.
    Urology 2002; 60: 164
    Abstract     Related articles   

  1189. MERAJ S, Narasimhan G, Gerber E, Nagler HM
    Bladder wall lipoma.
    Urology 2002; 60: 164
    Abstract     Related articles   

  1190. SULMAN A, Goldman H
    Malacoplakia presenting as a large bladder mass.
    Urology 2002; 60: 163
    Abstract     Related articles   

  1191. ELSOBKY E, El-Baz M, Gomha M, Abol-Enein H, Shaaban AA
    Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder.
    Urology 2002; 60: 69-73
    Abstract     Related articles   

  1192. SO A, Hickey L, Norman R
    Late ureteral conduit urinary leak as a presentation of urothelial carcinoma of the ureter.
    Urology 2002; 59: 946
    Abstract     Related articles   

  1193. XIA G, Kageyama Y, Hayashi T, Hyochi N, Kawakami S, Kihara K
    Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer.
    Urology 2002; 59: 774-8
    Abstract     Related articles   

  1194. YANG MH, Chen KK, Yen CC, Wang WS, Chang YH, Huang WJ et al
    Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan.
    Urology 2002; 59: 681-7
    Abstract     Related articles   

  1195. SOLOWAY MS
    Progression and survival in patients with T1G3 bladder tumors.
    Urology 2002; 59: 631
    Abstract     Related articles   

  1196. HIRANO Y, Suzuki K, Fujita K, Furuse H, Fukuta K, Kitagawa M et al
    Primary signet ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone.
    Urology 2002; 59: 601
    Abstract     Related articles   

  1197. IORI F, Di Seri M, De Nunzio C, Leonardo C, Franco G, Spalletta B et al
    Long-term maintenance bacille Calmette-Guerin therapy in high-grade superficial bladder cancer.
    Urology 2002; 59: 414-8
    Abstract     Related articles   

  1198. PEYROMAURE M, Weibing S, Sebe P, Verpillat P, Toublanc M, Dauge MC et al
    Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy.
    Urology 2002; 59: 409-13
    Abstract     Related articles   

  1199. SCHOENBERG MP
    Bladder cancer: current diagnosis and treatment. edited by Michael J. Droller Humana Press, Totowa, New Jersey, 2001, $135.00, ISBN 0-896- 03818-1.
    Urology 2002; 59: 313
    Abstract     Related articles   

  1200. SCHIPS L, Augustin H, Zigeuner RE, Galle’ G, Habermann H, Trummer H et al
    Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?
    Urology 2002; 59: 220-223
    Abstract     Related articles   

  1201. STAACK A, Koenig F, Daniltchenko D, Hauptmann S, Loening SA, Schnorr D et al
    Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder.
    Urology 2002; 59: 308-12
    Abstract     Related articles   

  1202. PANNEK J
    Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?
    Urology 2002; 59: 240-4
    Abstract     Related articles   

  1203. YANG MH, Yen CC, Chen PM, Wang WS, Chang YH, Huang WJ et al
    Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan.
    Urology 2002; 59: 232-8
    Abstract     Related articles   

  1204. PANSADORO V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN
    Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience.
    Urology 2002; 59: 227-31
    Abstract     Related articles   

  1205. SKEMP NM, Fernandes ET
    Routine bladder biopsy after bacille Calmette-Guerin treatment: is it necessary?
    Urology 2002; 59: 224-6
    Abstract     Related articles   

  1206. PYTEL A, Schmeller N
    New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology.
    Urology 2002; 59: 216-9
    Abstract     Related articles   

  1207. IRIE A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S
    Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.
    Urology 2002; 59: 53-7
    Abstract     Related articles   

  1208. MIYAKE H, Gleave M, Kamidono S, Hara I
    Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence.
    Urology 2002; 59: 150-4
    Abstract     Related articles   

  1209. FELDMAN PA, Madeb R, Naroditsky I, Halachmi S, Nativ O
    Metastatic breast cancer to the bladder: a diagnostic challenge and review of the literature.
    Urology 2002; 59: 138
    Abstract     Related articles   

  1210. DENNERY MP, Rushton HG, Belman AB
    Sonography for the detection and follow-up of primary nonsarcomatous bladder tumors in children.
    Urology 2002; 59: 119-21
    Abstract     Related articles   

  1211. HISATAKI T, Miyao N, Masumori N, Takahashi A, Yanase M, Itoh N et al
    Risk factors for multiple intravesical recurrences of superficial bladder cancer.
    Urology 2001; 58: 935-939
    Abstract     Related articles   

  1212. ISHII T, Okadome A, Takeuchi F, Hiratsuka Y
    Urinary levels of nuclear matrix protein 22 in patients with urinary diversion.
    Urology 2001; 58: 940-2
    Abstract     Related articles   

  1213. TEKIN MI, Aytekin C, Aygun C, PeSkircioglu L, Boyvat F, Ozkardes H
    Covered metallic ureteral stent in the management of malignant ureteral obstruction: preliminary results.
    Urology 2001; 58: 919-23
    Abstract     Related articles   

  1214. MYDLO JH, Gerstein M
    Patients with urologic cancer and other nonurologic malignancies: analysis of a sample and review of the literature.
    Urology 2001; 58: 864-9
    Abstract     Related articles   

  1215. FROEHNER M, Gaertner HJ, Manseck A, Wirth MP
    Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man.
    Urology 2001; 58: 799
    Abstract     Related articles   

  1216. DE DOMINICIS C, Iori F, De Nunzio C, Peris F, Di Crosta G, Leonardo C et al
    Technical modification of Mainz pouch II urinary diversion: preliminary experience.
    Urology 2001; 58: 777-8
    Abstract     Related articles   

  1217. DELIVELIOTIS C, Alargoff E, Skolarikos A, Varkarakis I, Argyropoulos V, Dimopoulos C
    Modified ileal neobladder for continent urinary diversion: experience and results.
    Urology 2001; 58: 712-6
    Abstract     Related articles   

  1218. SOULIE M, Seguin P, Mouly P, Thoulouzan M, Pontonnier F, Plante P
    Assessment of morbidity and functional results in bladder replacement with Hautmann ileal neobladder after radical cystectomy: a clinical experience in 55 highly selected patients.
    Urology 2001; 58: 707-11
    Abstract     Related articles   

  1219. KIM HL, Steinberg GD
    Complications of cystectomy in patients with a history of pelvic radiation.
    Urology 2001; 58: 557-60
    Abstract     Related articles   

  1220. PATARD J, Moudouni S, Saint F, Rioux-Leclercq N, Manunta A, Guy L et al
    Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years.
    Urology 2001; 58: 551-6
    Abstract     Related articles   

  1221. KAWAKAMI S, Kageyama Y, Yonese J, Fukui I, Kitahara S, Arai G et al
    Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival.
    Urology 2001; 58: 462
    Abstract     Related articles   

  1222. ZIETMAN AL, Grocela J, Zehr E, Kaufman DS, Young RH, Althausen AF et al
    Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Urology 2001; 58: 380-5
    Abstract     Related articles   

  1223. FRIMBERGER D, Zaak D, Stepp H, Knuchel R, Baumgartner R, Schneede P et al
    Autofluorescence imaging to optimize 5-ALA-induced fluorescence endoscopy of bladder carcinoma.
    Urology 2001; 58: 372-5
    Abstract     Related articles   

  1224. CHANG BS, Kim HL, Yang XJ, Steinberg GD
    Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
    Urology 2001; 57: 1063-6
    Abstract     Related articles   

Thank you for your interest in scientific medicine.


Thank you for your interest in scientific medicine.


Design:


;